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Abstract 
 
The thesis aims to improve treatment dose accuracy in brachytherapy using a high dose 
rate (HDR) Ir-192 stepping source and in external beam therapy using intensity 
modulated radiation therapy (IMRT). For HDR brachytherapy, this has been achieved by 
investigating dose errors in the near field and the transit dose of the HDR brachytherapy 
stepping source. For IMRT, this study investigates the volume effect of detectors in the 
dosimetry of small fields, and the clinical implementation and dosimetric verification of a 
6MV photon beam for IMRT. 
 
For the study of dose errors in the near field of an HDR brachytherapy stepping source, 
the dose rate at point P at 0.25 cm in water from the transverse bisector of a straight 
catheter with an active stepping source (Nucletron microSelectron HDR source) dwell 
length of 2 cm was calculated with Monte Carlo code MCNP 4.A. The source step sizes 
were 1 cm and 0.25 cm. The Monte Carlo (MC) results were used to compare with the 
results calculated with the Nucletron Brachytherapy Planning System (BPS) formalism, 
first with BPS variants and then with its respective MC calculated radial dose function 
and anisotropy function. The dose difference at point P calculated by BPS formalism and 
variants is +15.4% and +3.1% for the source step size of 1 cm and 0.25 cm respectively. 
This reduction of dose difference is caused by the increased importance of errors in the 
anisotropy function with the smaller step size, which counter the errors in the radial dose 
function. Using the MC calculated radial dose function and anisotropy function with the 
BPS formalism, 1% dose calculation accuracy can be achieved even in the near field with 
negligible extra demand on computation time. 
 
 iv
For the transit dose study in HDR brachytherapy, a video method was used to analyse the 
entrance, exit and the inter-dwell transit speed of the source for different path lengths and 
step sizes ranging from 2.5 mm to 995 mm. The transit speed was found to vary with the 
step size and path length. For the travelled distances of 2.5, 5.0, 10.0, 230 and 995 mm, 
the average transit speeds were 54, 72, 233, 385 and 467 mm/s respectively. The results 
also show that the manufacturer has attempted to compensate for the effects of inter-dwell 
transit dose by reducing the actual dwell time of the source. A well-type chamber was 
used to determine the dose differences between two sets of measurements, one being the 
stationary dose only and the other being the sum of stationary and transit doses. Single 
catheters of active lengths of 20 and 40 mm, different dwell times of 0.5, 1, 2 and 5 s and 
different step sizes of 2.5, 5 and 10 mm were used in the measurements with the well-type 
chamber. Most of the measured dose differences between stationary and stationary plus 
inter-dwell source movement were within 2%. The additional dose due to the source 
transit can be as high as 24.9% for the case of 0.5 s dwell time, 10 mm step-size and 20 
mm active length. The dose difference is mainly due to the entrance and exit source 
movement but not the inter-dwell movement. 
 
The small-field dosimetry study investigates the effect of detector size in the dosimetry of 
small fields and steep dose gradients with a particular emphasis on IMRT measurements. 
Comparisons of calculated and measured cross profiles and absolute dose values of IMRT 
treatment plans are presented. As a consequence of the finite size of the detector that was 
used for the commissioning of the IMRT tool, local discrepancies of more than 10 % are 
found between calculated cross profiles of intensity modulated beams and intensity 
modulated profiles measured with film. Absolute dose measurements of intensity 
modulated fields with a 0.6 cc Farmer-chamber show significant differences of more than 
 v
6 % between calculated and measured dose values at the isocentre of an IMRT treatment 
plan. Differences of not more than 2 % are found in the same experiment for dose values 
measured with a 0.015 cc pinpoint ion chamber. A method to correct for the spatial 
response of finite sized detectors and to obtain the “real” penumbra width of cross 
profiles from measurements is introduced. Output factor measurements are performed 
with different detectors and are presented as a function of detector size for a 1 x 1 cm2 
field. Because of its high spatial resolution and water-equivalence, a diamond detector is 
found to be the most suitable detector for output factor measurements in small fields. 
 
The study on the clinical implementation and dosimetric verification of a 6 MV photon 
beam for IMRT provides a systematic guideline for effective clinical implementation of 
IMRT in radiotherapy centres, starting from beam data collection, following by beam 
modeling and subsequently dose distribution verification. Limitations of the beam model 
need to be fully understood in the implementation process, in particular its modelling 
parameters for the MLC. Despite the beam model not taking in account for the effects of 
transmission through round leaf ends, adjusting the leaf position to account for the 
effective widening of the leaf opening shows good dose agreement within the acceptable 
criterion of ±3% or 2 mm in our in-house dose verification process.  The Radiological 
Physics Centre (RPC) IMRT phantom provides a valuable independent check by the RPC 
on IMRT commissioning, validation and QA process. The in-house dose verification 
process can be adopted as the patient specific IMRT QA process.  
 
 
 
 vi
Acknowledgements 
 
I would like to express my sincere gratitude to my supervisors Prof. Peter Johnston and 
Prof. Ian Bubb at RMIT University for their support and encouragement. I am grateful to 
Prof. Johnston for numerous helpful discussions and providing the highest quality 
guidance throughout the project. 
 
I would like to thank my former colleagues Dr. Steven Wallace for his help in Monte 
Carlo calculation, Wasantha Fernando for many useful technical discussions and help in 
high dose rate brachytherapy, Dr. Wolfram Laub for many inspiring discussions and help 
in small field dosimetry and my colleague Jin-song Ye for many helpful discussions in 
IMRT. I also like to thank Dr. Jamie Trapp of RMIT University for his valuable 
comments and suggestions. 
 
The cooperation of staff members at the Cancer Care Centre, Austin & Repatriation 
Medical Centre, Melbourne, Australia, Department of Radiation Oncology, William 
Beaumont Hospital, Royal Oak, Michigan, USA and Swedish Cancer Institute, Seattle, 
Washington, USA is acknowledged. 
 vii
Table of Contents 
 
Declaration          iii 
Abstract          iv 
Acknowledgments          vii 
Table of Contents         viii 
List of Figures         xi 
List of Tables          xv 
Symbols and Abbreviations        xvi 
 
Chapter 1 Introduction of the Thesis      1 
1.1 Introduction        1 
1.2 Dose error in the near field of an HDR brachytherapy   4 
stepping source  
1.3 Transit dose of an Ir-192 HDR brachytherapy stepping source 5 
1.4 The volume effect of detectors in the dosimetry of small fields  6 
used in IMRT 
1.5 Clinical implementation and dose verification of IMRT  6 
1.6 Summary        7 
 
Chapter 2 Summary of Literature Review     9 
2.1 Introduction        9 
2.2 Dose error in the near field of an HDR brachytherapy   9 
stepping source 
2.3 Transit dose of an Ir-192 HDR brachytherapy stepping source 10 
2.4 The volume effect of detectors in the dosimetry of small fields 12 
 used in IMRT 
2.5 Clinical implementation and dose verification of IMRT  13 
 
Chapter 3 Dose Errors in the Near Field of an HDR Brachytherapy 16   
Stepping Source  
3.1 Introduction        16 
3.2 Methods and Materials      17 
3.3 Results        23 
 viii
3.4 Discussion        27 
3.5 Conclusion        28 
 
Chapter 4 Transit Dose of an Ir-192 High Dose Rate Brachytherapy 30 
  Stepping Source 
4.1 Introduction        30 
4.2 Methods and Material       32 
4.2.1 Stationary and Dynamic Movement of the HDR   32 
Afterloader  
4.2.2 Video Method       33 
4.2.3 Well-type Chamber Method     34 
4.3 Results        37 
4.3.1 Video Method       37 
4.3.2 Well-type Chamber Method     38 
4.4 Discussion        41 
4.5 Conclusion        45 
 
Chapter 5 The Volume Effect of Detectors in the Dosimetry of Small 47 
  Fields used in IMRT 
5.1 Introduction        47 
5.2 Methods        48 
5.2.1 Detectors       48 
5.2.2 Measurement       50 
5.2.2.1  Profile and Dose Measurements of IMRT Beams 51 
5.2.2.2  Penumbra Measurement    52 
5.2.2.3  Output Factor Measurement    53 
5.3 Results and Discussion      55 
 5.3.1 Profile and Dose Measurement for IMRT Beams  55 
 5.3.2 Penumbra Measurement     58 
 5.3.3 Output Factor Measurement     62 
5.4 Summary and Conclusion      65 
 
Chapter 6 Clinical Implementation and Dosimetric Verification of a 67 
MV Photon Beam for IMRT 
 ix
6.1 Introduction        67 
6.2 Methods and Materials      68 
6.2.1 The IMRT Treatment Planning and Delivery System 68 
6.2.2 IMRT Beam Modelling     69 
6.2.2.1  Beam Data Measurements for Beam Modelling 72 
6.2.3 Dose Verification of IMRT Fields    75 
6.2.3.1 In-house Dose Verification    77 
6.2.3.2  RPC Dose Verification    80 
6.3 Results and Discussion      80 
6.3.1 IMRT Beam Modelling     80 
6.3.2 Verification of IMRT Fields     86 
6.3.2.1 In-house Phantom Measurements   86 
6.3.2.2  RPC Phantom Measurements   89 
6.4 Conclusion        91 
 
Chapter 7 Conclusion and Future Developments    92 
7.1 Conclusion        92 
7.2 Future Developments       97 
 
References          102 
 
Appendix A: Conference Presentations      118  
 
Appendix B: Journal Publications       119 
 x
List of Figures 
 
Figure 3.1. Internal construction of the MicroSelectron HDR 192Ir source 
simulated using MCNP4A. 
 
18
Figure 3.2. Simulated geometry of the MicroSelectron HDR 192Ir source in 
relation to the cylindrical water phantom and toroidal tally 
volumes. 
 
19
Figure 3.3. Simulated geometry of the MicroSelectron HDR 192Ir source in 
relation to the spherical co-ordinate toroidal tally volumes. 
 
20
Figure 3.4. A straight catheter with an active source dwell length of 2 cm at 
(a) 1 cm source step size and (b) 0.25 cm source step size. Dose 
point P is located at 0.25 cm in water from the transverse bisector 
of the 2 cm active source length catheter. 
 
22
Figure 3.5. Dose rate x distance2 (μGy.m2.h-1) in a water phantom (80 cm 
diameter) per unit air kerma strength (1U=1 μGy.m2.h-1 ) versus 
distance from the source centre. All results are absolute with no 
cross normalisation. 
 
23
Figure 3.6. Monte Carlo calculated polar dose profiles in water at the 
distances of 3-, 5- and 7-cm from the source centre (normalised to 
1.0 at 90 degree) versus the polar angle relative to the source’s 
cable. The BPS dose profile is in good agreement with the Monte 
Carlo results. 
 
25
Figure 3.7. Monte Carlo calculated polar dose profiles in water at the 
distances of 0.25-, 0.5- and 1.0-cm from the source centre 
(normalised to 1.0 at 90 degree) versus the polar angle relative to 
the source’s cable. The BPS dose profile shows large errors with 
the Monte Carlo results at the distances of 0.25- and 0.5-cm from 
the source centre. 
 
26
Figure 4.1. A sketch of the measurement of entry and exit charges at two 
dwell positions, A and B. The distance x and y are the indexer 
length at position B and A respectively. 
 
36
Figure 4.2. Response of the well chamber, which is the ratio of the measured 
stationary charge per second to the source air kerma source, over 
the dwell positions (indexer lengths) from 810 mm to 850 mm. 
 
38
Figure 5.1. Cross profiles as calculated in Pinnacle and measured with film for 
two different beams of an IMRT treatment plan. The profiles 
represent scans in A–B direction and have a off-axis distance to 
the central beam axis of 0.5 cm and 2.5 cm, respectively. 
 
56
 xi
Figure 5.2. Cross profiles as calculated in Pinnacle and measured with film for 
two different beams of an IMRT treatment plan. The profiles 
represent scans in A–B direction and have an off-axis distance to 
the central beam axis of 0.5 cm and 2.5 cm, respectively. 
 
56
Figure 5.3. Deviation between absolute dose values calculated in Pinnacle and 
measured with a Farmer-chamber and a pinpoint chamber for all 
five beams of a prostate IMRT treatment plan. 
 
58
Figure 5.4. Lateral distance between the 50 % dose value and various other 
dose values (ranging from 10 % to 90 %) vs. detector size. The x-
axis reflects both detector size and orientation: (a) the diamond 
with its axis in the scan direction, (b) the diamond with its axis 
perpendicular to the water surface, (c) the linear array LA 48, the 
0.125 cm3 rigid stem chamber with its detector axis (d) in the scan 
direction and (e) perpendicular to the scan direction, the 0.3 cm3 
rigid stem chamber with its detector axis (f) in the scan direction 
and (g) perpendicular to the scan direction, (h) the Markus 
chamber. For each relative dose value linear fits are plotted. 
 
60
Figure 5.5. Reconstructed penumbra region of a half blocked 15 MV photon 
beam, corrected for the volume effect of finite sized detectors. The 
penumbra region is also plotted as measured with (a) the diamond 
detector with its axis in the scan direction, (b) the diamond 
detector with its axis perpendicular to the water surface, and (c) 
the 0.3 cm3 rigid stem ionisation chamber with its detector axis in 
the scan direction. 
 
60
Figure 5.6. Output factors of a 6 MV and a 15 MV photon beam vs. detector 
size for a 1x1 cm2 field. With increasing detector size: a dosimetry 
diode, a diamond detector, a pinpoint chamber, a 0.125 cm3 
ionisation chamber and a Farmer chamber. Mean values from 
inside an area of the 3-dimensional Gaussian function that fits the 
measured cross profiles of the 1x1 cm2 field were calculated for 
the geometry of the different detectors. Quadratic fit curves are 
plotted for the measured output factors and for the resulting mean 
values. 
 
62
Figure 5.7. Cross profile of a 6 MV photon beam with a field size of 1x1 cm2 
as measured at 15 mm dose maximum and in A-B direction with a 
dosimetry diode. The best Gaussian fit curve is plotted. 
 
63
Figure 6.1. In the superposition process, dose at r is calculated due to TERMA 
at all interaction sites r’ via the kernel value corresponding to r-r’. 
 
69
Figure 6.2. The RPC IMRT head phantom is shown on the left while a 
transverse CT image of the phantom is shown on the right. The CT 
slice shows the positions of the primary PTV, secondary PTV, 
organ at risk and their TLDs (circular shape). Radiochromic films 
are imbedded in the axial and sagittal planes through the centre of 
75
 xii
the primary PTV. 
 
Figure 6.3. (a) The MapCheck 2D diode array, and (b) the MapCheck 
phantom comprises 3 cm thick solid water slab added to the 
MapCheck diode array. 
 
77
Figure 6.4. The Med-Tech IMRT phantom has pre-drilled housings for ion 
chamber at various locations for dose measurement. Ready-packed 
radiographic film can be placed in between phantom slabs for film 
dosimetry. 
 
78
Figure 6.5. Comparison of percentage depth dose measured by the CC04 and 
CC13 ion chambers for the field size of 5 x 5 cm2. Agreement is 
within 0.5%. 
 
80
Figure 6.6. 6 MV field output factors measured by diode, CC13 and CC04 ion 
chambers. The factors were normalized to 10 x 10 cm2 field. 
 
81
Figure 6.7 (a). The beam spectra used in the 6 MV Superposition beam model. 
The mean energies are 2.04 MeV and 1.82 MeV for the CAX and 
OAX spectra respectively. 
 
82
Figure 6.7 (b). A comparison of the CAX beam spectra for the modeled 6 MV 
Superposition beam (Curent (Elekta 6x)) and the published 6 MV 
spectra for the Elekta (BEAM (Elekta 6x)) and Varian (BEAM 
(Varian 6x)) linacs calculated by BEAMnrc. 
 
83
Figure 6.8. The agreement between calculated and measured PDD for all 
fields are well within the 2% / 2 mm criterion. Shown here is the 
comparison for the 10 x 10 cm2 field. Doses are normalized to 
100% at the depth of 10 cm. 
 
84
Figure 6.9. The agreement between calculated and measured profiles at 
various depths for all fields is within the 2% / 2 mm criterion. 
Shown here is the comparison for the 10 x 10 cm2 field. 
 
85
Figure 6.10. Result of 2D dose difference analysis by the MapCheck software 
for one beam. The calculated dose map is shown in gray scale in 
the background (shown in upper right) with the failed diodes - 
blue or red diodes for negative and positive differences 
respectively. The pass rate for this beam is 96.7% for ±3%/2mm 
criterion. 
 
87
Figure 6.11. (a) Calculated relative dose distribution and (b) threshold gamma 
map for the planar dose calculated by Xio. The locations where the 
gamma value equal to or greater than 1 indicates 3% or 2 mm 
tolerance was exceeded. X and Y axis for both figures are pixel 
values. The dimension of each pixel is 0.4 mm2. 
 
88
Figure 6.12. RPC film result showing the anterior – posterior profile. 
 
90
 xiii
Figure 6.13. RPC film result showing the superior - inferior profile. 
 
90
Figure 7.1. Evaluation of setup errors of a patient with rectal cancer using 
cone-beam CT mounted on the gantry of an Elekta Synergy linac. 
The left column shows the reference CT for treatment planning 
(showing coronal, saggital and transverse plans). The middle and 
the right columns are the images obtained immediately prior to 
treatment in the treatment room at the 9th and 14th fraction. PTV is 
shown in red contour and bladder is shown in yellow. 
 
100
 
 xiv
List of Tables 
 
Table 3.1. The dose rate at P, , calculated with BPS formalism and BPS 
variants or Monte Carlo (MC) variants are compared with full 
Monte Carlo calculations. The value in bracket indicates the 
percentage dose difference with respect to the full MC calculation. 
DP
.
 
27
Table 4.1. Well chamber measured stationary charges for the two active 
lengths of 40 mm (810-850 mm) and 20 mm (830-840 mm), with 
different step sizes ranging from 2.5-10 mm and different source 
dwell times of 5, 2, 1 and 0.5 s. 
 
39
Table 4.2. Percentage differences between the stationary charge (stat) alone 
to the charge of (stat + total transit) and to the charge of (stat + 
interdwell) for the two active lengths of 40 mm (810-850 mm) and 
20 mm (830-840 mm), with different step sizes ranging from 2.5-
10 mm and different source dwell times of 5, 2, 1 and 0.5 s. 
Percentage difference is defined as [stat – (stat + total transit)] / 
stat or [stat – (stat + interdwell)] / stat. The total transit charge 
comprises entry, interdwell and exit charges. 
 
40
Table 4.3. Some typical HDR fractionation schemes used in our centre or 
reported in the literatures 
 
43
Table 4.4. Doses to various points in rectum and bladder at a transverse plan 
1 cm from the base of the prostate. The transit dose is due to the 
source entry and exit movements and is calculated at a source 
transit speed of 467 mm/s. The percentage differences indicate the 
increases in doses at various points in the rectum and bladder due 
to the source transit. 
 
45
Table 6.1. Good agreement in dose measurements in the “solid water slab” 
phantom using ion chamber and also the 2D planar dose 
measurements in the MapCheck phantom. Gantry angle for all 
beams were at 0°. 
 
86
Table 6.2. RPC results for the RPC IMRT phantom. The IMRT beam model 
meets the RPC credential criterion of ±7% for PTVs and ±4 mm 
for OAR dose gradient displacement. 
 
89
 
 xv
Symbols and Abbreviations 
 
Symbols 
 
ΔD&    is the dose rate and Δ is a correction factor D&
DP
.
  dose rate at the point P 
D(u)  real profile of a radiation beam 
( )xDm   measured profile of a radiation beam 
dmax  depth of maximum dose 
D(r)  dose at position r 
d(si )  dose rate to the point P from the source at position si   
F(r,θ) anisotropy factor 
F(θ) anisotropy function 
f(x, y)  Gaussian function of a profile 
g(r) radial dose function 
g(x)  best Gaussian fit function for the profiles measured in G-T direction 
h(y)  best Gaussian fit function for the profiles measured in A-B direction 
H(r-r’)  kernel value comprising primary and scattered radiation components 
i  detector current 
K(x)  spatial convolution kernel of detectors 
r  radius 
1
2r
 geometric factor 
Q  electric charge 
Sc  collimator scatter factor 
Sc,p  field output factor 
kS   air kerma source strength [μGy/m2/h] 
Ti  source dwell time at position i 
T(r’)  total energy released per unit mass 
t  time 
vi  source velocity at position i 
Δr  cross section dimension of the tally toroid in the radial direction 
Δz  cross section dimension of the tally toroid in the z direction 
 xvi
Δθ  cross section polar angle of the tally toroid in spherical co-ordinate 
Λ dose-rate constant for a radioactive source and surrounding medium 
[cGy/h/U] (1 U= 1 cGy/cm2 /h) 
ϕ(r) modified Van Kleffens and Star correction for absorption and scattering in 
water 
θ  angle 
aveρ  average density along the straight line path between the interaction and 
dose deposition sites 
)'(rρ   density at the interaction site 
 
μ
ρ
en
air
tiss⎛
⎝⎜
⎞
⎠⎟  ratio of mean mass energy absorption coefficient in tissue and air 
n)/( ρμ  mass attenuation coefficient for energy component n 
nψ (r’)  energy fluence of primary photons in spectral component n 
 
 
Abbreviations 
 
AAPM  American Association of Physicists in Medicine 
BEAMnrc “BEAM” Monte Carlo Code 
BPS  Brachytherapy Planning System 
CAX  central axis 
Ci  curies 
Cr  Chromium 
CT  computed tomography 
CBCT  cone beam computed tomography 
DIMRT dynamic intensity modulated radiation therapy 
EGS4  “Electron Gamma Shower 4” Monte Carlo Code 
FDG  Fluorine-18 deoxygloucose 
Fx  fraction  
Fe  Iron 
Gy  gray 
 xvii
GBq  gigabecquerel 
HDR  high dose rate 
IGRT  image guided radiation therapy 
IMRT  intensity modulated radiation therapy 
Ir  Iridium 
KV  kilovoltage 
MLC  multileaf collimator 
MU  monitor unit 
MC  Monte Carlo Code 
MCNP  Monte Carlo N Particle 
Mn  Manganese 
MV  megavolt 
nC  nanocoulomb 
Ni  Nickel 
OAR  organ at risk 
OAX  off-axis 
PET  positron emission tomography 
PTV  planning target volume 
PDD  percentage depth dose 
QA  quality assurance 
RPC  Radiological Physics Centre 
RTOG  Radiation Therapy Oncology Group 
Si  Silicon 
SIMRT segmental intensity modulated radiation therapy 
TERMA total energy released per unit mass 
TG  task group 
TLD  thermo luminescence dosimetry / dosimeter 
TPS  treatment planning system 
 
 
 
 
 
 
 xviii
Chapter 1 
Introduction of the Thesis 
 
1.1 Introduction 
Radiation Oncology, commonly known as Radiotherapy, is the branch of clinical 
medicine concerned with the application of ionizing radiation in the treatment of disease. 
It is one of the most effective forms of curative and palliative treatments for cancer. 
Depending upon the type and stage of the cancer, radiotherapy can also be used in 
conjunction with surgery, chemotherapy or hormone therapy, or a combination of these. 
Radiotherapy can be applied externally (teletherapy or external beam therapy) or 
internally (brachytherapy).  
 
External beam therapy normally uses megavoltage linear accelerators to deliver a 
treatment beam of photons or electrons, but photon beams are used more extensively. In 
brachytherapy, radioactive sources are in direct contact with, or very close to, the 
malignant tissue. As well as treating malignant tumours, radiotherapy can be used 
effectively to treat benign tumours.  
 
For cancer treatment the objective of radiotherapy is to delivery a radiation dose high 
enough to eradicate all tumour cells but spare the surrounding normal tissues from 
radiation damage. Often the treatment options are limited by the tolerance doses of the 
surrounding normal tissues. Problems occur if radiation sensitive organs, or organs at risk 
(OAR), are in close proximity to the tumour or the tumour is partially enclosed by some 
organs at risk. To improve the therapeutic value of radiotherapy, highly conformal 
treatment techniques need to be applied. The aim of the highly conformal radiotherapy is 
1 
to deliver a lethal dose to the planning target volume (PTV) (including microscopic 
disease, lymphatic drainage and a margin for positioning uncertainties) while keeping the 
dose to OARs well within their tolerance doses. 
 
Conformal radiotherapy in 3 to 4D (if time dependent variables are taken into account) 
can be delivered either using external beams or brachytherapy. For treatment using 
external beams, treatment units have evolved from orthvoltage (typically 100 – 400 KV) 
x-rays units to highly advanced computer-controlled megavoltage linear accelerators 
(linacs) capable of intensity modulated radiation therapy (IMRT) and image-guided 
radiation therapy (IGRT). 
 
There is an excellent review by Van Dyk (2003) which describes the historical 
development of radiation therapy technologies. Orthvoltage treatment units were widely 
used during 1895 – 1940s. The disadvantage of orthvoltage treatment unit is non-uniform 
dose to deep-seated tumours with relatively high incidence of skin and bone toxicities. 
Cobalt-60 treatment units and 20-30 MeV betatrons were developed and were widely 
used during 1950s to 1960s (van Dyk 2003). The megavoltage photons provide skin 
sparing with improved dose uniformity in the target and reduced doses to normal tissues. 
In 1970s, multi-modality linacs, treatment simulators, computed tomography (CT) 
scanners and computerized treatment planning system were developed and used in 
radiation therapy. The use of these technology improved tumour delineation, dose 
calculation and reduced treatment complications. Since 1995, the development of 
computer-controlled linacs for dynamic field shaping and treatment further improve the 
variability and precision of treatment delivery.  
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IMRT is a recently evolved extension of conformal radiotherapy with external beams 
(Boyer 1998). IMRT can be implemented using either sequences of very narrow beams 
(fan beams) or sequences of extended beams (cone beams). The use of a multileaf 
collimator to produce sequences of cone beams in a “step and shoot” fashion is the most 
common approach (Boyer 1998).  The cost of implementing IMRT is high. For the most 
common “step and shoot” technique, the basic required equipment will be a linear 
accelerator equipped with a multileaf collimator, a record and verify system, a dedicated 
Inverse Treatment Planning system, and the associated IMRT quality assurance dose 
verification equipment. 
 
By placing radioactive sources in direct contact or very close to the malignant tissue, 
brachytherapy can be regarded as conformal radiotherapy by its nature. Brachytherapy 
has been practiced for more than 100 years, after the discovery of radium by Marie and 
Pierre Curie in 1898 (Pierquin 1988). Brachytherapy with radium and some artificial 
radionuclides being loaded manually into the tumours was very popular for cancer 
treatments during the first half of last century and several dosimetry systems (e.g. 
Manchester, Paris and Stockholm) evolved. It gradually lost its popularity in the 1950’s to 
megavoltage teletherapy machines, mainly due to the technological advances in these 
machines, increasing awareness of the radiation protection to staff and the importance of 
archiving an accurate and homogeneous dose distribution to the treated volume. 
 
Due to the development of the computer controlled remote afterloading system with a 
High Dose Rate (HDR) stepping source, and the increased understanding of the 
radiobiological effects with respect to both tumour control and late effects of HDR 
brachytherapy in the last decade, the interest in HDR brachytherapy has surged in recent 
years. The increased abilities of applicator reconstruction from different imaging 
3 
modalities, increased ease of achieving optimized dose distribution, elimination of 
radiation exposure to staff and the potential of delivery an effective 3-D conformal 
radiotherapy with a relatively low cost all contribute to this surge of interest in HDR 
brachytherapy. In addition, the effective use of brachytherapy in reducing restenosis  in 
blood vessels after angioplasty also attracts great interest since the late 1990s (Waksman 
1996) until the use of drug coated stent proved to be effective since 2003 (Grube et al 
2003). 
 
The thesis aims to investigate the improvement of treatment dose accuracy in radiation 
therapy, both in brachytherapy using a HDR stepping source and in external beam 
radiotherapy using IMRT. Specifically, the thesis is divided into the following sections: 
 
1.2 Dose Errors in the Near Field of an HDR Brachytherapy Stepping 
Source 
The Nucletron (Nucletron, Veenendaal, The Netherlands) microSelectron remote 
afterloading HDR brachytherapy unit (the Classic unit) and its Brachytherapy Treatment 
Planning System (BPS) are used in the HDR brachytherapy study. The microSelectron is 
the most popular HDR afterloading unit. It has 18 channels for treatment applicator 
connection. The source is a Ir-192 pellet of 0.6 mm diameter and 3.5 mm length 
encapsulated by stainless steel of 1.1 mm diameter and 5.0 mm length (for their Classic 
unit) with a typical source activity of 370 GBq (10 Ci). The source is moved in a “step-
forward” manner through an applicator connected to one of its channels under 
microprocessor control. For the system used in the study, up to 48 dwell positions can be 
programmed in each channel with a maximum dwell time of 999 seconds in each 
position. 
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The dose calculation algorithms widely used in HDR brachytherapy are correction based 
algorithms. The most widely used one (e.g. Nucletron’s Plato BPS version 13.X) is based 
on Van Kleffens and Star correction for absorption and scattering in water and additional 
anisotropy correction factors based on measurements at different angular positions, but at 
a fixed radius from the centre of the HDR source. While the algorithm is reasonably 
accurate in calculating dose in a homogeneous medium at a distance more than 1 cm from 
the source centre, the error can be very high in the near field region of 1 cm or less. In 
some clinical situations where dose is prescribed in the near field region, such as in 
intravascular brachytherapy or the dose prescribed points are in close proximity to the 
catheters of an implant, patients may receive an incorrect treatment dose. Chapter 3 in the 
thesis is to investigate the sources of the error, and to provide a method to improve the 
dose calculation. 
 
1.3 Transit Dose of an Ir-192 High Dose Rate Brachytherapy 
Stepping Source 
Clinical dosimetry for HDR brachytherapy with a single stepping source generally 
neglects the transit dose. This assumes that clinically significant dose delivery only 
occurs while the source is stationary and that the dose is proportional to the dwell time of 
the source at each dwell position. However, the source moves with a finite speed and 
deposits additional dose within the target volume as well as along the entrance and exit 
path. The transit dose may be significant in some clinical situations, in particular when 
large numbers of catheters or treatment applicators are involved (e.g. treating prostate 
with 15 or more treatment applicators). Chapter 4 is to investigate the effect of transit 
dose in the target volume of the Nucletron microSelectron HDR brachytherapy stepping 
source. 
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1.4 The Volume Effect of Detectors in the Dosimetry of Small Fields 
Used in IMRT 
The concept of IMRT succeeds in limiting damage to normal tissue, while high doses can 
be delivered to target volumes. This has the potential to improve local control and 
tolerance of radiation therapy. To be able to deliver the planned dose distributions in 
IMRT, intensity profiles are most commonly translated into various multileaf collimator 
segments. The delivery of small segments with at least one dimension smaller than 2 cm 
is often required as a result. To calculate dose distribution and monitor units (MUs) for 
such small segments accurately, small field dosimetry of field sizes less than 2 cm x 2 cm 
is of great importance. This provides a new challenge since in conventional 3D 
radiotherapy small field dosimetry has not been fully studied. Without properly studying 
the small field dosimetry, inaccurate dose may be delivered to patients undergoing IMRT. 
Chapter 5 is to investigate the effect of radiation detector size in the dosimetry of small 
fields and steep dose gradients with a particular emphasis on IMRT measurements. 
 
1.5 Clinical Implementation and Dose Verification of IMRT 
The efficacy of radiation therapy relies on the accuracy of dose delivery to patients. 
Proper implementation of a treatment planning system for accurate treatment dose 
calculations and quality assurance procedures to detect dosimetric errors are of critical 
importance. The treatment planning and delivery of IMRT are more complex than 3D 
conformal radiation therapy, and less intuitive to the users. The use of IMRT places even 
more stringent demands on the correct implementation and quality assurance procedures. 
Most IMRT fields are highly non-uniform and quite often have high dose gradients in the 
field. In addition, errors in the individual IMRT beam dose distributions calculated by 
treatment planning systems may occur because of inaccurate beam models for small field 
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dosimetry. Moreover, interleaf and intraleaf leakage and transmission of the multileaf 
collimator may not been accurately accounted for. Proper clinical implementation of 
IMRT involves accurate beam data collection, followed by beam modelling and 
subsequently dose distribution verification. Patients will receive inaccurate treatment dose 
if there is any error introduced in any step of the implementation and verification process. 
Chapter 6 investigates the use of various dosimetric detectors and methods for effective 
clinical implementation and dose verification of a 6 MV photon beam for IMRT. 
 
1.6 Summary 
The results of the investigations improve treatment dose accuracy in radiation therapy. 
For HDR brachytherapy, the radial dose distribution and source anisotropy are found to 
be the sources of error in the near field for the BPS dose calculation algorithm based on 
the point source approximation. With the improved method being developed, 1% dose 
calculation accuracy can be achieved even in the near field. Indeed, most HDR treatment 
planning systems have adopted this approach now. As to the transit dose, it is found that 
the microSelectron HDR afterloader compensates the inter-dwell transit dose by reducing 
the actual dwell time at each dwell position. The transit dose for the microSelectron HDR 
afterloader is mainly contributed by the entry and exit components. Knowing the transit 
speed for the source entry and exit moment, the transit dose to the organ at risk can be 
calculated. 
 
For IMRT using external beams, it is found that volume effect of detectors could lead to 
inaccurate dose measurement and calculation and subsequently leads to inaccurate 
conclusions upon clinical verification of IMRT plans. The results demonstrate that the 
commissioning of IMRT treatment planning systems with detectors that have a limited 
spatial resolution can lead to systematic errors. A systematic procedure for effective 
7 
clinical implementation of IMRT in radiotherapy centres for the dose agreement criterion 
of 3% or 2 mm distance to agreement has also been developed.  
 
No assumed probability distributions were used in the evaluation of the uncertainty 
reported in the thesis. The uncertainties were evaluated from the statistical distribution of 
the results of a series of measurements. All the uncertainties reported in this thesis are 
type A. 
 
8 
Chapter 2 
Summary of Literature Review 
 
2.1 Introduction 
This chapter provides a summary of review of literatures on the four distinct studies on 
improving treatment dose accuracy in radiation therapy using an Ir-192 HDR 
brachytherapy stepping source and IMRT. The four studies are (a) investigation of dose 
errors in the near field of an HDR brachytherapy stepping source, (b) investigation of 
transit dose of an HDR brachytherapy stepping source, (c) investigation of the volume 
effect of detectors in the dosimetry of small fields used in IMRT and (d) investigation of 
specific procedures for effective clinical implementation and dose verification of a 6 MV 
photon beam for segmental IMRT. 
 
2.2  Dose Errors in the Near Field of an HDR Brachytherapy Stepping 
Source 
There has been a growing interest since 1993 in endovascular irradiation to prevent 
restenosis caused by intimal hyperplasia in the arteries following angioplasty (Bottcher et 
al 1994, Liermann et al 1994, Scholpohl et al 1996, Fox 1997). A high dose (typically 12 
Gy) is needed to be delivered to the arterial wall (Waksman 1996). The use of 
brachytherapy is favourable to external beams as a high dose can be applied to the arterial 
wall while the dose to the normal tissue is minimised. The use of the HDR stepping 
source to prevent restenosis has a great potential to provide a quick and easy treatment, 
but requires accurate dose calculation at the near field (less than 1 cm). 
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There have been several analytical and Monte Carlo dosimetry studies on the 
microSelectron HDR brachytherapy stepping source (Podgorsak et al 1995, Williamson 
& Li 1995, Dries 1997, Wallace et al 1998 a & b, Baltas et al 1998).  They have shown 
that dose calculation algorithms based on a point source approximation would have errors 
in the near field (less than 1 cm). These are caused by errors in the radial dose function 
and the anisotropy function. Dries (1997) has suggested that near field dosimetry 
accuracy of the Nucletron Plato Brachytherapy Planning System  (BPS) version 13 can be 
greatly improved by using a HDR source step size of 0.25 cm instead of 1 cm. He 
explained that the negative error opposite the source tips was largely compensated by the 
positive error opposite the source centre when the source was moved to the next dwell 
position at + 0.25 cm. However, the sources of these positive and negative errors were not 
fully explained.  
 
The study investigates the sources of errors of the widely used BPS dose calculation 
algorithm in HDR brachytherapy, and to provide a method to improve the dose 
calculation. 
 
2.3 Transit Dose of an Ir-192 HDR Brachytherapy Stepping Source 
Dosimetry of high dose rate (HDR) brachytherapy with a stepping Ir-192 source has been 
reported in many studies (Williamson & Li 1995, Kirov et al 1994, Muller-Runkel & Cho 
1994, Podgorsak et al 1995, Nath et al 1995, Russel & Ahnesjo 1996, Mishra et al 1997, 
Dries 1997, Baltas et al 1998, Wallace et al 1998, Wong et al 1999). The results of 
various studies have indicated that dose calculation algorithm for HDR brachytherapy 
using a stepping source should conform to the AAPM TG43 formalism (Nath 1995). 
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Clinical treatment planning for a single stepping-source HDR brachytherapy unit 
generally neglects the transit dose, in line with the AAPM TG-43 formalism which also 
neglects the transit dose. This assumes that clinically significant dose delivery occurs 
only while the source is stationary and the dose is proportional to the dwell time of the 
source at each dwell position.  
 
There are limited reports in the literature on the measurement of transient dose or 
transient speed of HDR brachytherapy stepping sources. Houdek et al (1992) used an 
oscilloscope to count the Nucletron microSelectron HDR (Nucletron BV, The 
Netherlands) stepping motor pulses as a measure of source speed. Williamson et al (1994) 
used a large volume ion chamber and Sahoo (1998) used a well-type ionisation chamber 
to measure the source speed from ionisation measurements. The results reported by 
Williamson et al and Sahoo are not in agreement with each other. For example, while 
Sahoo found the speed of the source to be in the range of 50-172 mm/s for source step 
intervals of 5, 50 and 100 mm, Williamson et al reported the speed to be in the range of 
450-570 mm/s for source step intervals of 5, 10 and 20 mm. Bastin et al (1993) measured 
the transit speed of the microSelectron HDR Ir-192 source to be 452 mm/s for a 
pathlength of 995 mm using a video monitor and stopwatch, but the method was not 
reported. They also measured the transit dose using TLD and reported that the total transit 
dose delivered to tissue within or outside the prescribed treatment volume could exceed a 
few hundred cGy, but is typically under 100 cGy. DeWerd et al (1995) reported the use of 
a well-type ionisation chamber as a quality assurance tool and for measurement of the 
transit time of the microSelectron HDR stepping source. However, the reported transit 
time of 0.39±0.06s is the end effect time accounting for the source transit to the dwell 
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position only. There is a lack of reliable results reported in the literature on transit speed 
and transit dose of the HDR stepping source. 
 
The study investigates the transit speed and the effect of transit dose in the target volume 
of an HDR brachytherapy stepping source. 
 
2.4 The Volume Effect of Detectors in the Dosimetry of Small Fields 
Used in IMRT 
The concept of intensity modulated radiation therapy (IMRT) succeeds in limiting 
damage to normal tissue, while high doses can be delivered to target volumes (Huang et 
al, 2000, Portelance et al 2001). The delivery of small field segments with at least one 
dimension smaller than 2 cm is often required in IMRT. To calculate dose distributions 
and monitor units (MUs) for such small segments accurately, high-resolution absolute and 
relative dosimetry is of great importance. This requires the study of various detectors for 
small field dosimetry. 
 
Silicon dosimetry diode type 60008 (PTW-Freiburg) has a high signal-to-noise ratio and a 
very good spatial resolution. However, the relatively high atomic number of silicon leads 
to a higher sensitivity to low-energy photons as compared with water. As a consequence, 
an over-response is expected for broad beams, where scattered photons contribute a larger 
portion of dose. This is, however, not a big problem, as the detector is designed for 
narrow photon beams where the effect is not critical (Westermark et al 2000). Another 
disadvantage of single diode detectors is the relatively large directional dependence of the 
detector response (Westermark et al 2000), which is due to the asymmetry inherent in the 
silicon chip and has a magnitude of approximately 3 %.  
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The diamond detector type 60003 (PTW-Freiburg) is reported to show a slight sub-
linearity of the current and dose rate (Hoban et al 1994, Laub et al 1997). Detector 
current and dose rate are related by the expression , where i is the detector current, 
 is the dose rate and Δ is a correction factor. A correction factor is often needed to 
apply to measured data with the diamond detector (Hoban et al 1994, Laub et al 1997). 
Δ∝ Di &
D&
 
For penumbra measurements, inaccuracies in the determination of the “real” penumbra 
width of profiles as a result of the finite sized measuring volume of detectors have been 
reported (Metcalfe et al 1993, Garcia-Vicente et al 1998). Garcia-Vicente et al have 
presented an experimental method for the determination of the spatial convolution kernel 
of detectors. Photographic films have a high spatial resolution, but the calibration curve 
can be slightly different for each film and an over-response of low dose values in the 
penumbra region can occur as a result of an energy dependence of the used film 
(Esthappan et al 2002, Childress et al 2002). 
 
For output factor measurement, Haryanto et al (2002) reported the use of various 
detectors to measure the output factor of a 6 MV photon beam for small field sizes down 
to 1 x 1 cm2. They also compared their results with Monte Carlo simulations. 
 
The study investigates the effect of detector size (volume effect) in the dosimetry of small 
fields and of steep dose gradient regions that are frequently encountered in IMRT.  
 
2.5 Clinical Implementation and Dose Verification of IMRT 
The clinical implementation of IMRT requires special consideration during 
commissioning, including machine and patient-related quality assurance beyond that 
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performed for conventional 3D conformal radiation therapy. Many factors can affect the 
accuracy of the dose calculation due to the limitations of beam models used in IMRT. 
Limitations of beam model include failure to fully model the physics of photon and 
electron transport.  This will result in large dose calculation error when low density tissue, 
such as an air cavity or a lung is irradiated with small field sizes. The large error is due to 
the beam model failing to account for the effect of lateral electronic disequilibrium 
(Wong et al 1992, Kan et al 1995). This situation is frequently encountered in IMRT 
where beam segments with very small MLC formed field size are used. The demand for 
small field dosimetry also poses a technical challenge for beam modelling (Laub & Wong 
2003). While there are no international guidelines for IMRT commissioning and QA, 
there are various publications including the guidance document from the AAPM, describe 
some procedures for the implementation of IMRT (LoSasso et al 1998 & 2001, Palta et al 
2003, Ezzell et al 2003, Low & Dempsey 2003, Carlos & Pelayo 2004). There is still a 
need for radiotherapy centres to have a systematic guideline for effective clinical 
implementation of IMRT. 
 
Film dosimetry with radiographic film suffers from several technical challenges, such as 
changes in film processing conditions, emulsion differences between batches and even 
between films during manufacturing, transportation and storage.  Its energy response also 
warrants careful optical density and absorbed dose calibration (Williamson et al 1981, 
Wong et al 1992). Film dosimetry with radiochromic film (Gafchromic MD-55-2) has 
become an attractive alterative to dosimetry with radiographic film due to properties such 
as lesser energy dependence, automatic development and physical toughness (Butson et al 
1998). Radiochromic film is an ideal dosimeter in volumetric regions due to its flexible 
nature and high spatial resolution. The film can be curled around an area of interest for 
dose assessment in solid phantom materials (Klassen et al 1997, Butson et al 1998, 
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Meigooni et al 1996). Radiochromic film has been reported to be an adequate detector for 
dosimetry in a water phantom where high spatial resolution is needed and angle of beam 
incidence at the point of interest is important (Butson et al 2001). The newly released 
Gafchromic EBT film offers both low energy dependence and high spatial resolution. It 
provides adequate measure of penumbral dose for high energy x-ray beams (Cheung et al 
2006). 
 
Thermoluminescence dosimetry (TLD) is a versatile tool for the dosimetry of ionizing 
radiation (Kron et al 1993, Kron 1994). The most commonly used TL material in clinical 
dosimetry is lithium fluoride (LiF) doped with magnesium and titanium. TLD has a 
number of advantages which make them a useful tool in particular for measurements in 
anthropomorphic phantoms (Knoos et al 1986, Kron et al 1993, Kron 1994). These 
advantages include small physical size with various shapes, close tissue equivalent and no 
directional dependence of the dose reading. In addition, TL dosimeters are reusable and 
TLD does not require cables and is therefore a stand-alone measuring technique. Wong et 
al  (1994) reported a technique of using 50 LiF TLD rods (1 mm x 1 mm x 6 mm) for 
penumbra measurement of a 6 MV photon beam at mid lung in a lung phantom. TLD has 
been used for measurement of skin dose, entrance and exit dose measurement for setup 
verification and dose measurement at steep dose gradient region, such as build-up and 
field junction regions were also reported (Kron 1995). 
 
The aim of the study is to investigate the specific procedures for the effective clinical 
implementation and dosimetric verification of a 6 MV photon beam for segmental IMRT.  
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Chapter 3 
Dose Errors in the Near Field of an HDR Brachytherapy 
Stepping Source 1 
 
3.1 Introduction 
There has been a growing interest in recent years in endovascular irradiation to prevent 
restenosis caused by intimal hyperplasia in the arteries following angioplasty (Bottcher et 
al 1994, Liermann et al 1994, Scholpohl et al 1996, Fox 1997). A high dose (typically 12 
Gy) is needed to be delivered to the arterial wall (Waksman 1996). The use of 
brachytherapy is favourable to external beams as a high dose can be applied to the arterial 
wall while the dose to the normal tissue is minimised.  
 
There are pros and cons between the use of a HDR stepping source in vascular 
brachytherapy against some beta emitters in the form of liquid, seeds, wires or stents. 
However, the use of the HDR stepping source to prevent restenosis has a great potential 
to provide a quick and easy treatment. Therefore, the accuracy of the dose calculation 
algorithm implemented in treatment planning systems to handle near field dosimetry 
becomes important for such an application. Moreover, even for some conventional HDR 
brachytherapy interstitial implants, dose points may be placed very close to the catheters 
or needles (less than 1 cm) due to the physical configuration of the implants. This 
warrants the requirement of an algorithm which can calculate dose accurately in the near 
field. 
 
                                                          
1 Sections of this chapter appear in Phys. Med. Biol. 44 (1999) 357-363, under the title “Dose errors in the 
near field of an HDR brachytherapy stepping source”. 
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There have been several analytical and Monte Carlo dosimetry studies on the 
microSelectron HDR brachytherapy stepping source (Podgorsak et al 1995, Williamson 
& Li 1995, Dries 1997, Wallace et al 1998 a & b, Baltas et al 1998).  They have shown 
that dose calculation algorithms based on a point source approximation would have errors 
in the near field (less than 1 cm). These are caused by errors in the radial dose function 
and the anisotropy function. Dries (1997) has suggested that near field dosimetry 
accuracy of the Plato Brachytherapy Planning System  (BPS) version 13 can be greatly 
improved by using a HDR source step size of 0.25 cm instead of 1 cm. He explained that 
the negative error opposite the source tips was largely compensated by the positive error 
opposite the source centre when the source was moved to the next dwell position at + 
0.25 cm. However, the sources of these positive and negative errors were not fully 
explained. This study is to examine the near field dosimetry using the Monte Carlo code 
MCNP (Monte Carlo N Particle) version 4A. The Monte Carlo results are used to validate 
the accuracy of the BPS, and in particular, focus in the cause of the reduction of dose 
calculation differences by reducing the source step size as reported by Dries (1997). A 
modified algorithm is also proposed to achieve accuracy comparable to Monte Carlo 
results with negligible extra demand on computation time. 
 
3.2 Methods and Materials 
The internal construction and dimensions of the Nucletron microSelectron HDR source as 
reported by Williamson & Li (1995) were used for the Monte Carlo simulation. Figure 
3.1 is a schematic of the source. It consists of a solid 192Ir source pellet (density 22.42 
g/cm3) of 0.6 mm diameter and 3.5 mm length encapsulated by AISI 316L stainless steel 
of 1.1 mm diameter and 5.0 mm length. All stainless steel components were 
approximated by the composition of AISI 304 (by weight 2% Mn, 1% Si, 19% Cr, 10% 
Ni, and 68% Fe) with a density of 8.02 g/cm3. The cable, included for anisotropic effects, 
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was approximated by a solid 1.1 mm diameter AISI 304 cylinder extending to a distance 
of 20 mm from the source capsule.   
 
Figure 3.1. Internal construction of the MicroSelectron HDR 192Ir source 
simulated using MCNP4A. 
 
The MCNP 4A Monte Carlo code was used to calculate the dose distribution in water 
about the source. A minimum of 5 million source photon histories were simulated for a 
statistical error of approximately 1% in dose calculation. As shown in figure 3.2, the 
MicroSelectron HDR 192Ir source is located in the centre of a cylindrical water phantom 
of diameter (D) 80 cm and length (L) 80 cm. To take advantage of the circumferential 
symmetry, the tally volumes take the form of concentric toroids centred on the source and 
lying in the transverse plane of the source. The cross section size of the tally toroids (Δr x 
Δz) was 0.1 x 0.1 cm from 0.1 to 1 cm distance from the source (r), 0.2 x 0.2 cm from 1 to 
4 cm distance, 0.5 x 0.5 cm from 4 to 7 cm distance, and 1 x 1 cm from 7 to 15 cm 
distance. This tally structure provides high spatial resolution at the high dose gradient 
region close to the source, yet enough volume in the outer low dose gradient tallies to 
enable statistically reliable results to be achieved. Dose distribution along the transverse 
bisector axis of the source was first calculated. 
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 Figure 3.2. Simulated geometry of the MicroSelectron HDR 192Ir source in 
relation to the cylindrical water phantom and toroidal tally volumes. 
 
Figure 3.3 shows the simulated geometry of the MicroSelectron HDR 192Ir source for 
angular dose distribution calculation. The source was located in the centre of a spherical 
water phantom of radius 100 cm. To take advantage of the circumferential symmetry of 
the source, the tally volumes take the form of spherical co-ordinate toroids of cross 
section Δr x Δθ (see Figure 3.3). By varying the radius (r) and polar angle (θ), a 2D dose 
calculation matrix (in spherical co-ordinates) is obtained. Discrete radii of 7.0, 5.0 and 3.0 
cm in the far field were chosen to match the measurements of Baltas et al, upon which the 
BPS V13.X dose calculation algorithm is based. Radii of 1.0, 0.5 and 0.25cm were also 
chosen to analyse the near field polar dose profiles. To minimise the effects of volume 
averaging of the dose, Δr was chosen as one tenth of the given r value. For all toroids, Δθ  
was fixed at 2 degrees centred on each 5 degree interval of the polar angle (θ) from 0 to 
180 degrees (0 degrees is defined as the cable direction). This tally structure provides 
high spatial resolution at the high dose gradient region close to the source, yet enough 
volume in the outer low dose gradient tallies to enable statistically reliable results to be 
achieved. Each angular dose profile was normalised to unity at the transverse axis. 
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Readers are referred to Wallace et al (1998 & 1999) for details of the Monte Carlo 
calculations. 
 
 
Figure 3.3. Simulated geometry of the MicroSelectron HDR 192Ir source in 
relation to the spherical co-ordinate toroidal tally volumes. 
 
The dose calculation formalism used by the Plato Brachytherapy Planning System version 
13.X (Yeung 1996, Plato BPS Training Manual 1994) is that the dose rate:  
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absorption coefficient in tissue and air and it has a value of 1.11 for the Ir-192 source, 
ϕ(r) = Modified Van Kleffens and Star correction for absorption and scattering in water, 
F(θ) = anisotropy function and 12r  is the geometric factor. Note that Equation (3.1) can 
easily be modified to the AAPM TG-43 (Nath et al 1995) formalism: 
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where Λ= dose-rate constant for the source and surrounding medium [cGy/h/U] (1 U= 1 
cGy/cm2 /h) - for the microSelectron HDR source, the value of Λ in water is 1.115 
cGy/h/U (Williamson & Li 1995, Wallace et al 1998), g(r)= radial dose function, F(r,θ)= 
anisotropy factor. In the AAPM TG-43, the recommended value for Λ in water is 1.12, 
which is a round off value of 1.115. Strictly the TG-43 formalism uses a line source 
model for the geometric factor but the point source model (1/r2) is retained here for ease 
of comparison. 
 
Figure 3.4 shows a straight catheter with an active source dwell length of 2 cm. The dose 
rate at the point P,  , at a distance r of 0.25 cm in water at the transverse bisector of the 
2-cm active source length catheter was calculated using eqn (1) - one at a source’s step 
size of 1 cm and the other at 0.25 cm. The source dwell time, t, at each source stepping 
position was assumed to be identical. The dose rate   is: 
DP
.
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.
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where d(si ) = dose rate to the point P from the source at position si  , calculated using eqn 
(3.1). Note that in the calculation of d(si ), only the BPS (version 13.X) dose calculation 
formalism as shown in eqn (3.1) was used but not the BPS itself. 
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Figure 3.4. A straight catheter with an active source dwell length of 2 cm at (a) 1 
cm source step size and (b) 0.25 cm source step size. Dose point P is located at 
0.25 cm in water from the transverse bisector of the 2 cm active source length 
catheter. 
 
DP
.
 was first calculated with the BPS variants, namely ϕ(r) and F(θ). Calculations were 
then repeated with either the BPS’s F(θ) or ϕ(r) replaced by the respective Monte Carlo 
(MC) calculated F(r,θ) or g(r). Note that as the geometric factor is accounted for by 
(1/r2), radial dose is equal to the medium’s “absorption and scattering” factor since Λ is 
numerically equal to the mean mass absorption coefficient in tissue and air. Calculations 
were again repeated such that both the MC calculated F(r,θ) and g(r) were used. The 
calculated results were compared with the results obtained by full Monte Carlo 
calculations. 
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3.3 Results 
The Monte Carlo calculated transverse radial dose distribution and the angular dose 
profiles [ ] are in good agreement with those obtained by Williamson 
& Li (1995) and Dries (1997). Figure 3.5 shows the variation of the radial dose (dose rate 
x distance2 ) with the distance from the source. This is in effect to compare the Monte 
Carlo calculated transverse radial dose, g(r),  with ϕ(r) used in the BPS, which is 
modelled by Van Kleffens and Star correction. They are in good agreement except in the 
near field where the distance is less than 1 cm from the source centre. In such a near field 
the Van Kleffens and Star correction overestimates the radial dose. For example, at a 
distance 0.25 cm from the source centre, ϕ(r) overestimates the dose by 17.7% compared 
with the Monte Carlo calculated g(r). 
D r D r
. .
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Figure 3.5. Dose rate x distance2 (μGy.m2.h-1) in a water phantom (80 cm 
diameter) per  unit air kerma strength (1U=1 μGy.m2.h-1 ) versus distance from the 
source centre. All results are absolute with no cross normalisation. 
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The source anisotropy in BPS is taken as radially invariant, based on average values 
determined from measurements at 3 cm, 5 cm and 7 cm as reported by Baltas et al (1992). 
Figure 3.6 shows that the anisotropy function implemented in BPS is in good agreement 
with the Monte Carlo calculated angular dose profiles at distances of 3 cm, 5 cm and 7 cm 
from the source centre. Note that the anisotropy function in the BPS is identical to the 
angular dose profile as the geometric factor is modelled by 1/r2. Figure 3.7 shows the 
angular dose profiles at distances of 0.25 cm, 0.5 cm and 1 cm from the source centre. 
The profiles show significant variation at the distance of 0.25 cm and 0.5 cm from the 
source centre compared with the BPS’s anisotropy function. For example, at 160° the 
BPS anisotropy factor is 0.89  while the Monte Carlo calculated anisotropy factor is 1.57 
and 0.97 at the distance r of 0.25 cm and 0.5 cm respectively. This indicates that large 
errors in dose calculation can be introduced in the near field (less than 1 cm) due to errors 
in the anisotropy function as well as in the radial dose function. 
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 Figure 3.6. Monte Carlo calculated polar dose profiles  in water at the distances of 
3-, 5- and 7-cm from the source centre (normalised to 1.0 at 90 degree) versus the 
polar angle relative to the source’s cable. The BPS dose profile is in good 
agreement with the Monte Carlo results. 
 
25 
 Figure 3.7. Monte Carlo calculated polar dose profiles in water at the distances of 
0.25-, 0.5- and 1.0-cm from the source centre (normalised to 1.0 at 90 degree) 
versus the polar angle relative to the source’s cable. The BPS dose profile shows 
large errors with the Monte Carlo results at the distances of 0.25- and 0.5-cm from 
the source centre. 
 
Table 3.1 summarises the dose rate at P,   , calculated with BPS formalism (eqn (3.1)) 
and BPS variants (i.e. ϕ(r) and F(θ)) or Monte Carlo variants (i.e. g(r) and F(r,θ)), and 
compared with full Monte Carlo calculation.  For the 2 cm active source length catheter 
with a 1 cm source step size, dose difference at the point P calculated by BPS formalism 
and variants is +15.4% compared with the full Monte Carlo calculation. With the source 
step size reduced to 0.25 cm, the dose difference is reduced to +3.1%. However, when the 
BPS’s ϕ(r) is replaced with the MC calculated g(r), the dose difference at P increases to -
7.6%. Similarly, a dose difference of +12.6% is found when only the BPS’s F(θ) is 
replaced with MC calculated F(r,θ). When both the MC calculated F(r,θ) and g(r) are 
DP
.
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used, the dose differences at P are reduced to 1% for both the source step-size of 1 cm 
and 0.25 cm. 
 
   
DP
.
 [cGyh-1/U] calculated by BPS formalism with 
 
Step 
size 
[cm] 
Monte Carlo 
calculated 
DP
.
 [cGyh-1/U] 
 
BPS ϕ(r) 
and 
BPS F(θ) 
MC g(r) and 
BPS F(θ) 
MC F(r,θ) 
and  
BPS ϕ(r) 
MC F(r,θ) 
and  
MC g(r) 
1.0 17.18 19.83 
(15.4%) 
 
17.08 
(0.6%) 
19.81 
(15.3%) 
17.06 
(0.7%) 
0.25 45.43 46.83 
(3.1%) 
 
41.98 
(-7.6%) 
51.13 
(12.6%) 
45.92 
(1.1%) 
 
Table 3.1. The dose rate at P, , calculated with BPS formalism and BPS 
variants or Monte Carlo (MC) variants are compared with full Monte Carlo 
calculations. The value in bracket indicates the percentage dose difference with 
respect to the full MC calculation. 
DP
.
 
3.4 Discussion 
A minimum of 5 millions source photon histories were simulated using the MCNP 4A 
Monte Carlo code, which resulted a statistical error of approximately 1%. The calculated 
dose distribution around the microSelectron Ir-192 stepping source agrees to within +2% 
with the independent Monte Carlo data calculated by Williamson & Li (1995). Moreover, 
compared to Mishra et al (1997) measured anisotropy factors at a radial distance of 5 cm 
from the source, the present Monte Carlo results agree to within +3% over the entire 
range of polar angles. These results justify the accuracy of the Monte Carlo dose 
calculation for the microSelectron Ir-192 stepping source. 
 
27 
Compared to the Monte Carlo results, the dose difference at P as calculated by BPS has 
reduced from +15.4% to +3.1% when the step size is reduced from 1.0 cm to 0.25 cm. 
This result agrees with the finding by Dries (1997). While Dries (1997) did explain that 
this reduction of dose difference was caused by the negative error opposite the source tips 
compensated the positive error opposite the source centre, he did not explain the sources 
of these positive and negative errors in detail.  
 
At a step size of 1.0 cm, the dose difference of +15.4% is mainly due to errors in the 
BPS’s ϕ(r) in the near field. When a step size is reduced to 0.25 cm, extra errors of the 
BPS’s F(θ) (in addition to ϕ(r)) in the near field as shown in Figure 3.7 are introduced at 
source positions close to the point P. The reduction of dose difference at P to +3.1% is 
caused by the “countering effect” of these two errors. This is evident when the BPS’s ϕ(r) 
is replaced with the MC calculated g(r), the dose difference at P increases to -7.6%. 
Similarly, a dose difference of +12.6% is found when only the BPS’s F(θ) is replaced 
with the MC calculated F(r,θ). 
 
3.5 Conclusion 
Based on the point source approximation, both the radial dose distribution and source 
anisotropy currently used in the BPS algorithm (version 13.X) have errors in the near 
field where the distance is less than 1 cm from the source centre. At the point P, using the 
BPS formalism and variants the dose difference as compared to the Monte Carlo 
calculation, is reduced from 15.4% to 3.1% simply by changing the source step size from 
1 cm to 0.25 cm. Note that when using the 0.25 cm step size, source anisotropy error will 
be introduced besides the radial dose error. It is, therefore, important to emphasis that this 
reduction in dose difference is due to the “countering effect” of these two errors. It 
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certainly does not imply that the dose calculation accuracy has been improved with 
reducing source step size.  
 
It is straight forward to modify the BPS formalism to the AAPM TG-43 recommended 
formalism as shown in eqn (3.2). Note that the AAPM TG-43 recommends using a line 
source model for the geometric function of the HDR stepping source. The geometric 
factor of 1/r2 , currently implemented in BPS, can still be retained provided that the line 
source effect is accounted for by the radial dose function, g(r), and the anisotropy 
function, F(r,θ). By replacing both the BPS’s ϕ (r) and F(θ) with MC calculated g(r) and 
F(r,θ), 1% dose calculation accuracy can be achieved even in the near field. 
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Chapter 4 
Transit Dose of an Ir-192 High Dose Rate  
Brachytherapy Stepping Source 2 
 
4.1. Introduction 
Dosimetry of high dose rate (HDR) brachytherapy with a stepping Ir-192 source has been 
reported in many studies (Williamson & Li 1995, Kirov et al 1994, Muller-Runkel & Cho 
1994, Podgorsak et al 1995, Nath et al 1995, Russel & Ahnesjo 1996, Mishra et al 1997, 
Dries 1997, Baltas et al 1998, Wallace et al 1998, Wong et al 1999). The results of 
various studies have indicated that dose calculation algorithm for HDR brachytherapy 
using a stepping source should conform to the AAPM TG43 formalism (Nath 1995). 
 
Clinical treatment planning for a single stepping-source HDR brachytherapy unit 
generally neglects the transit dose, in line with the AAPM TG-43 formalism which also 
neglects the transit dose. This assumes that clinically significant dose delivery occurs 
only while the source is stationary and the dose is proportional to the dwell time of the 
source at each dwell position. However, the source moves with a finite speed and does 
deposit additional dose within the target volume as well as along the entrance and exit 
path. The additional dose comprises the dose associated with the entry, inter-dwell and 
exit of the source and is related to the speed of the source. This additional dose may be 
significant for a high activity source and small dwell times, as the source transit time may 
become significant. The investigation of the transit dose requires measurement of the 
source speed under various conditions. The validity of the stationary source dosimetric 
                                                          
2 Sections of this chapter appear in Phys. Med. Biol. 46 (2001) 323-331, under the title “Transit dose of an 
Ir-192 high dose rate brachytherapy stepping source”. 
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approximation (i.e. ignoring the source transit dose) can then be evaluated and 
appropriate corrections implemented if necessary. 
 
There are limited reports in the literature on the measurement of transient dose or 
transient speed of HDR brachytherapy stepping sources. Houdek et al (1992) used an 
oscilloscope to count the Nucletron microSelectron HDR (Nucletron BV, The 
Netherlands) stepping motor pulses as a measure of source speed. Williamson et al (1994) 
used a large volume ion chamber and Sahoo (1998) used a well-type ionisation chamber 
to measure the source speed from ionisation measurements. The results reported by 
Williamson et al and Sahoo are not in agreement with each other. For example, while 
Sahoo found the speed of the source to be in the range of 50-172 mm/s for source step 
intervals of 5, 50 and 100 mm, Williamson et al reported the speed to be in the range of 
450-570 mm/s for source step intervals of 5, 10 and 20 mm. Bastin et al (1993) measured 
the transit speed of the microSelectron HDR Ir-192 source to be 452 mm/s for a 
pathlength of 995 mm using a videomonitor and stopwatch, but the method was not 
reported. They also measured the transit dose using TLD and reported that the total transit 
dose delivered to tissue within or outside the prescribed treatment volume could exceed a 
few hundred cGy, but is typically under 100 cGy. DeWerd et al (1995) reported the use of 
a well-type ionisation chamber as a quality assurance tool and for measurement of the 
transit time of the microSelectron HDR stepping source. However, the reported transit 
time of 0.39±0.06s is the end effect time accounting for the source transit to the dwell 
position only. It is not the transit time of the complete travel of the source. Hence, the 
result cannot be used to evaluate the actual transit dose for different step sizes and path 
lengths of the source. 
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There is a lack of reliable results reported in the literature on transit speed and transit dose 
of the HDR stepping source. It leads to difficulties in predicting the significance of transit 
dose in situations when the source dwell times are short, especially in situations when 
high source activity and multiple-channel implant are involved, for example, in the 
treatment of prostate cancer where 15 to 18 needles are frequently used. 
 
This chapter reports the measurement of the transit speed of the Nucletron microSelectron 
HDR Classic Ir-192 stepping source using a video method. A new method of measuring 
the transit dose using a well-type ionisation chamber was developed to determine how 
well the transit dose compensation algorithm in the HDR control console corrects for 
transit dose in the target volume. 
 
4.2. Methods and Materials 
4.2.1 Stationary and Dynamic Movement of the HDR Afterloader 
From the information given by Nucletron, the maximum travel speed of the 
microSelectron HDR Ir-192 stepping source is 500 mm/s. The step size is 0.25 mm for 
the stepping motor for both an in or out drive. Both values correlate to a 500 μs period 
(2000 Hz) for each pulse. Along each trajectory the source travels, 1/15th of the transit 
pathlength is used for acceleration and 1/15th is used for deceleration. The acceleration 
and deceleration is achieved by increasing or decreasing the stepping motor pulse 
frequency. 
 
During a short trajectory the maximum speed of the source is lowered to avoid overshoot. 
For step sizes of 2.5, 5 and 10 mm the frequency of the motor pulses is approximately 
1136 Hz, which results in a speed of 284 mm/s. So the times taken for moving the 
distance of 2.5, 5 and 10 mm are 8.8, 17.6 and 35.2 ms respectively. The dwell time at 
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each dwell position is modified by the HDR control console algorithm to compensate for 
transit dose. This time difference is defined as the transit dose compensation time in this 
chapter. Therefore, the actual dwell time will be the planned dwell time minus the transit 
dose compensation time. The maximum transit dose compensation time is 100 ms, 
because for inter-dwell times greater than 100 ms, the internal clock drive is reset. 
Therefore, for n dwell positions with programmed dwell time of Ti and transit speed of vi 
in between the dwell positions, the actual dwell times, in seconds, are (Williamson et al 
1994): 
 n
n
n
n Tv
x
T
v
xT ,,1.0min...,,1.0min
1
1
1
1
1
1 ⎟⎟⎠
⎞
⎜⎜⎝
⎛−⎟⎟⎠
⎞
⎜⎜⎝
⎛−
−
−
−
δδ     (4.1) 
 
4.2.2 Video Method 
A video camera (JVC Videomovie GR-S707) was used to capture the source movement 
in a 6 French flexible and transparent endobronchial catheter (Lumencath, Nucletron) 
along with a digital stopwatch of 1/100th second resolution placed next to the catheter. 
The shutter speed of the camera was set at 1 ms. The catheter was connected to the HDR 
afterloader with an indexer length of 995 mm. The speed of the source was measured 
while it travelled through distances of 995, 230, 10, 5 and 2.5 mm. A video player (JVC 
HR-55520 AM) was used to replay the captured source movement in a frame-by-frame 
motion. 
 
To measure the source speed while it travelled a path length of 995 mm, the source was 
sent to the most distal dwell position, which is at 995 mm from the Indexer of the HDR 
afterloader, for a dwell time of 1 s. The catheter was kept straight to minimise any drag 
effects. To achieve the best resolution of the source movement and display of the 
stopwatch, the maximum length of the catheter that the camera could capture was 
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approximately 300 mm. The video camera, therefore, was positioned to capture the 
movement of the source at the middle portion of the catheter over a length of 230 mm. 
Therefore, the recorded speed was the maximum speed that excluded the acceleration and 
deceleration of the source. Six measurements were taken - three for entry and three for 
exit source movement.  
 
To measure the source speed for travelling a distance of 230 mm, the source was sent to 
995 mm and 765 mm positions, with a dwell time of 1 s at each position. The captured 
image of the source movement in this case, would include acceleration and deceleration 
of the source. Six measurements were taken - three for entry and three for exit source 
movement.  
 
To measure the source speed while it travelled distances of 10, 5 and 2.5 mm, the source 
was sent to an initial dwell position of 915 mm and then stepped to 995 mm in the 
required steps. The dwell time at each dwell position was set to be 2 s and the 
measurement was repeated with dwell times of 5 and 10 s.  
 
4.2.3 Well-type Chamber Method 
A well-type ionisation chamber (PTW Type No. 077.091) (Dimensions: Height 150 mm, 
Diameter 93 mm, Insert Height 160 mm, Insert Diameter 32 mm) was used to measure 
the total charge due to the stationary dose alone and the total charge due to the stationary 
and transit doses for a particular active length, step size and dwell time of the stepping 
source. The ionisation chamber was calibrated to measure air kerma strength and from 
which dose could be calculated. However, in the present work only the proportionality of 
charge and dose is required.  
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The standard perspex insert, which was supplied with the well-type ionisation chamber, 
was used in the measurement to provide reproducible and stable measurement geometry. 
The ionisation chamber was connected to an electrometer (NE Doseleader) with the 
polarising voltage of 300 V. The perspex insert and its connecting catheter, which in turn 
was connected to the indexer of the HDR afterloader, was used in the measurements. 
When the source was sent to the position 830 mm, which was the position of maximum 
response in the well-type chamber, the source was at a distance of 61 mm from the 
bottom of the well. 
 
For the measurement of the total charge contributed by the stationary dose alone, the 
source was sent to the dwell positions from the indexer length of 810 mm to 850 mm. At 
each dwell position, the dwell time was programmed to be at least 100 s so that at least 
two measurements were taken with the source stationary at the dwell position. The 
measured charge at each dwell position did not contain any transit dose component. This 
was because the measurement of the charge collected by the well-type chamber was only 
started when the source was stationary in the dwell position. The built-in timer of the 
electrometer, which had been validated with a stopwatch, was used in these 
measurements. The stop time of the electrometer was set to be 20 s for each measurement 
to obtain the charge per second at each stationary dwell position. The measurements were 
repeated at the next dwell position, which was 2.5 mm from the previous one.  
 
The same set-up for the stationary dose measurement was used for the measurement of 
the entry and exit components of the transit dose, except that the electrometer was started 
for charge measurement as soon as the source was about to leave the HDR afterloader. 
For the measurement of entry and exit charges at 850 mm and 810 mm, the source was 
sent to the two dwell positions, marked as position A and B respectively as shown in 
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Figure 4.1. The source was first programmed to dwell at B for T1 = 5 s and the charge was 
measured, QT1(B). Three measurements were taken and the average reading was noted. 
Measurements were repeated for a dwell time of T2 = 10 s at B, QT2(B). For the source 
position A, same measurements as for B were taken for a dwell time of 5 and 10 s at A. 
Assume Qx and Qy are the transit charge from the safe of the HDR afterloader to B and A 
respectively and Qa(t), Qa(2t), Qb(t) and Qb(2t) are the stationary charge at A and B for 
time t and 2t. At position B: 
 )        (4.2) ()(2 1 BQtQQ Tbx =+
 )        (4.3) ()2(2 2 BQtQQ Tbx =+
Using the above equations and assuming 2Qb(t) = Qb(2t), the entry and exit charge at 810 
and 850 mm can be found. The same method was used for the entry and exit charges 
measurement at 820 and 840 mm. In these measurements A would be 840 mm and B 
would be 820 mm. 
 
X Indexer of the afterloader
x
y
X Dwell Position B
X Dwell Position A
 
Figure 4.1. A sketch of the measurement of entry and exit charges at two dwell 
positions, A and B. The distance x and y are the indexer length at position B and 
A respectively. 
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Using the same setup as the above, the total charge contributed by the stationary and 
transit doses (i.e. stationary, entry, inter-dwell and exit) was measured. Again, the 
electrometer was started for charge measurement as soon as the source was about to leave 
the HDR afterloader. Therefore, the integral charge measured by the electrometer was the 
total charge from the dwell positions as well as during source transit. The active lengths 
used in the measurement were either 40 mm (850 – 810 mm) or 20 mm (840 – 820 mm), 
with a source step size of 2.5 mm and a dwell time of 5 s at each dwell position. 
Measurements were repeated with shorter dwell times of 2, 1, and 0.5 s. The results were 
used to compare the measured total charge given from the stationary dwell positions only, 
with an identical active length, step size and dwell time. 
 
4.3. Results  
4.3.1 Video Method 
Using the video method the average transit speeds were 54 + 23 mm/s, 72 + 16 mm/s and 
233 + 73 mm/s for the step size of 2.5, 5.0 and 10 mm respectively. The average transit 
speeds for the source to travel the distances of 230 mm and 995 mm were 385 + 7 mm/s 
and 529 + 15 mm/s respectively. The uncertainties in the measurements of the transit 
speeds are in the measurement of the source position and the reading of the time display 
of the stopwatch. The measured 529 mm/s for the travelled distance of 995 mm was the 
maximum speed and it did not include the acceleration and deceleration of the source as 
the video camera only captured the source movement at the middle portion of the 
catheter. Assuming constant acceleration, 1/15th of the distance for acceleration and 1/15th 
for deceleration, the actual average source speed to travel the distance of 995 mm is 
computed to be 467 mm/s.  
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The results also showed that the dwell time of the source at each dwell position was 
reduced by the time taken for the source during transit to compensate for the transit dose. 
For example, for a source step size of 5.0 mm and a planned source dwell time of 2 s, the 
measured average dwell time was 1.93 + 0.01s with an average transit dose compensation 
time of 0.07 + 0.01 s. 
 
4.3.2 Well-type Chamber Method 
The response of the well-type chamber over the dwell positions from 810 mm to 850 mm, 
which is expressed in the unit of μC/s per air kerma strength (cGy.m2/h), is shown in 
Figure 4.2. The measured charge at each dwell position does not contain any transit dose 
component and the measured charge is proportional to the dose. From Figure 4.2 the 
stationary charge component at each dwell position for any dwell time and active length 
can be calculated.  
 
Figure 4.2. Response of the well chamber, which is the ratio of the measured 
stationary charge per second to the source air kerma source, over the dwell 
positions (indexer lengths) from 810 mm to 850 mm. 
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Table 4.1 summarises the stationary charge obtained from Figure 4.2 for the two active 
lengths of 40 mm (810-850 mm) and 20 mm (820-840 mm), with a different step size 
ranging from 2.5- 10 mm and different source dwell times of 5, 2, 1 and 0.5 s.  
 
Active Length (mm) Step Size (mm) Dwell Time (s) Measured Charges (μC) 
40 10 5.0 0.9330 
  2.0 0.3732 
  1.0 0.1866 
  0.5 0.0933 
20 10 5.0 0.5662 
  2.0 0.2265 
  1.0 0.1132 
  0.5 0.0566 
 5 5.0 0.9450 
  2.0 0.3780 
  1.0 0.1890 
  0.5 0.0945 
 2.5 2.0 0.6809 
  1.0 0.3404 
  0.5 0.1702 
  
Table 4.1. Well chamber measured stationary charges for the two active lengths 
of 40 mm (810-850 mm) and 20 mm (830-840 mm), with different step sizes 
ranging from 2.5-10 mm and different source dwell times of 5, 2, 1 and 0.5 s. 
 
The combination of the entry and exit components of the transit charge measured by the 
well-type chamber for the active lengths of 40 mm (810- 850 mm) and 20 mm (820- 840 
mm) were 0.0134 and 0.0157 μC respectively for the source air kerma strength of 3.4902 
cGy.m2/h. The stationary and inter-dwell charge components can be calculated by 
deducting the entry and exit components of the transit charge from the measured total 
stationary plus transit charge for these two active lengths. Table 4.2 compares the 
percentage differences between the charge for stationary component alone to the charge 
for (stationary + entry + inter-dwell + exit), and to the charge for (stationary + inter-
dwell). The former can be regarded as a comparison between the dose calculated by most 
algorithms where only the doses from stationary dwell positions are calculated, and the 
dose actually delivered to patients. 
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Active Length 
(mm) 
Step Size 
(mm) 
Dwell Time 
(s) 
% Difference 
Stat vs (Stat + 
Total Transit) 
% Difference 
Stat vs (Stat + 
Inter-dwell) 
40 10 5.0 -1.2 0.2 
  2.0 -3.3 0.3 
  1.0 -7.1 0.1 
  0.5 -14 0.3 
20 10 5.0 -1.9 0.9 
  2.0 -5.4 1.5 
  1.0 -11.6 2.2 
  0.5 -24.9 2.8 
 5 5.0 -1.1 0.6 
  2.0 -3.0 1.2 
  1.0 -6.6 1.7 
  0.5 -12.7 3.9 
 2.5 2.0 -1.9 0.6 
  1.0 -3.4 1.2 
  0.5 -7.5 1.8 
 
 
Table 4.2. Percentage differences between the stationary charge (stat) alone to the 
charge of (stat + total transit) and to the charge of (stat + interdwell) for the two 
active lengths of 40 mm (810-850 mm) and 20 mm (830-840 mm), with different 
step sizes ranging from 2.5-10 mm and different source dwell times of 5, 2, 1 and 
0.5 s. Percentage difference is defined as [stat – (stat + total transit)] / stat or [stat 
– (stat + interdwell)] / stat. The total transit charge comprises entry, interdwell and 
exit charges. 
 
For the percentage difference between the charge for stationary component alone and to 
the charge for (stationary + entry + inter-dwell + exit), the differences are negligible when 
the dwell times are more than 2 s. The difference increases with a decrease in dwell time. 
This is because the stationary dose is related to the dwell time. With a decrease in dwell 
time for a fixed active length and step size, the stationary dose component will be reduced 
compared to the transit dose component. Therefore, the transit dose component is 
becoming more significant, resulting in an increase in charge difference. In an extreme 
case where the active length is 20 mm, 10 mm step size and 0.5 s dwell time, the dose 
based on stationary component alone underestimates the dose due to stationary and total 
transit components by 24.9%. 
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For the percentage difference between the charge for stationary component alone and to 
the charge for (stationary + inter-dwell), the differences are negligible and mostly are 
within 2% with the highest of 3.9%. This is because the dwell time at each dwell position 
has been reduced to absorb the transit time of the source; that is, the actual dwell time is 
the planned dwell time minus the transit dose compensation time.  
 
4.4. Discussion 
The source speed is approximately inversely proportional to the distance travelled by the 
source. The measured maximum speed of the source of 529 mm/s matches well with the 
maximum speed of 500 mm/s claimed by Nucletron.  Nucletron also claims that for a 
shorter distance the speed will be reduced to 284 mm/s to avoid overshoot of the source 
but they have not specified the actual distance this speed refers to. The results obtained 
for the smaller step sizes indicate that the speed is much slower when the step size is 
reduced to 2.5 mm. The Nucletron quoted speeds are based on the pulsing of the stepping 
motor by which the source cable is driven. The slower speeds obtained from video 
measurements may be due to the mechanical resistance in the whole driving mechanism 
of the source cable and as such they represent the true speed of the source in travel. The 
slower speed at small step sizes may contribute a relatively large transit dose and may 
cause dose errors if the transit dose is not accounted for. However, it has been shown that 
the Nucletron HDR afterloader does attempt to compensate for the transit dose. This is 
achieved by reducing the actual dwell time at each dwell position to absorb the transit 
time of the source. The maximum transit dose compensation time is 100 ms. The 
commonly used step sizes for treatment are 2.5, 5 and 10 mm. The average transit speeds 
that we measured using the video method for step sizes of 2.5, 5 and 10 mm are 54, 72 
and 233 mm/s respectively. Therefore, the inter-dwell transit times for step sizes of 2.5, 5 
and 10 mm are 46, 69 and 43 ms respectively. These transit times are well within the 
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maximum transit dose compensation time of 100 ms. The results in Table 4.2 also show 
that the dose differences between the stationary and (stationary + transit) doses are due to 
the entry and exit component of the transit dose, but not the inter-dwell transit. 
 
For the entry and exit components of the transit dose, the average transit speed of the 
source is found to be 467 mm/s. At this high speed, the effect of transit dose can be 
regarded as negligible in the Planning Target Volume (PTV) for most clinical cases. For 
example, considering an active length catheter of 20 mm, 10 mm step size and dwell time 
of 5 and 0.5 s, the doses at 10 mm on the transverse bisector of the 20 mm active length 
catheter would be 111 cGy and 11.1 cGy respectively, for the source air kerma strength of 
3.5898 cGy.m2/h. While the dose difference between the stationary dose alone and the 
stationary plus transit doses is 24.9% for a dwell time of 0.5 s, the difference for a dwell 
time of 5 s is 1.9%. For most endobronchial treatments with HDR brachytherapy, the 
prescribed dose at 10 mm is much higher than 111 cGy per fraction. For most 
brachytherapy implants the dose at the prescribed points would be typically a few Gy per 
fraction. 
 
There is still a lack of consensus over the optimal dose fractionation schedules for HDR 
brachytherapy (Petereit & Fowler 2003) despite various published data and 
recommendations by the American Brachytherapy Society (Nag et al 2000). Many 
radiotherapy centres have their own dose fractionation scheme based on their clinical 
outcomes analysis and experiences. Table 4.3 shows some typical HDR fractionation 
schemes used in our centre or reported in the literatures. For treating cancers of cervix, 
endometrium and prostate, HDR usually serves as a boost to external beam radiation 
therapy (EBRT). Depending on treatment site, the typical prescribed dose in HDR 
brachytherapy is a few Gy per fraction. 
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Treatment Site EBRT Dose HDR FX 
6 - 8 Gy in 2 - 4 Fx Cervix (Petereit & Fowler 
2003) 
45 Gy 25 Fx 
5.3 - 7.5 Gy in 5 - 8 Fx  
   
6 - 8 Gy in 2 - 4 Fx Endometrium (Nag et al 
2000) 
45 Gy 25 Fx 
5.5 - 8 Gy in 2 - 3 Fx  
   
Prostate 45 Gy 25 Fx 6 - 8.5 Gy in 2 - 3 Fx 
   
Breast (Mammosite) none 3.4 Gy in 10 Fx 
   
Endobronchial obstruction none 5 - 6 Gy in 2 - 4 Fx 
 
 
Table 4.3. Some typical HDR fractionation schemes used in our centre or reported 
in the literatures.  
 
 
For prostate cancer treatment, one of the dose fractionation schemes used in our centre is 
45 Gy in 25 fractions using EBRT, and then followed by 8.5 Gy in 2 fractions using HDR 
as a boost. For a typical prostate HDR implant comprises 18 catheters and assuming a 
source air kerma strength of 3.8838 cGy.m2/h at the time of patient treatment, the total 
treatment time calculated by the Nucletron BPS system is found to be 874 seconds. As 
discussed earlier, the source transit dose is mainly due to the entry and exit components, 
as the inter-dwell transit is accounted for by the treatment unit. The doses at three 
positions on the surface of the prostate - one at the apex, one at the mid-plan and one at 
the base of the prostate are calculated to be 852, 911 and 875 cGy respectively. To 
investigate the transit dose due to the source entry and exit movements, the dose at the 
surface of the prostate at the apex is calculated as this point represents the worst case 
scenario for the transit dose. It is assumed that the catheter transferred tubes are all 
straight with a path length of 930 mm for source entry and exit and a source speed of 467 
mm/s. Using Eqn (3.1) and a finite approximation method assuming that the whole 930 
mm path length is divided into a series of 2.5 mm finite path length, the extra dose to the 
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apex of the prostate is found to be 28.5 cGy or a transit dose of 3.3% at this point. The 
extra dose due to the source entry and exit movements to the prostate has no clinical 
significant in HDR brachytherapy. 
 
While the effect of entry and exit components of the transit dose may not be clinically 
significant for the PTV, they may be significant for tissue residing along the source path 
outside the PTV. In particular, if the HDR treatment involves many fractions or many 
applicators in which a large number of source movements to and from the HDR 
afterloader are involved. For those cases, the transit dose can be calculated as the transit 
speed is known. 
 
For the same prostate HDR plan and dose calculation method as reported in the previous 
paragraph, the prostate and bladder are identified at the axial plan 1 cm from the base of 
the prostate. Three dose points are assigned to each structure. For the rectum, R1 and R3 
are the dose points at the anterior rectal wall and the posterior rectal wall respectively 
while R2 is the dose at the centre of the rectum at the plan of interest. For the bladder, B1 
and B3 are the dose points at the posterior and anterior borders of the bladder respectively 
while B2 is at the centre of the bladder. Table 4.4 summarises the dose to these dose 
points due to the source transit during entry and exit movements at a speed of 467 mm/s. 
The maximum increase in dose in organs at risk due to the source transit is 2.9 %, and this 
increase has no clinical significant for patient receiving HDR brachytherapy. 
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Dose 
Points 
Distance from 
Prostate 
Surface (cm) 
BPS 
Calculated 
Doses (cGy)  
Calculated 
Transit Doses 
(cGy) 
% 
differences 
R1 1.3 597 17.1 2.9 
R2 2.1 372 6.2 1.7 
R3 3 346 3.6 1.0 
B1 2.3 264 5.5 2.1 
B2 4.1 143 2.5 1.7 
B3 6.2 86 0.9 1.0 
 
Table 4.4. Doses to various points in rectum and bladder at a transverse plan 1 cm 
from the base of the prostate. The transit dose is due to the source entry and exit 
movements and is calculated at a source transit speed of 467 mm/s. The 
percentage differences indicate the increases in doses at various points in the 
rectum and bladder due to the source transit. 
 
 
4.5. Conclusion 
There have been many improvements in the dose calculation accuracy for HDR 
brachytherapy using a stepping source. However, the current HDR brachytherapy 
treatment planning systems still only calculate the dose from the stationary dwell 
positions. The transit dose from the movement of the source is assumed to be negligible 
and is ignored. The transit dose is inversely proportional to the transit speed. It has been 
found that the transit speed of the stepping source in the Nucletron microSelectron HDR 
afterloader increases with the increase in its distance travelled. If the afterloader does not 
compensate the inter-dwell transit dose by reducing the actual dwell time at each dwell 
position, the slower speed of the source for step sizes smaller than 10 mm may create 
noticeable dose errors in the PTV.  
 
It is found that the transit dose for the microSelectron HDR afterloader is mainly 
contributed by the entry and exit components, as the inter-dwell transit dose has been 
mostly accounted for by the afterloader itself. The transit speed for the entry and exit 
movement of the source is 467 mm/s. With this high transit speed, the transit dose to the 
45 
PTV is negligible. However, the transit dose may be significant for tissue residing along 
the source path outside the PTV. Knowing the transit speed of 467 mm/s for the source 
entry and exit movement, the transit dose to the organs at risk can be calculated if 
necessary. 
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Chapter 5 
The Volume Effect of Detectors in the Dosimetry of  
Small Fields Used in IMRT 3 
 
5.1  Introduction 
The practice of intensity modulated radiation therapy (IMRT) succeeds in limiting 
damage to normal tissue, while high doses can be delivered to target volumes (Huang et 
al, 2000, Portelance et al 2001). This has the potential to improve local control and 
tolerance of radiation therapy. Segmental IMRT (SIMRT) and dynamic IMRT (DIMRT) 
are the two main modalities that utilize a multileaf collimator (MLC). For segmental 
IMRT, the non-uniform fluence distribution is delivered using a sequence of fixed 
irregular fields. Each MLC field segment is delivered using monitor units (MUs) 
determined by the IMRT treatment planning system. Radiation is delivered only when the 
MLC is stationary and the radiation is off when the MLC changes from one MLC field 
segment to the other segment. For dynamic IMRT, the leaves move during irradiation. 
Because the leaves are moving during irradiation, a fluence gradient is produced by the 
passing of the leaves. Different fluence gradients are produced by varying the leaf 
velocity. 
 
To deliver the planned dose distributions, intensity profiles are most commonly translated 
into a large number of beam segments created by the MLC. The delivery of small 
segments with at least one dimension smaller than 2 cm is often required as a result. To 
calculate dose distributions and monitor units (MUs) for such small segments accurately, 
                                                          
3 Sections of this chapter appear in Med. Phys. (2003) 341-347, under the title “The volume effect of 
detectors in the dosimetry of small fields used in IMRT”. 
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high-resolution absolute and relative dosimetry is of great importance. One issue 
associated with the segmental IMRT or the “step & shoot” technique is that the exact 
position of MLC depends on the penumbra calculated in the IMRT planning engine for 
segments. An inaccurate calculation of the penumbra can result in cold or hot spots 
between two adjacent segments. For this reason it is important to provide IMRT planning 
engines with accurate dosimetric data.  
 
This study investigates the effect of detector size (volume effect) in the dosimetry of 
small fields and of steep dose gradient regions that are frequently encountered in IMRT. 
Calculated and measured absolute dose values and cross profiles of IMRT treatment plans 
are compared. Presented is the penumbra width of cross profiles plotted vs. detector size 
of various different detectors. In order to obtain the “real” penumbra width of cross 
profiles from measurements, an established method to correct for the spatial response of 
finite sized detectors is modified and applied. Output factor measurements are performed 
with different detectors and are presented as a function of detector size for a 1 x 1 cm2 
field.  
 
5.2  Methods 
5.2.1 Detectors 
The dosimetry diode type 60008 (PTW-Freiburg) is a p-type Si diode. Because of the 
high signal-to-noise ratio of the diode, the effective measuring volume of the detector can 
be made small and allows data acquisition with a very good spatial resolution. The 
detector features a small sensitive volume shaped as a disc with an area of 1 mm2 and a 
thickness of only 2.5 micrometer. The relatively high atomic number of silicon leads to a 
higher sensitivity to low-energy photons as compared with water. As a consequence, an 
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over-response is expected for broad beams, where scattered photons contribute a larger 
portion of dose. This is, however, not a big problem, as the detector is designed for 
narrow photon beams where the effect is not critical (Westermark et al 2000). Another 
disadvantage of single diode detectors is the relatively large directional dependence of the 
detector response (Westermark et al 2000), which is due to the asymmetry inherent in the 
silicon chip and has a magnitude of about 3 %. Therefore, over-response can be observed 
in the low dose region of profiles measured with a diode for positive lateral distances to 
the central axis. Resulting profiles are slightly asymmetric in the low dose regions. It 
would be difficult to correct for the directional dependence of the diode response, but the 
effect is minor and can be tolerated. The advantage of a high spatial resolution is of more 
relevance. 
 
The radiation-sensitive region of the diamond detector type 60003 (PTW-Freiburg) is a 
low-impurity natural diamond disc of thickness 0.32 mm and volume 3 mm³. This 
diamond plate is fixed in a polystyrene housing of diameter 7.3 mm, the surface of the 
crystal lies 1.0 mm below the top of the housing. The diamond detector was connected to 
a Unidos Universal Dosimeter (PTW-Freiburg) with an applied detector bias of +100 V. 
After the high voltage was switched on a pre-irradiation of the detector with a dose of 
about 5 Gy was performed to settle the response of the diamond at a stable level. 
Diamond detectors are known to show a slight sub-linearity of the current and dose rate 
(Hoban et al 1994, Laub et al 1997). Detector current and dose rate are related by the 
expression , where i is the detector current,  is the dose rate and Δ is a 
correction factor. A correction factor of approximately 0.963 was found for the used 
diamond detector and applied to all measured data with the diamond detector similar to 
data presented in various studies (Hoban et al 1994, Laub et al 1997). 
Δ∝ Di & D&
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Another detector that is specifically designed for small field dosimetry is the pinpoint 
ionisation chamber type 31006 (PTW-Freiburg). The measuring volume of this ionisation 
chamber is 0.015 cm3. As reported, the chamber over-responds to low-energy Compton 
scatter due to its aluminium electrode. Therefore, the pinpoint chamber is primarily 
suitable for relative dose measurements in small field dosimetry (Martens et al 2000).  
 
Other detectors used in this study are the 0.125 cm3 semiflex tube type 31002, with a 
uniform spatial resolution during phantom measurements along all three axis and 
designed for relative dose measurements, the 0.3 cm3 type 233641 and 0.125 cm3 type 
233642 rigid stem chambers, both designed as reference chambers for absolute dosimetry, 
the linear array LA 48, designed for relative dosimetry, the 0.6 cm3 Farmer-chamber type 
30001, designed for absolute dosimetry, and the Markus chamber type 23343, designed 
mainly for electron absolute dosimetry (all PTW-Freiburg).  
 
Film measurements were performed in a RW-3 solid-water phantom. Kodak EDR2 films 
were irradiated with doses of approximately 180 cGy and scanned with a VXR-12 
scanner (Vidar Systems Corp.). Calibration data were measured for each film batch 
separately and for doses higher than 25 cGy in 25 cGy increments. 
 
5.2.2 Measurements 
Two linear accelerators were deployed: an Elekta SLi plus linear accelerator with 6 MV 
and 15 MV X-rays and an Elekta SLi plus linear accelerator with 6 MV and 18 MV 
X-rays. All detector measurements were carried out in an MP3-water tank 
(PTW-Freiburg) or in a 30 x 30 x 23 cm3 solid-water phantom. Absolute dose 
measurements were performed with a Unidos Universal Dosimeter with an applied 
detector bias of 300 V. Ionisation chambers were calibrated at room temperature, using a 
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reference system with a radioactive emitter for measuring pressure and temperature. 
Therefore a temperature correction factor, allowing for the difference between water and 
room temperature, was required. Unless stated otherwise, detectors were always 
positioned at the central beam axis of a photon beam with gantry angle zero degree 
normal to the surface of the water phantom. 
 
5.2.2.1  Profile and Dose Measurements for IMRT Beams 
To emphasize the importance of high-resolution dosimetry in IMRT, prostate treatment 
plans with five equally spaced 18 MV photon beams were generated in the treatment 
planning system Pinnacle (ADAC, Milpitas, USA) with the IMRT tool Orbit (RaySearch 
Laboratories, Sweden). Each beam had a field size of about 12 x 12 cm2 and between 
three and seven “step & shoot” segments. For the commissioning of Pinnacle, the 
required water phantom measurements across the beam profiles at different depths were 
carried out with a standard 0.125 cm3 ionisation chamber type 31002. Because of the 
volume effect of this ion chamber, the penumbra of measured profiles is broadened 
compared to the “real” penumbra of the beams. As a result, the penumbra of profiles 
calculated in Pinnacle is also expected to be broadened, since the measured data are used 
for beam modelling in Pinnacle. After the IMRT planning process on the CT dataset of a 
patient, the prostate treatment plans were mapped to the CT dataset of a 30 x 30 x 23 cm3 
solid-water phantom. In the phantom the dose distribution was recalculated for each 
imported intensity modulated beam separately, with the gantry angle of all beams set to 
zero degree. For comparison with the dose calculations in Pinnacle, Kodak EDR2 film 
measurements were performed at a depth of 5 cm in the solid-water phantom. The MLC 
positions were validated before film measurements. The phantom was positioned with its 
geometrical centre at isocentre position and irradiated with the “step & shoot” segments 
of the intensity modulated photon beams. To minimize artefacts caused by inaccuracies in 
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the reproducibility of the MLC-positioning, each film was irradiated with the same 
intensity modulated beam twice. All data from the film measurements were imported into 
the RIT 113 software tool (Radiological Image Technology, Inc.). The dose cube 
calculated with a 2 mm grid size in Pinnacle was also imported into RIT and compared to 
the measured film data. In addition, absolute dose measurements were carried out at the 
centre of the solid water phantom with a Farmer-chamber and with a pinpoint chamber. 
 
5.2.2.2  Penumbra Measurements 
The volume effect of detectors was investigated by the determination of the penumbra 
width with different detectors. The size of a detector was defined as the geometrical 
dimension of the measuring volume in the scan direction. Measured profiles were 
normalized to a relative dose value of 50 % at the point of inflexion in the penumbra 
region. To produce a sharp penumbra, a rectangular 15 x 8 x 7 cm3 cerrobend block was 
aligned in the transverse (A-B) direction and attached to a block tray with one edge at the 
centre of a 15 MV photon beam. A SSD of 110 cm was set and measurements were 
performed at the depth of maximum dose dmax of 27 mm. To achieve the best possible 
spatial resolution, the diamond detector was oriented with its axis in the scan direction. 
The diamond detector was also used with its axis perpendicular to the water surface. The 
0.125 cm3 and 0.3 cm3 rigid stem chambers type 233641 and 233642 were both used with 
their detector axis in the scan direction and perpendicular to the scan direction. The linear 
array LA 48 and the Markus chamber type 23343 were used with their flat surface 
parallel to the water surface.  
 
Inaccuracies in the determination of the “real” penumbra width of profiles as a result of 
the finite sized measuring volume of detectors have been reported earlier (Metcalfe et al 
1993, Garcia-Vicente et al 1998). Garcia-Vicente et al have presented an experimental 
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method for the determination of the spatial convolution kernel of detectors. They 
mathematically describe the effect of the finite size of any detector as the convolution of a 
kernel K(x) representative of a measuring system with the real profile: 
( ) ( ) ( ) duxuKuDxDm ⋅−⋅= ∫+∞
∞−
,      (5.1)  
where D(u) represents the real profile of a beam and ( )xDm  is the measured profile. They 
use the scanned profile of a step function to determine the kernel of the densitometer 
system. Next, film is exposed with an x-ray beam from a linear accelerator and scanned. 
By deconvolution of the measured profiles with the known kernel of the densitometer 
system, the real profiles are derived. Once the real profiles are known, they can be used to 
determine the kernels of other measuring devices. The major disadvantage of this method 
is that it makes film measurements necessary to correct ionisation chamber 
measurements. Photographic films have a high spatial resolution, but the calibration curve 
can be slightly different for each film and an over-response of low dose values in the 
penumbra region can occur as a result of an energy dependence of the used film 
(Esthappan et al 2002, Childress et al 2002). Hence, a detailed study of the properties of 
the film material and of the used film scanner is necessary to achieve accurate dosimetric 
results with photographic films. This study therefore modifies the method of Garcia-
Vicente et al and presents a method to correct for the spatial response of finite sized 
detectors and to obtain the “real” penumbra width of cross profiles from measurements 
with ionisation chambers and without film measurements. 
 
5.2.2.3  Output factor measurements 
Output factors for fields with sizes between 1 x 1 cm2 and 15 x 15 cm2 were measured 
with the dosimetry diode and the diamond detector, as well as with the pinpoint chamber, 
the 0.125 cm3 semiflex tube and the Farmer-chamber. The size of a detector was defined 
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as the maximum of the geometrical dimension of the measuring volume in gantry-couch 
(G-T) and transverse (A-B) direction. Output factors were defined as the ratio of the dose 
at a reference depth for a given field to the dose at the same depth for a 10x10 cm2 field. 
To avoid dose from electron contamination of the photon beam at measuring depth, a 
measuring depth of 10 cm was chosen as reference depth with a SSD of 100 cm. Output 
factor measurements were performed with 6 MV and 15 MV photon beams. The Monte 
Carlo system EGS4/BEAM was used to model the 6 MV photon beam of the Sli 
accelerator. Individual component modules that are available with the code and data 
provided by the manufacturer were used to model the beam (Roger et al 1995, Martens et 
al 2000). Output factors were obtained from Monte Carlo simulations for field sizes 
between 1 x 1 cm2 and 10 x 10 cm2 and for different voxel sizes of 1 mm and 5 mm as 
defined in the irradiated water phantom used in the simulations. More details about the 
output factor measurements and Monte Carlo simulations in this study are given in 
Haryanto et al (2002). 
 
To investigate the volume effect for output factor measurements in small fields, which 
leads to an averaging of the dose across the detectors volume, profiles of a 1 x 1 cm2 field 
were measured at 15 mm dmax with a dosimetry diode. A good fit for the measured 
profiles in G-T and in A-B direction was found with a Gaussian curve. In general, 
average values of a 3-dimensional Gaussian function f(x, y) can be calculated using the 
equation: 
∫∫
∫∫
=
dydx
dydxyxf
yxf
),(
),( .       (5.2) 
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If g(x) is the best Gaussian fit function for the profiles measured in G-T direction and h(y) 
the best Gaussian fit function for the profiles measured in A-B direction, we can write: 
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If we assume that our detectors have a measuring volume with a dimension of 2a in G-T 
direction and 2b in A-B direction, it follows: 
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Dividing 2a into n intervals and 2b into m intervals leads to ymbxna Δ⋅=Δ⋅= 2 and 2 . 
As a result, we can form the equation: 
 
m
yh
n
xg
m
yh
n
xg
ym
yyh
xn
xxg
yxf
bab
b
a
a
b
b
a
a
∑∑∑∑∑∑
⋅⋅=⋅=Δ⋅
Δ
⋅Δ⋅
Δ
≈ −−−− 00
)()(
4
)()()()(
),( . (5.5) 
 
Mean values inside an area of the 3-dimensional Gaussian function that fit the measured 
cross profiles of the 1 x 1 cm2 field were calculated with this expression for the geometry 
of a dosimetry diode, a diamond detector, a pinpoint chamber, and a 0.125 cm3 ionisation 
chamber. 
5.3  Results and Discussion 
5.3.1  Profile and Dose Measurements for IMRT Beams 
Figures 5.1 and 5.2 show a comparison of cross profiles calculated in Pinnacle and 
measured with film for two different beams of a prostate IMRT treatment plan. The 
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profiles represent scans in A–B direction and have different off-axis distances to the 
central beam axis. As expected, the penumbra of the calculated profiles is broader than 
the penumbra measured with film (Figure 5.1). 
 
Figure 5.1. Cross profiles as calculated in Pinnacle and measured with film for 
two different beams of an IMRT treatment plan. The profiles represent scans in 
A–B direction and have a off-axis distance to the central beam axis of 0.5 cm and 
2.5 cm, respectively. 
 
 
Figure 5.2. Cross profiles as calculated in Pinnacle and measured with film for 
two different beams of an IMRT treatment plan. The profiles represent scans in 
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A–B direction and have a off-axis distance to the central beam axis of 0.5 cm and 
2.5 cm, respectively. 
 
Because of the high spatial resolution of film and of the VXR-12 scanner (0.2 mm), the 
penumbra measured with film is close to the “real” penumbra of the beam. As mentioned 
before, water phantom measurements were carried out with a standard 0.125 cm3 
ionisation chamber for the commissioning of Pinnacle, which leads to penumbra 
broadening due to the volume effect at regions with high dose gradients. For conventional 
treatment planning this volume effect is of small importance. The planning target volume 
(PTV) generally has to be encompassed by the 95 % isodose line and field edges must 
therefore have a margin to the PTV of at least the penumbra widths. Consequently, the 
penumbra region is situated outside the PTV and penumbra broadening will only lead to 
an overestimation of dose values in a small volume of surrounding tissue. However, for 
IMRT with “step & shoot” delivery the situation is different. Intensity modulated beams 
are composed of a number of “step & shoot” segments. Segments can have a small field 
size and their field edges are often situated inside the PTV. As shown in figure 5.2 this 
can lead to local differences between calculated and measured dose values of more than 
10 %. Although no further investigations have been made in the study to determine the 
clinical effect of inaccurate dose calculations in the penumbra region of beam segments, it 
is reasonable to suggest that such differences may be of clinical significance. 
 
In Figure 5.3 the deviation between absolute dose values calculated in Pinnacle and dose 
values measured with a Farmer-chamber and a pinpoint chamber are plotted for all five 
beams of a prostate IMRT treatment plan. Deviations of measurements using the pinpoint 
chamber are much smaller than deviations of measurements using the Farmer-chamber. 
Maximum differences of less than 2 % are found for the pinpoint chamber, while 
differences of more than 6 % can be found for the Farmer-chamber measurements. The 
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larger measuring volume of the Farmer-chamber in comparison to the small measuring 
volume of the pinpoint chamber explains why high dose gradients in the proximity of the 
effective measuring point can lead to an over- or underestimation of dose values. This 
volume effect of the Farmer-chamber could lead to inaccurate conclusions upon clinical 
verification of IMRT plans. The possibility of calculating a volume dose value in 
Pinnacle instead of a point dose to account for the volume effect of the Farmer-chamber 
was not investigated. 
 
Figure 5.3. Deviation between absolute dose values calculated in Pinnacle and 
measured with a Farmer-chamber and a pinpoint chamber for all five beams of a 
prostate IMRT treatment plan. 
 
5.3.2 Penumbra Measurements 
Figure 5.4 shows the lateral distance between the 50 % dose value and various other dose 
values (ranging from 10 % to 90 %) in the penumbra region of a beam profile. These 
measurements were made using several different detectors. The x-axis reflects both 
detector size and orientation: (a) the diamond with its axis in the scan direction, (b) the 
diamond with its axis perpendicular to the water surface, (c) the linear array LA 48, the 
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0.125 cm3 rigid stem chamber with its detector axis (d) in the scan direction and (e) 
perpendicular to the scan direction, the 0.3 cm3 rigid stem chamber with its detector axis 
(f) in the scan direction and (g) perpendicular to the scan direction, (h) the Markus 
chamber. With decreasing detector size, the measured penumbra width and therefore the 
distance to the point of inflexion decreases. Linear fit curves are plotted for each relative 
dose value. No data obtained from detectors with a detector size of 3 mm or larger were 
used to find the best linear fit curve. Nevertheless, confidence values of 0.99 and higher 
are found for the fit curves and indicate that the linear dependency between the distance 
to the point of inflexion and the size of the detector is very strong. Discrepancies between 
the linear fit curves and the measured distances can only be noticed for the 10 % and 
20 % dose values measured with the diamond detector positioned with its axis in scan 
direction, and for the 10 %, 90 % dose values measured with the diamond detector 
positioned with its axis perpendicularly to the water surface. Dose gradients are lower in 
the high and low-dose regions of the penumbra and as a result small differences in the 
measured dose can lead to relatively large differences in the distance to the point of 
inflexion. Hence, the reconstruction of the “real” penumbra of profiles is possible by a 
linear extrapolation of the data of penumbra measurements with detectors that do not 
have a high spatial resolution and are not primarily designed for relative dose 
measurements. 
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 Figure 5.4. Lateral distance between the 50 % dose value and various other dose 
values (ranging from 10 % to 90 %) vs. detector size. The x-axis reflects both 
detector size and orientation: (a) the diamond with its axis in the scan direction, 
(b) the diamond with its axis perpendicular to the water surface, (c) the linear 
array LA 48, the 0.125 cm3 rigid stem chamber with its detector axis (d) in the 
scan direction and (e) perpendicular to the scan direction, the 0.3 cm3 rigid stem 
chamber with its detector axis (f) in the scan direction and (g) perpendicular to the 
scan direction, (h) the Markus chamber. For each relative dose value linear fits are 
plotted. 
 
Figure 5.5. Reconstructed penumbra region of a half blocked 15 MV photon 
beam, corrected for the volume effect of finite sized detectors. The penumbra 
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region is also plotted as measured with (a) the diamond detector with its axis in 
the scan direction, (b) the diamond detector with its axis perpendicular to the 
water surface, and (c) the 0.3 cm3 rigid stem ionisation chamber with its detector 
axis in the scan direction.  
 
A good agreement between the reconstructed penumbra region and the penumbra region 
measured with the diamond detector is found in Figure 5.5. As a consequence, if the 
diamond detector is oriented with its axis in scan direction to achieve the best possible 
spatial resolution. In agreement to the results in Figure 5.4, differences can only be seen 
for dose values in the shallow part of the penumbra region. Results of measurements 
performed with the diamond detector, oriented with its axis perpendicular to the water 
surface, and with a 0.3 cm3 ionisation chamber, oriented with its axis in the scan 
direction, are also plotted in Figure 5.5. Large discrepancies can be seen between the 
measurements and the reconstructed penumbra region, which emphasizes the importance 
of a high spatial resolution in regions with high dose gradients. 
 
The results show that a reconstruction of the real penumbra width of beams is possible 
with a linear extrapolation, if measurements are performed with different detectors or 
detector orientations. Once the real penumbra is known, the kernel K(x) representative of 
a measuring system can be derived for all used detectors and measured profiles can be 
corrected as described by Garcia-Vicente et al (1998). However, in contrast to Garcia-
Vicente et al, no film measurements are required with the modified method for the 
determination of the spatial convolution kernel of detectors. This can be an advantage, 
since determining the real penumbra width of beams from film measurements can be 
problematic if the used film has an over-response to low-energy photons. Accurate film 
dosimetry is also very time consuming. 
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5.3.3 Output Factor Measurements 
Another important aspect of small field dosimetry is the measurement of output factors. 
For field sizes larger than 10 x 10 cm2, the pinpoint chamber overestimates output factors 
due to its over-response to low-energy Compton scatter (Martens et al 2000). For field 
sizes smaller than 3 x 3 cm2, significant differences of measured output factors can be 
found among different detectors (Haryanto et al 2002). If measured with a diode detector, 
which is non-water-equivalent, the increase of the importance of secondary electrons in 
small fields leads to an overestimation of output factors. If measured with ionisation 
chambers, reason for an underestimation of output factors is the increase of lateral 
electron disequilibrium with an increase of the detectors measuring volume. Another 
reason for differences is the volume effect of detectors. In this section, the importance of 
the volume effect in the measurement of output factors of small fields for different 
detectors is investigated. 
 
Figure 5.6. Output factors of a 6 MV and a 15 MV photon beam vs. detector size 
for a 1x1 cm2 field. With increasing detector size: a dosimetry diode, a diamond 
detector, a pinpoint chamber, a 0.125 cm3 ionisation chamber and a Farmer 
chamber. Mean values from inside an area of the 3-dimensional Gaussian function 
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that fits the measured cross profiles of the 1x1 cm2 field were calculated for the 
geometry of the different detectors. Quadratic fit curves are plotted for the 
measured output factors and for the resulting mean values. 
 
Figure 5.6 shows output factors of a 6 MV and 15 MV photon beam vs. detector size for a 
1x1 cm2 field. A quadratic function was used to fit the output factors measured with a 
dosimetry diode, a diamond detector, a pinpoint chamber and a 0.125 cm3 ionisation 
chamber. The detector size of the Farmer-chamber that was used is 26 mm. Output factors 
determined with the Farmer-chamber for both photon energies are plotted on the 
quadratic fit curves, at 12 mm for 6 MV and 11.4 mm for 15 MV (Figure 5.6). The 
1x1 cm2 field blocks a large part of the measuring volume, but obviously, a slightly larger 
part of the measuring volume contributes to the measured dose value if the detector is 
irradiated with the 6 MV photon beam due to lateral scatter. 
 
Figure 5.7. Cross profile of a 6 MV photon beam with a field size of 1x1 cm2 as 
measured at 15 mm dose maximum and in A-B direction with a dosimetry diode. 
The best Gaussian fit curve is plotted. 
 
The cross profiles of a 1 x 1 cm2 field were measured at dose maximum with a dosimetry 
diode (Figure 5.7). Mean values inside an area of the 3-dimensional Gaussian function 
63 
that fits the measured cross profiles of the 1 x 1 cm2 field were calculated for the 
geometry of a dosimetry diode, a diamond detector, a pinpoint chamber, and a 0.125 cm3 
ionisation chamber. The determined mean values and a quadratic function that fits these 
values are added to Figure 5.6. The Gaussian function was normalised to a maximum 
value of 0.68, in agreement with the output factor determined with Monte Carlo 
simulations for the 6 MV photon beam (Haryanto et al 2002). 
 
The quadratic fit curves of the measurements and of the mean values are different. This is 
expected, since the determined mean values simply reflect the volume effect, while the 
detector measurements also reflect other influences. The small differences between the 
correct output factor and the output factor that was measured with the diamond detector, 
which is water-equivalent and has a very high spatial resolution, can be explained with 
the volume effect. The overestimation of the output factor as measured with the diode 
detector is a result of the non-water-equivalent material surrounding diode detectors and 
was investigated in detail by Haryanto et al (2002). As a consequence, the extrapolation 
of the quadratic fit curves for a detector size of 0 mm that result from measurements leads 
to an overestimation of the correct output factor. 
 
For ionisation chambers the importance of the volume effect is relatively small (Figure 
5.6). With increasing measuring volume the volume effect increases, but its importance 
relative to the total underestimation of the output factor decreases. The main reason for an 
underestimation of the correct output factor is the increase of lateral electron 
disequilibrium with an increase of the detectors measuring volume. Consequently, if 
corrections are applied, they primarily need to correct for lateral electron disequilibrium, 
not so much for the averaging of the dose across the detector volume. In general, it can be 
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concluded that both, spatial resolution and water-equivalence of the detector are 
important for output factor measurements in small fields.  
 
5.4 Summary and Conclusion 
This study deals with the importance of accurate absolute and relative dose measurements 
with particular emphasis on quality assurance measurements in IMRT. Measurements at 
the isocentre of an IMRT treatment plan were performed in a phantom with a 0.6 cm3 
Farmer-chamber. Significant differences of more than 6 % were found between calculated 
and measured absolute dose values. In contrast, differences of less than 2 % were found 
in the same experiment for dose values measured with a 0.015 cm3 pinpoint ion chamber. 
This volume effect of the Farmer-chamber could lead to inaccurate conclusions upon 
clinical verification of IMRT plans. Because of the insufficient spatial resolution of the 
detector that was used to collect beam data for the commissioning of the IMRT planning 
tool, local relative discrepancies of more than 10 % were found between calculated cross 
profiles and profiles measured with film. The results demonstrate that the commissioning 
of IMRT treatment planning tools with detectors that have a limited spatial resolution can 
lead to the introduction of systematic errors. Requirements for both the commissioning of 
clinical IMRT planning tools and the quality assurance procedures in IMRT should 
therefore be similar to the requirements for stereotactic treatment planning and delivery. 
The MLC positioning and re-producibility of the MLC positioning is equally important 
and requires appropriate quality assurance tests as well.  
 
An established method to correct for the volume effect of finite sized detectors in the 
penumbra region of profiles was modified so that film measurements are no longer 
required to determine the convolution kernel that describes the effect of the finite size of a 
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detector. As demonstrated in figure 5.4, the modified method can be applied by 
extrapolating penumbra widths measured with detectors with different spatial resolutions. 
 
Output factor measurements with different detectors demonstrate that both, spatial 
resolution and water-equivalence of the used detector are important for output factor 
measurements in small fields. For ionisation chambers the importance of the volume 
effect is small compared to the underestimation of the correct output factor that results 
from lateral electron disequilibrium. A diamond detector was found to be suitable for 
output factor measurements of small fields because of its water-equivalence and high 
spatial resolution. Therefore, the diamond detector is a good alternative to other detectors 
used for small field dosimetry as there are photographic and photochromic film, TLDs or 
water-equivalent scintillation detectors. 
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Chapter 6 
Clinical Implementation and Dosimetric Verification of a 
6 MV Photon Beam for IMRT 
 
6.1 Introduction 
The clinical implementation of IMRT requires special consideration during 
commissioning, including machine and patient-related quality assurance beyond that 
performed for conventional 3D conformal radiation therapy. Many factors can affect the 
accuracy of the dose calculation due to the limitations of beam models used in IMRT. 
Limitations of beam model include failure to fully model the physics of photon and 
electron transport.  This will result in large dose calculation error when low density tissue, 
such as an air cavity or a lung is irradiated with small field sizes. The large error is due to 
the beam model failing to account for the effect of lateral electronic disequilibrium 
(Wong et al 1992, Kan et al 1995). This situation is frequently encountered in IMRT 
where beam segments with very small MLC formed field size are used. In addition, 
various MLC parameters are usually not fully modelled. The demand for small field 
dosimetry also poses a technical challenge for beam modelling (Laub & Wong 2003). 
While there are no international guidelines for IMRT commissioning and QA, there are 
various publications describe some procedures for the implementation of IMRT (LoSasso 
et al 1998 & 2001, Palta et al 2003, Ezzell et al 2003, Low & Dempsey 2003, Carlos & 
Pelayo 2004). There is still a need for radiotherapy centres to have a systematic guideline 
for effective clinical implementation of IMRT, starting from beam data collection, 
followed by beam modelling and subsequently dose distribution verification. The aim of 
this study is to investigate the specific procedures for the clinical implementation and 
dosimetric verification of a 6 MV photon beam for segmental IMRT. While the methods 
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used and the results reported in this chapter refer to a specific type of linear accelerator 
and treatment planning system, the methodology is applicable to other IMRT treatment 
delivery and planning systems. 
 
6.2 Methods and Materials 
6.2.1  The IMRT Treatment Planning and Delivery System 
The treatment planning system (TPS) used for IMRT was CMS Xio v4.1 (St. Louis, MI, 
USA). While the TPS offered three dose calculation algorithms – Clarkson, Convolution 
and  Superposition, the Superposition algorithm was used for IMRT because it accounts 
for lateral electron disequilibrium and is the most accurate dose calculation algorithm 
among the three (Metcalfe et al 1990, Papanikdaou et al 1993, Hoban et al 1994, Miften 
et al 2000, Ding et al 2004). Optimization in Xio IMRT inverse planning is the process of 
finding a minimum value of a dose-based cost function in a multi-dimensional space that 
is defined by treatment-machine-controllable parameters. Xio IMRT has a two-stage 
process. In Stage 1, optimization is over ideal beamlet intensities and, in Stage 2, 
optimization is over deliverable dose beam weights (CMS IMRT technical reference 
2004). Xio uses a “conjugated gradient” optimization algorithm (Nocedal & Wright 2000, 
Press et al 2002). The IMRT delivery is segmental IMRT or commonly known as “step & 
shoot”. The MLC segmentation is based on the algorithm of Convery & Rosenbloom 
(1992).  
 
An Elekta Synergy linear accelerator (Elekta, Crawley, UK), equipped with 80-leaf MLC, 
was used for segmental IMRT. The Elekta MLC replaces the conventional upper 
collimators and has a back-up collimator below the MLC. The linac has 6, 10 and 18 MV 
photon beams and 6, 9, 12, 15, 18 and 20 MeV electron beams. The treatment energy 
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used for IMRT was 6 MeV photons. The linac and TPS were interfaced with IMPAC 
(IMPAC Medical System Inc, CA) treatment record and verification system. 
 
6.2.2  IMRT Beam Modelling 
The Superposition dose calculation algorithm (Mackie et al 1985, Ahnesjo 1989, 
Metcalfe et al 1990, Papanikdaou et al 1993, Hoban et al 1994, Miften et al 2000) was 
modeled in CMS Xio. The algorithm computes the dose by convolving the total energy 
released in the patient with Monte Carlo-generated energy deposition kernels computed 
by Mackie et al (1988).  
 
 
Figure 6.1. In the superposition process, dose at r is calculated due to TERMA at 
all interaction sites r’ via the kernel value corresponding to r-r’. 
 
If the total energy imparted to a unit mass at r’ is the TERMA, T(r’), the energy deposited 
in the unit volume at another point r due to this energy imparted is given by T(r’) H(r-r’), 
where H(r-r’) is the kernel value comprising primary and scattered components, for a 
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displacement r-r’ from the kernel origin. The total dose at r is given by integrating over 
all unit masses in the irradiated volume. With the kernel separated into primary Hp and 
scattered Hs components, the dose is given by 
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where )'(rρ is the density at the interaction site and aveρ  is the average density along the 
straight line path between the interaction and dose deposition sites. 
 
The poly-energetic TERMA is given by 
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where n)/( ρμ  is the mass attenuation coefficient for energy component n, and nψ (r’) is 
the energy fluence of primary photons in spectral component n. 
 
The accelerator central axis (CAX) and off-axis (OAX) energy spectra were the primary 
physical data required to model the superposition dose calculation algorithm. The 
modelling process involved multiple cyclic iterations of the energy spectra and various 
beam parameters until the required accuracy of 2% or 2 mm (at steep dose gradient 
region) was achieved (Van Dyk et al 1993). The beam parameters included collimator 
transmission, MLC transmission, penumbra focal radiation sigmas and extra focal 
radiation sigma. The penumbra focal radiation sigmas are parameters to convolve the 
incident fluence distribution with various Gaussian functions to mimic penumbra effects 
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as defined at various stages of the accelerator head (collimator, MLC, block). Larger 
values of sigmas produced narrower profiles with more sloped penumbra while smaller 
values produced squarer cornered profiles with steeper penumbras. While a shielding 
block is not used in IMRT, the sigma for shielding block is still needed in the beam 
model. The extra focal radiation sigma is a parameter used to convolve an initial fluence 
distribution which would be scaled using the head scatter to primary fluence ratio 
(determined automatically by the CMS Xio software) added to the incident fluence to 
model the extra-focal fluence contribution. The main effect of the head scatter 
contribution on dose distributions is the contribution to dose outside the field edge. 
Varying the extra-focal radiation sigma results in a very subtle change outside the field 
edge. The default minimum TERMA extent of 4 cm was used in the beam model. This 
value represented the distance beyond the field edge for TERMA calculation. 
 
The poly-energetic CAX and OAX linac energy spectra derived by Sheikh-Bagheri & 
Rogers (2002) were used as the starting point of the iterative process. The OAX spectra 
values were defined at a distance of 12.5 cm from the CAX, 100 cm from the source 
(hence also termed tan 0.125). Xio TPS linearly interpolates the spectra between the CAX 
and 12.5 cm. Beyond 12.5 cm, it uses OAX spectra only. The OAX spectra correct for 
unique characteristics of the flattening filter in the linac head. In general, OAX spectra 
should have a lower average energy than CAX spectra. 
 
Xio used the 40 x 40 cm2 large field diagonal profile measured in water to model the 
incident lateral fluence distribution. This is valid if few electron contamination artifacts 
exist and excessive scatter at the edge of the profile does not exit. Otherwise, it is 
necessary to carefully measure the fluence in air with a build-up cap to remove electron 
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contamination, or to edit the intensity distribution manually to get a good fit in the beam 
model. The diagonal profile measured at depth of maximum depth, dmax, (dmax = 1.5 cm) 
was used as the starting point in beam modelling. 
 
The reference output of the linac was set at 10 cm depth for a reference field size of 10 x 
10 cm2 using the AAPM’s TG-51 photon beam dosimetry protocol (Almond et al 1999). 
The radiation output was calibrated in water so that 1 monitor unit (MU) delivered 1 cGy 
at dmax at the isocentre. 
 
6.2.2.1  Beam Data Measurements for Beam Modelling 
The CMS Xio TPS does not account for the round leaf end of the Elekta MLC. To 
account for the round leaf end of the MLC, the position of the MLC was calibrated to the 
50% decrement line of the radiation field (Ezzell et al 2003, Cadman, et al 2002, 
Williams & Metcalfe 2006). This was done before any beam data were measured. Data 
required for the 6 MV photon IMRT beam included percentage depth dose (PDD), 
diagonal profile scans of the largest open field, open field aligned profile scans, field 
output factors (Sc,p), collimator factor (Sc), MLC transmission factor and collimator 
transmission factor. The Scanditronix-Wellhofer Blue Phantom 3D dosimetry scanning 
system was used along with the Omni-Pro Accept software version 6.3 (Scanditronix-
Wellhofer, Bartlett, TN). All the PDD and profile scans were measured at a source to 
water surface distance (SSD) of 100 cm. The effective points of measurement for ion 
chambers and diodes recommended by the AAPM’s TG-51 protocol were used. 
 
PDD along the beam central axis were scanned with CC13 ion chambers (Scanditronix-
Wellhofer) for the field sizes 4 x 4 cm2 to 40 x 40 cm2. The air cavity volume of the 
chamber is 0.13 cm3 (cavity length: 5.8 mm, cavity radius: 3 mm). A small volume CC04 
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micro-chamber of air cavity volume 0.04 cm3 (cavity length: 3.6 mm, cavity radius: 2 
mm) was also used for PDD measurement for smaller field sizes from 2 x 2 cm2 to 15 x 
15 cm2. When measuring 2 x 2 cm2  PDD, point-by-point measurement was used without 
a reference chamber to avoid any possible perturbation caused by the reference chamber. 
The 5 x 5 cm2 and 10 x 10 cm2 PDDs were repeated using the micro-chamber in the point-
by-point and scanning fashions to test if the chamber has any non-linear response to dose 
rate. 
 
Beam profiles were measured with diode detectors (Scanditronix-Wellhofer PFG3G 
photon diode) for better spatial resolution. The diameter of the active measuring area is 2 
mm with a thickness of the active volume of 0.06 mm. Diagonal profiles of the largest 
field size of 40 x 40 cm2 were measured at depths of dmax, dmax – 0.5 cm, dmax + 0.5 cm, 1, 
2, 3, 5, 10, 20, and 30 cm. Open field aligned profile scans were measured for MLC 
formed square fields of 2 x 2 cm2 to 40 x 40 cm2 were measured at depths of dmax, 5, 10, 
15, 20 and 30 cm. The open profile scans were repeated for the MLC formed field but 
without the MLC backup jaws for field sizes 5 x 5 cm2, 10 x 10 cm2, and 30 x 30 cm2, 
and the position was offset by 5 mm to avoid scanning at the interleaf position. The 
repeated scans were to check if there were any discrepancies compared with scans 
measured for the MLC formed fields with the back up jaws. 
 
For field output factor (Sc,p) measurements for field sizes 4 x 4 to 40 x 40 cm2, the CC13 
ion chamber was placed at the isocentre and at the reference depth of 10 cm in water. The 
small volume CC04 micro-chamber was used for field sizes from 1 x 1 to 15 x 15 cm2. 
100 MU was used for each measurement. The central diode (0.8 mm x 0.8 mm) of the 
MapCheck (Sun Nuclear, Melbourne, FL) diode array was also used for the output factor 
measurement for the field sizes from 1x1 to 15x15 cm2 (Letourneau et al 2004). The 
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MapCheck measurements were performed with a water equivalent buildup of 10 cm with 
the diode placed at isocentre. Collimator factors (Sc) were calculated from published data 
(Storchi & van Gasteren 1996).The data were previously validated within an accuracy of 
1% with another Elekta linac of identical energy and treatment head using the method 
proposed by Jursinic & Thomadsen (1999). 
 
For collimator transmission factor measurement, a 0.6cc ion-chamber (PTW 30013) was 
used with a build-up cap. As the lower collimator pairs cannot travel across the isocentre, 
an off CAX 10x10 cm2 field was used. Therefore, the position of the right collimator was 
set at 0 (i.e. at the isocentre) while the left collimator was set at 10 cm. The centre of the 
field was at 5 cm lateral to the isocentre. The chamber was placed in air at the field 
centre. The dose was measured with a MU setting of 100. The left collimator was then 
moved from the position of 10 cm to 0.5 cm and the ion chamber was completed shielded 
by the left collimator.  The dose measurement was then repeated with 100 MU. The ratio 
of these measurements was the collimator transmission factor. 
 
For MLC transmission factor measurement, Xio TPS needs the true MLC-only 
transmission but not the combination of MLC and the MLC back-up collimator. For 
Elekta linacs, the conventional upper collimator was replaced by the MLC and the MLC 
back-up collimator. The MLC back-up collimator is much thinner than the conventional 
upper collimator (3 cm vs. 8.5 cm of tungsten typically).  The function of the MLC back-
up collimator is to further reduce MLC transmission, in particular the inter-leaf 
transmission. Xio TPS does not separately account for the interleaf and intraleaf leakages. 
For the open field measurement, the 0.6cc ion chamber with the build-up cap was placed 
at the isocentre and at the centre of a 10 x 10 cm2 field. The MU setting was 100 MU. 
Measurement was repeated after one bank of the MLC traveled 4.5 cm across the CAX to 
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shield the ion chamber, while the position of the back-up collimators remained 
unchanged. The ratio of the measurements was the MLC transmission factor. 
 
6.2.3  Dose Verification of IMRT Fields 
The anthropomorphic head phantom supplied by the Radiological Physics Centre (RPC) 
at the University of Texas, M.D. Anderson Cancer Centre in Houston was used for 
verification of the IMRT dose calculation. The planning and irradiation of the phantom 
using IMRT techniques is a credentialing requirement for the RTOG H-0022 IMRT 
treatment protocol. 
 
Figure 6.2. The RPC IMRT head phantom is shown on the left while a transverse 
CT image of the phantom is shown on the right. The CT slice shows the positions 
of the primary PTV, secondary PTV, organ at risk and their TLDs (circular 
shape). Radiochromic films are imbedded in the axial and sagittal planes through 
the centre of the primary PTV. 
 
The phantom houses a rectangular dosimetry polystyrene insert of dimension 7.5 cm x 
10.5 cm x 13 cm, which includes TLDs and radiochromic film (GAFChromic MD-55-2 
films; Nuclear Associates, NY) in various locations. TLD-100 powder, placed in custom-
built capsules is used as an absolute dosimeter. The capsules are small cylinders with 
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outer dimensions of 5 mm (height) x 5 mm (diameter), with a 1-mm wall thickness. Each 
capsule holds approximately 40 mg of powder that yields two readings. The accuracy of 
the TLD for absolute dose is within +4% at a 90% confidence interval, with a precision to 
within +3% (Molineu et al 2005). The recommendations for the handling and evaluation 
of radiochromic film for use in dosimetry were followed (Molineu et al 2005). 
 
Figure 6.2 shows the hollow phantom head with the insert in place. The crown of the head 
is removable so that insert can be placed into its watertight housing. The base contains a 
port that allows the shell to be filled with water during CT scanning and IMRT dose 
delivery. The base is fitted with adjustable screws so that the head can be placed on the 
type of headrest commonly used in clinics.  
 
The insert contains primary and secondary planning target volumes (PTV1 and PTV2) 
plus a critical structure region or organ at risk, OAR (spinal cord) which are easily 
identifiable on CT (see Figure 6.2). TLDs are contained within the superior and inferior 
positions of PTV1, a third TLD is located at the centre of PTV2 and a forth TLD is 
centred in the critical structure. Radiochromic films are also contained in the axial and 
sagittal planes through the centre of the primary PTV. 
 
The RPC phantom was imaged using a GE Hi-speed CT scanner (GE Healthcare, 
Piscataway, NJ). The dose prescription, which was a factor of 10 lower than the RTOG 
protocol, was 6.6 Gy to at least 95% of the primary PTV and 5.4 Gy to at least 98% of the 
secondary PTV. Only 1% or less of the primary and secondary PTVs could receive less 
than 93% of the prescribed dose. The OAR was to receive less than 4.5 Gy and the 
normal tissue could not receive more than 110% of the primary PTV prescription dose. 
IMRT fields were planned with the CMS Xio TPS with the 6 MV IMRT beam being 
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modelled. An equally spaced 6-MV x-ray, 5-field arrangement was used and the plan met 
all the dose and volume prescriptions. The mean dose to the whole active volume of the 
TLD was used in the measured vs. calculated dose comparison. 
 
6.2.3.1  In-house Dose Verification 
Three phantoms were used in the in-house dose verification process – a “solid water slab” 
phantom, a MapCheck test phantom and a Med-Tech IMRT phantom (MedTech, Orange 
City, IA). The dimension of the “solid water slab” phantom was 30 cm (W) x 30 cm (L) x 
20 cm (H) and was made of various thicknesses of solid water slabs of 30 cm (W) x 30 
cm (L) (Gammex RMI, Middleton, WI). The MapCheck test phantom, as shown in Figure 
6.3, consisted of the MapCheck diode array and an added 3 cm solid water slab of 30 
cm(W) x 30 cm(L). The MapCheck 2D diode array, as shown in Figure 6.3(a), contains 
445 n-type diodes distributed over an area of 22 x 22 cm2. The diode spacing is 7.07 mm 
in the 10 x 10 cm2 central portion of the detector and increases to 14.14 mm outside of 
this area. Each individual MapCheck diode is 0.8 x 0.8 mm2. The diode detector plane has 
a 2 cm thick water-equivalent buildup material and a 2.3 cm thick water-equivalent 
backscattering material.  
 
 
Figure 6.3. (a) The MapCheck 2D diode array, and (b) the MapCheck phantom 
comprises 3 cm  thick solid water slab added to the MapCheck diode array. 
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The dimension of the Med-Tech IMRT phantom is 30 cm (H) x 35 cm (L) x 17 cm (W) 
and is made of solid water (see Figure 6.4). The Med-Tech IMRT phantom has pre-drilled 
housings for ion chamber at various locations for dose measurement. Ready-packed 
radiographic film can be placed in between phantom slabs for film dosimetry. The three 
phantoms were scanned by the GE Hi-speed CT scanner and the images were exported to 
the Xio TPS for dose calculation. 
 
 
Figure 6.4. The Med-Tech IMRT phantom has pre-drilled housings for ion 
chamber at various locations for dose measurement. Ready-packed radiographic 
film can be placed in between phantom slabs for film dosimetry. 
 
For dose verification in the “solid water slab” phantom and the Med-Tech IMRT 
phantom, a 0.6 cc Farmer type ion chamber (PTW 30013) was used. The mean dose of 
the volume dose value of the ion chamber was calculated in the Xio TPS instead of a 
point dose to account for the volume effect of the ion chamber. The MapCheck phantom 
was used for 2D dose distribution verification for each beam. Kodak EDR2 film was used 
in the Med-Tech IMRT phantom for composite beam dosimetry (i.e. total dose delivery 
for all 5 beams with each beam at its designated gantry angle). For all the in-house 
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phantom measurements, the 5-field plan was scaled down by a factor of 3 to avoid any 
potential saturation of the detectors (e.g. diode).  
 
For the dose verification using an ion chamber, the ion chamber was placed at the 
isocentre. For the “solid water slab” phantom, the ion chamber was placed at a depth of 
10 cm in a “solid water slab” phantom. All the beam gantry angle were set at 0° (IEC 
61217 convention, i.e. gantry pointing vertically downward) for the “solid water slab” 
phantom for dose analysis and also for the MapCheck phantom analysis for 2D dose 
distribution analysis. The mean dose to the whole active volume of the ion chamber was 
used in the measured vs. calculated dose comparison. The validity of the use of the 
MapCheck diode array for IMRT 2D dose distribution analysis was well documented 
(Jursinic & Nelms 2003, Letourneau et al 2004). The detector plan of the MapCheck 
phantom was placed at the isocentre for dose measurement. 
 
For the Med-Tech IMRT phantom for composite beam analysis, the chamber was placed 
at the isocentre with the dose delivered by each IMRT field at its designated gantry angle. 
The planar dose at the isocentre for the composite beam was also measured using Kodak 
EDR2 film. The film was placed in the Med-Tech IMRT phantom in the transverse plan 
containing the isocentre. The film was placed in parallel with the radiation beams. The 
recommendations for the handling and evaluation of EDR2 film dosimetry were followed 
(Zhu et al 2002, Shi et al 2006). The EDR2 film was scanned using the VXR-12 Plus 
Dosimetry film digitizer (Vidar, Herndon, VA). The RIT 113 (v4.1) software (RIT, 
Colorado, CO) was used for the film analysis. 
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6.2.3.2  RPC Dose Verification 
For the RPC validation, the RPC IMRT phantom was placed on the treatment couch and 
positioned with lasers and phantom fiducials. The dose was delivered with the planned 5-
field segmental IMRT arrangement, which met the RPC dose prescriptions. 
 
6.3 Results and Discussion 
6.3.1  IMRT Beam Modelling 
Comparing the PDD measured by the CC13 ion chamber for field sizes 4 x 4 cm2 to 15 x 
15 cm2, the PDD measured by the CC04 micro-chamber for the same field sizes showed 
excellent agreement to within 0.5%. Figure 6.5 shows the comparison of the PDD 
measured by the CC13 and CC04 ion chambers for the field size of 5 x 5 cm2. In addition, 
the PDD were identical for the field sizes of 5 x 5 cm2 and 10 x10 cm2 measured by the 
micro-chamber with point-by-point and scanning fashions. Therefore, the PDD measured 
by the CC04 micro-chamber, including smaller field size PDD of 2 x 2 cm2, were valid. 
 
 
Figure 6.5. Comparison of percentage depth dose measured by the CC04 and 
CC13 ion chambers for the field size of 5 x 5 cm2. Agreement is within 0.5%. 
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Among other beam parameters, the Xio TPS required field output factors for field size as 
small as 1 x 1 cm2. The output factors of the 6 MV photon beam measured for different 
field sizes with the MapCheck central diode, the CC13 and CC04 chambers are presented 
in Figure 6.6. The results are normalized to the 10 x 10 cm2 field. For field sizes equal to 
2 x 2 cm2 or larger, the output factors measured by the diode and CC04 agree to within 
1.5%. For the field size of 1 x 1 cm2, the dimension of the detector has a major effect on 
the accuracy of the measurement due to the volume effect of the detector (Laub & Wong 
2003). The output factor measured by the CC04 chamber for the 1 x 1 cm2 field is 6% 
lower than that measured with the MapCheck diode. Despite its small active dimension (4 
mm diameter by 3.6 mm active length), the CC04 chamber seems less suitable than the 
0.8 x 0.8 mm2 MapCheck diode. The 1 x 1 cm2 output factor measured with the diode 
agrees to within 2% of published data (Haryanto et al 2002, Letourneau et al 2003, Laub 
& Wong 2003). Therefore, the 1 x 1 cm2 output factor measured with the diode was used 
in the beam model. 
 
 
Figure 6.6. 6 MV field output factors measured by diode, CC13 and CC04 ion 
chambers. The factors were normalized to 10 x 10 cm2 field. 
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The measured collimator and MLC transmissions were 0.5% and 2.1% respectively. The 
measured MLC transmission can be regarded as the average effect of  inter- and intra-leaf 
transmissions. The measured values were used in the beam model. 
 
The modelling process for the Superposition algorithm involved multiple cyclic iterations 
of the energy spectrum and various parameters until the required accuracy of 2% or ±2 
mm (at steep dose gradient) for all field sizes was achieved. The iterations process 
involved varying the CAX energy spectrum to get a good fit of the PDD in comparison 
with the measured PDD of all field sizes. This was followed by tuning the OAX energy 
spectra for profile matching at varied depths. Figure 6.7 (a) shows the final energy spectra 
used in the Superposition beam model after multiple cyclic iterations. The mean energy of 
the 6 MV beam was 2.04 MeV while the mean energy of the OAX energy spectra was 
1.82 MeV.  
 
Figure 6.7 (a). The beam spectra used in the 6 MV Superposition beam model. 
The mean energies are 2.04 MeV and 1.82 MeV for the CAX and OAX spectra 
respectively. 
 
It is important to note that the spectral distribution for Convolution and Superposition 
beam models is simply chosen to match correct depth dose and dose profiles and does not 
necessarily match those beam spectrum produced using Monte Carlo method, such as 
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BEAMnrc (Ottawa, Canada). BEAMnrc is a widely used Monte Carlo code system in 
radiation therapy physics for simulating radiation therapy sources (Francescon et al 2000, 
Jeraj & Keall 2000, Sheikh-Bagheri & Rogers 2002). Figure 6.7 (b) shows the 
comparison of the CAX beam spectra for the modeled 6 MV Superposition beam and the 
published 6 MV spectra for the Elekta and Varian linacs calculated by BEAMnrc 
(Sheikh-Bagheri & Rogers 2002). 
  
Figure 6.7 (b). A comparison of the CAX beam spectra for the modeled 6 MV 
Superposition beam (Curent (Elekta 6x)) and the published 6 MV spectra for the 
Elekta (BEAM (Elekta 6x)) and Varian (BEAM (Varian 6x)) linacs calculated by 
BEAMnrc. 
 
The diagonal profile of the 40 x 40 cm2 field at various depths was used to model the 
incident lateral fluence distribution as part of iteration process. Subsequently, the 
diagonal profile at 1.5 cm along with the energy spectra was used to achieve the best fit. 
While the off-axis beam spectra had negligible effect on the CAX PDD, it affected the 
accuracy of the beam model in the off-axis region at different depths. Figure 6.8 shows 
the comparison between the measured PDD and the calculated PDD for a 10 x 10 cm2 
field.  
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 Figure 6.8. The agreement between calculated and measured PDD for all fields 
are well within the 2% / 2 mm criterion. Shown here is the comparison for the 10 
x 10 cm2 field. Doses are normalized to 100% at the depth of 10 cm. 
 
From the measured beam profiles, the difference in penumbra between the collimator, the 
MLC with and without the backup jaws was negligible. Using the measured beam profiles 
for MLC formed fields as reference, the value of 0.12 for the penumbra focal radiation 
sigmas for collimator, MLC and block were used to achieve the required accuracy 2% or 
±2 mm (at steep dose gradient) after multiple iterations. Figure 6.9 shows the comparison 
between the measured and calculated profiles at different depths for a 10 x 10 cm2. 
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 Figure 6.9. The agreement between calculated and measured profiles at various 
depths for all fields is within the 2% / 2 mm criterion. Shown here is the 
comparison for the 10 x 10 cm2 field. 
 
Xio TPS (v4.3) offers a simple model for the MLC. Varying the available beam 
modelling parameters of penumbra focal radiation sigmas and leaf transmission to obtain 
the best match between calculated and measured profiles for MLC leaves is indirect and 
restricted. The shape of the dose profile in the vicinity of the leaf ends and underneath the 
leaf is compromised. 
 
Monitor unit (MU) calculations of the beam model for square fields for field sizes from 4 
x 4 cm2 to 35 x 35 cm2 at 5 cm, 10 cm and 20 cm depths in water for SSD and SAD 
setups were verified in water according to Van Dyk et al 1993, with a PTW 31003 
Farmer chamber and a Keithley 617 electrometer (Cleveland OH). The accuracy of the 
MU calculations was all within 1%. 
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6.3.2  Verification of IMRT Fields 
6.3.2.1  In-house Phantom Measurements 
An IMRT plan comprising 5 equally spaced IMRT fields was planned which met the RPC 
dose prescription for the IMRT head phantom. A total of 93 beam segments were used. 
The MU for each beam was scaled down by a factor of 3 for the dose verification process 
using the in-house phantoms.  
 
Table 6.1 shows the results of the dose measurement in the “solid water slab” phantom 
using ion chamber and also the 2D planar dose measurement in the MapCheck phantom. 
A nominal gantry angle of 0° was used for all beams for these two phantoms. For the 
“solid water slab” phantom, the ratio of the calculated mean dose to the measured dose at 
10 cm depth at the isocentre was 0.994, which is well within the acceptable criterion of  
±3%. For the MapCheck result, the 2D measured planar dose was in good agreement with 
the calculated dose distribution. Figure 6.10 shows the 2D dose difference analysis by the 
MapCheck software for one beam. The calculated dose map is shown in gray scale in the 
background (shown in upper right) with the failed diodes - blue or red diodes for negative 
and positive differences respectively. The pass rate for all beams with ±3%/2mm dose 
agreement criterion was better than 95%. The failed points were examined and they were 
all in the low dose and/or high dose gradient regions. 
 
Table 6.1. Good agreement in dose measurements in the “solid water slab” 
phantom using ion chamber and also the 2D planar dose measurements in the 
MapCheck phantom. Gantry angle for all beams were at 0°. 
86 
 Figure 6.10. Result of 2D dose difference analysis by the MapCheck software for 
one beam. The calculated dose map is shown in gray scale in the background 
(shown in upper right) with the failed diodes - blue or red diodes for negative and 
positive differences respectively. The pass rate for this beam is 96.7% for 
±3%/2mm criterion. 
 
For the composite beam analysis in the Med-Tech phantom, the ion chamber was placed 
at the isocentre and the 5 IMRT fields were delivered to the phantom at their designated 
gantry angles. The ratio of the calculated mean dose to the measured dose was 0.988 and 
again was well within the acceptable criterion of ±3%. 
 
To provide a quantitative measure, gamma analysis was performed on the evaluated 
composite beams measured by the EDR-2 film (Low et al 1998). The Xio planar dose 
map was compared to the measured doses. The dose agreement criterion of 3% or 2 mm 
was used in the analysis (Palta et al 2003). Figure 6.11(a) shows the calculated dose while 
Figure 6.11(b) shows the threshold gamma map for the planar dose calculated by Xio. 
The locations where the gamma value equal to or greater than 1 indicates 3% or 2 mm 
tolerance was exceeded. Within the PTVs and the organ at risk, the gamma analysis 
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shows good agreement. The deficits in agreement are mainly in the low dose and steep 
dose gradient regions. This may due to the slight misalignment of the irradiation setup 
(e.g. gantry angle and phantom positioning) and also the alignment of image registration 
between the calculated planar dose map and the measured dose map. 
 
The CMS Xio TPS beam model does not account for the round leaf end of the Elekta 
MLC. It is therefore necessary to stress the importance of the MLC being calibrated to 
match the radiation field within a precision of ±0.2 mm. During the dose verification 
process, each MLC was deliberately shifted by approximately ±1 mm from its calibrated 
position. The MLC shift resulted in an average of ±5% change in dose from the dose 
measurements. The dose disagreement caused by the ±1 mm was in general agreement as 
reported by Cadman et al 2002. Therefore, MLC quality assurance, such as the use of 
picket fence patterns (Ezzell et al 2003), should be performed on a daily basis. 
 
 
Figure 6.11. (a) Calculated relative dose distribution and (b) threshold gamma 
map for the planar dose calculated by Xio. The locations where the gamma value 
equal to or greater than 1 indicates 3% or 2 mm tolerance was exceeded. X and Y 
axis for both figures are pixel values. The dimension of each pixel is 0.4 mm2. 
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6.3.2.2  RPC Phantom Measurements 
The RPC provided a report of their independent evaluation of the TLD and radiochromic 
film measurement for the RPC IMRT head phantom. The four TLD capsules, two for the 
primary PTV and one for the secondary PTV and OAR, provided dose information. The 
radiochromic films provided dose profiles through the centre of the primary PTV.  
 
Film profiles through the centre of the primary PTV were scaled to TLD dose values. The 
results were plotted with dose distribution calculated by TPS. The displacement between 
the measured dose gradient and the TPS calculated dose gradient, as defined by RPC, was 
determined in the region between the primary PTV and the OAR.  
 
Table 6.2 summarizes the RPC results and Figures 6.12 and 6.13 show the dose profile 
measurements 
 
Location Measured / Calculated 
Primary PTV superior 1.00 
Primary PTV inferior 0.98 
Secondary PTV 0.97 
OAR (dose) 0.93 
OAR (dose gradient displacement) 0 mm 
 
Table 6.2. RPC results for the RPC IMRT phantom. The IMRT beam model 
meets the RPC credential criterion of ±7% for PTVs and ±4 mm for OAR dose 
gradient displacement.  
 
RPC TLD measurements showed good agreement with the Xio TPS calculation for the 
primary and secondary PTVs, and the results were within experimental error. The 
measured dose for the critical structure was 7% lower than the calculated mean dose. This 
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may due to the steep dose gradient and lower dose in the OAR region. Therefore, RPC 
did not use the absolute dose measurement for the OAR as one of their acceptable 
criterion. Instead, the displacement of the dose gradient in the region between the primary 
PTV and the OAR was used. Film results showed good displacement agreement between 
measured and calculated profiles. While the RPC defined dose gradient displacement (i.e. 
between primary PTV and OAR) was excellent, the discrepancy for other dose gradients 
was good and was within 2 mm.  
 
Figure 6.12. RPC film result showing the anterior – posterior profile. 
 
Figure 6.13. RPC film result showing the superior - inferior profile. 
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RPC’s criteria for credentialing individual institution to enter patients into RTOG 
protocols that allow the use of IMRT is ±7% for the primary and secondary PTVs, and a 
dose gradient displacement ≤4 mm for the organ at risk. The results meet all the 
acceptance criteria. 
 
6.4 Conclusion 
This study provides a systematic guideline for effective clinical implementation of IMRT 
in radiotherapy centres, starting from beam data collection, following by beam modelling 
and subsequently dose distribution verification. Limitations of the beam model need to be 
fully understood in the implementation process, in particular its modelling parameters for 
the MLC. Despite the beam model not taking in account for the effects of transmission 
through round leaf ends, adjusting the leaf position to account for the effective widening 
of the leaf opening shows good dose agreement in the in-house dose verification process.  
The RPC IMRT phantom provides a valuable independent check by RPC on IMRT 
commissioning, validation and QA process. The in-house dose verification process can be 
adopted as the patient specific IMRT QA process.  
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Chapter 7 
Conclusion and Future Developments 
 
7.1 Conclusions 
 
The thesis investigates several methods of improving treatment dose accuracy in radiation 
therapy through the results presented as four distinct studies. Chapter 3 investigates the 
sources of errors of a widely used correction-based dose calculation algorithm in HDR 
brachytherapy, and to provide a method to improve the dose calculation. Chapter 4 
investigates the effect of transit dose in the target volume of an HDR brachytherapy 
stepping source. Chapter 5 investigates the effect of radiation detector size in the 
dosimetry of small fields and steep dose gradients with a particular emphasis on IMRT 
measurements. Chapter 6 investigates the use of various dosimetric detectors and methods 
for clinical implementation and dosimetric verification of a 6 MV photon beam for 
IMRT. 
 
 
 Treatment dose calculations in HDR brachytherapy using a stepping source and IMRT 
using external beams have been improved. For HDR brachytherapy, the BPS dose 
calculation algorithm based on the point source approximation, both the radial dose 
distribution and source anisotropy can introduce errors in the near field where the 
distance is less than 1 cm from the source centre. At the dose point P located at 0.25 cm 
in water from the transverse bisector of a 2 cm active source length catheter, using the 
BPS formalism and variants the dose difference as compared to the Monte Carlo (MC) 
calculation is 15.4%. It is straight forward to modify the BPS formalism to the AAPM 
TG-43 recommended formalism. It has been found that by replacing both the BPS’s ϕ (r) 
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and F(θ) with MC calculated g(r) and F(r,θ), 1% dose calculation accuracy can be 
achieved even in the near field. Indeed, most HDR treatment planning systems have 
adopted this approach now. 
 
With this improvement in dose calculation accuracy for HDR brachytherapy using a 
stepping source, most treatment planning systems still only calculate the dose from the 
stationary dwell positions and ignore the dose contribution while the dose is in transit. It 
has been found that the transit speed of the stepping source in the Nucletron 
microSelectron HDR afterloader increases with the increase in its distance travelled. The 
afterloader compensates the inter-dwell transit dose by reducing the actual dwell time at 
each dwell position. Otherwise, the slower speed of the source for step sizes smaller than 
10 mm may create noticeable dose errors in the PTV.  Therefore, the transit dose for the 
microSelectron HDR afterloader is mainly contributed by the entry and exit components. 
The transit speed for the entry and exit movement of the source is found to be 467 mm/s. 
With this high transit speed, the transit dose to the PTV is negligible. However, the transit 
dose may be significant for tissue residing along the source path outside the PTV. 
Knowing the transit speed of 467 mm/s for the source entry and exit movement, the 
transit dose to the organs at risk can be calculated if necessary. Care should be taken for 
other HDR treatment systems as they may not account for the transit dose as the 
microSelectron HDR afterloader. 
 
For IMRT using external beams, the volume effect of detectors could lead to inaccurate 
dose measurement and calculation and subsequently leads to inaccurate conclusions upon 
clinical verification of IMRT plans. Because of the insufficient spatial resolution of the 
detector that was used to collect beam data for the commissioning of IMRT planning 
systems, relative discrepancies of more than 10 % were found between calculated cross 
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profiles and profiles measured with film. The results demonstrate that the commissioning 
of IMRT treatment planning systems with detectors that have a limited spatial resolution 
can lead to the introduction of systematic errors. The MLC positioning accuracy is 
equally important and requires appropriate quality assurance tests as well. Output factor 
measurements with different detectors demonstrate that both, spatial resolution and water-
equivalence of the used detector are important for output factor measurements in small 
fields.  
 
A systematic procedure for effective clinical implementation of IMRT in radiotherapy 
centres has also been developed. It highlights the proper clinical beam data collection 
methods, followed by beam modelling and subsequently IMRT dose distribution 
verification. Limitations of the beam model need to be fully understood and accounted for 
in the implementation process, in particular its modelling parameters for the MLC. 
Despite the beam model ignoring the effects of transmission through round leaf ends, 
adjusting the leaf position to account for the effective widening of the leaf opening shows 
good dose agreement in the in-house dose verification process.  The RPC IMRT phantom 
provides a valuable independent check by RPC on IMRT commissioning, validation and 
QA process. The in-house dose verification process can be adopted as the patient specific 
IMRT QA process.  
 
While MLC systems employ leaves with rounded ends in an attempt to keep the 
penumbra relatively constant over the range of leaf travel, the partial transmission 
through the rounded leaf ends can affect the dose accuracy for IMRT (Cadman et al 2002, 
Cadman et al 2005, Williams and Metcalfe 2006, Vial et al 2006).  
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For a beam model which does not account for the rounded leaf ends, Cadman et al (2002) 
shows the model is improved if a MLC leaf gap reduction of 1.4 mm is used for a 6 MV 
photon beam for segmental IMRT. This leaf gap reduction, also commonly known as 
radiation field offset (RFO), is needed to obtain an agreement between calculated and 
measured profile 50% dose points. Using film dosimetry, their result indicates that a 
maximum underestimation of calculated dose of 12% if no RFO is used. The discrepancy 
occurs mainly in the high dose gradient region in the vicinity of critical structures. Using 
a RFO of 1.4 mm, the discrepancy between measured and calculated phantom dose values 
is reduced to ±5%. In addition to RFO, Vial et al (2006) shows that a modification of the 
leaf position offset (LPO) table in linacs can further improve dose accuracy. LPO 
accounts for the differences between the geometric leaf position and the projected leaf tip 
position that varies as a function of distance from the collimator central axis due to the 
MLC geometry. Using film and ion chamber measurements of segmental and dynamic 
IMRT fields, RFO can be measured to within 0.1 mm accuracy at the central axis and 
LPO can be measured to within 0.2 mm at the off-axis positions (Vial et al 2006). 
 
Cadman et al. (2005) improved on existing beam models to account for the rounded leaf 
ends. In this improved model, the MLCs are modeled by creating an effective 
transmission array. This array is created to model the presence of the MLC leaf, the 
rounded leaf ends, and the tongue-and-groove effects. The MLC transmission parameter, 
which is defined as the dose reduction due to the attenuation of a MLC leaf, is used for 
regions below the full thickness of a leaf. In regions below the leaf tip, the rounded leaf 
tip radius and the leaf position offset are used to generate the increase in transmission in 
the transition from the full thickness MLC leaf to the leaf tip. In regions where the tongue 
or groove is at the edge of the field, the transmission is calculated for one-half a leaf 
thickness and applied over the tongue-and-groove width. In regions between two adjacent 
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leaves, a specified additional interleaf leakage transmission is applied over the tongue-
and-groove width. The final effective MLC transmission array is multiplied by the 
incident energy fluence array to incorporate the presence of the MLC. For a head and 
neck IMRT field, the doses calculated by the improved model agree with the measured 
doses at all points to within 1% of the maximum dose of the field (Cadman et al 2005). 
Williams & Metcalfe (2006) shows that the new MLC model provides better agreement 
between the calculated and measured dose for a 6 MV IMRT field. While the largest 
discrepancy of 5% is observed along match-lines between calculated and measured dose, 
the new MLC model predicts the presence of match-lines and is a significant 
improvement over the model which does not account for the rounded leaf ends (Williams 
& Metcalfe 2006). 
 
It is important to ensure the accuracy of the leaf position through routine quality 
assurance measurements. A leaf position error of 1 mm for a 1-cm dynamic IMRT field 
could give a 10% error in delivery dose (Losasso et al 1998). For the segmental IMRT 
plan which meets the RPC dose prescription for the IMRT phantom, a 1-mm leaf position 
error introduces a dose error of 5% as measured with an ion chamber in the in-house 
“solid water slab” phantom. 
 
The current beam model in the CMS Xio treatment planning system does not account for 
the rounded leaf ends. Adjusting the leaf position to the 50% of the measured profile as 
reported in the previous paragraphs is effectively to apply the RFO caused by the rounded 
leaf ends. To better model the Elekta MLC system, a separate collimator transmission 
factor should be used for the upper collimator (MLC backup collimator) and the lower 
collimator as they are very different in transmission. In addition, an improved MLC 
model is needed to account for the inter-leaf and intra-leaf MLC transmissions, rounded 
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leaf tip radius, tongue-and-groove width and MLC leaf position offset as a function of the 
nominal MLC leaf position. 
 
7.2 Future Development 
While improving dose calculation accuracy is a fundamental and one of the most 
important processes in improving accuracy and precision in radiation therapy, various 
uncertainties in the entire radiation therapy process need to be considered. These 
uncertainties include the limits of the capabilities of imaging devices to reveal the true 
extent of the disease, the inter-fraction variations of anatomy at the time of treatment 
relative to the time of imaging, the intra-fraction variations of anatomy during treatment 
and imaging, and the variation of dose-response of individual patient. While the 
accelerating use of fluorine-18 deoxygloucose – positron emission tomography (FDG-
PET) in recent years offers functional imaging to improve staging and tumour delineation  
of cancer patients, the most exciting development in precision radiation therapy is 
arguably the rapid development in image-guided radiation therapy (IGRT) in reducing 
treatment setup and delivery errors. 
 
The use of 3D conformal radiotherapy has greatly improved the physical conformality of 
treatment planning and delivery. The development of IMRT has provided the “dose-
painting” or “dose sculpting” ability to further customise the delivered dose. Biological 
images using PET reveal metabolic, functional, physiological, genotypic and phenotypic 
data are useful to guide “dose painting” (Ling et al 2000). Hypoxic microenvironments of 
solid tumours contain clonogenic cells that are resistance to radiation therapy and 
chemotherapy. Several radiolabelled markers of viable hypoxic cells in solid tumours 
have been developed and used in clinical image studies, such as the use of 18F-labelled 
fluoromisonidazole (FMISO) with PET (Ling et al 2000, Chapman et al 2001, Piert et al 
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2005). Identification the hypoxia of tumour cells can govern the prescription of novel 
hypoxia-targeted therapy, including increased “dose painting” to resistant tumour regions 
by IMRT. 
 
With conventional radiotherapy technique using external beams, a generous safety margin 
is commonly employed to account for some of these uncertainties. However, with 
conformal and IMRT techniques widely used in current practice, daily setup precision, 
inter- and intra-treatment position reproducibility becomes a more demanding challenge.  
For example, IMRT field design for head and neck commonly introduces relatively steep 
dose gradients between complex primary gross tumour volume, at-risk nodal volumes and 
normal tissue avoidance structures. The potential clinical benefit associated with dose 
reduction to the parotids, optic and auditory apparatus, spinal cord, mandible and other 
normal structures requires that “idealized” IMRT treatment plans are accurately delivered 
throughout the entire treatment course of typically 25-35 daily fractions. Internal organ 
motion can possess a significant challenge to IMRT technique for some treatment sites, 
such as lung and prostate. The motion of internal anatomy with respect to bony structures 
has been the topic of many investigations over the past 10 years with the displacement in 
prostate gland position receiving the most attention (Balter et al 1995, Van Herk et al 
1995, Van Lin et al 2005, De Boer et al 2005). The impact of internal anatomical motion 
has also been investigated in other sites such as lung (Wong et al 1999, Underberg 2005) 
and breast (Bagland et al 2003, Frazier et al 2004).  
 
Patient setup and organ motion uncertainties, if not well account for, can cause significant 
dose discrepancy. The potential magnitude of over- or under-dosing is far greater than 
that which would arise from typical dose calibration error (Harrison 1993, Jaffray et al 
2005). 
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Precision radiation therapy with high dose sparing to organ at risk and/or dose escalation 
to PTV requires IGRT. Several tools and techniques have been developed for IGRT in 
recent years. Examples of IGRT tools include the use of implanted radio-opaque markers 
and mostly recently the electromagnetic wireless transponders (Calypso, Seattle, USA) as 
surrogates for target location, and the use of ultrasound for prostate location. One of the 
new technologies in IGRT is the KV on-board imager attached to the gantry of a linac to 
provide KV-KV planar image matching. The on-board imager and its associated 
processing software can be used to generate and analyze radiographic KV x-ray images 
prior to each patient's treatment, compare them with reference images, and in particular 
with some surrogate fiducial markers such as gold seeds implemented in the target 
volume, from the treatment plan. The information obtained can be used to fine-tune the 
patient's treatment position to reduce inter-fraction errors. The use of a daily kV-kV 
image matching system allows for a more precise system for patient setup compared to 
traditional weekly MV imaging, and also results in a substantial reduction in non-
therapeutic dosage to the patient, an unavoidable consequence of high energy MV setup 
confirmation (Perkins et al 2006). 
 
The most innovative tool in IGRT is arguably the on-board cone-beam CT (CBCT) 
mounted on a treatment linac. Figure 7.1 shows treatment setup error of a patient with 
rectal cancer evaluated using a KV CBCT. The setup error was mainly caused by internal 
organ motion. The left column shows the reference CT used for treatment planning 
(showing coronal, sagittal and transverse plans). The middle and the right columns are the 
images obtained immediately prior to treatment in the treatment room at the 9th and 14th 
fraction using the on-board KV cone-beam CT mounted on the gantry of an Elekta 
Synergy linac recently installed in our centre. Rectal filling and gas in the rectum caused 
significant organ motion and resulted in deformation as well as angular and translational 
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shifts of the PTV (shown in red). Using the “grey-value” image registration method for 
the reference CT and CBCT, up to 1.5 cm shift in the centre of mass of the PTV was 
observed. The angular error was noted to be as high as 15º using rigid body registration of 
the PTV. Without correcting or accounting for these errors, significant dose error will be 
the result. 
 
 
Figure 7.1. Evaluation of setup errors of a patient with rectal cancer using cone-
beam CT mounted on the gantry of an Elekta Synergy linac. The left column 
shows the reference CT for treatment planning (showing coronal, saggital and 
transverse plans). The middle and the right columns are the images obtained 
immediately prior to treatment in the treatment room at the 9th and 14th fraction. 
PTV is shown in red contour and bladder is shown in yellow. 
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To further improve precision and accuracy in radiation therapy, treatment setup and organ 
motion errors for different treatment sites warrant detailed investigation. Precision 
radiation therapy requires clear definition and understanding of four processes – clinical 
objective, margin design, correction strategies and action level. With further 
understanding of treatment setup and organ motion uncertainties, site and patient specific 
margins for PTV and organ at risk can be developed.  This may result in redefining the 
clinical objective (e.g. dose escalation) in relation to adopting appropriate correction 
strategies (e.g. on-line correction, off-line correction, adaptive radiotherapy) and action 
level.  
 
While CBCT attempts to correct for inter-fraction errors, intra-fraction errors due to intra-
fractional anatomical organ motions, such as respiratory and cardiac motions require 
different correction strategies. The use of 4D CT is valuable in studying the impact of 
intra-fraction motion for an individual patient. Depending on the clinical objective and 
PTV margin design, appropriate correction strategies including motion-encompassing 
method, respiratory gated technique, breath-hold technique, forced shallow-breathing 
method and respiration-synchronized technique can be developed (Keall et al 2006). 
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Abstract. The dose rate at point P at 0.25 cm in water from the transverse bisector of a straight
catheter with an active stepping source (Nucletron microSelectron HDR source) with a dwell length
of 2 cm was calculated using Monte Carlo code MCNP 4.A. The source step sizes were 1 cm and
0.25 cm. The Monte Carlo (MC) results were used for comparison with the results calculated
with the Nucletron brachytherapy planning system (BPS) formalism, first with BPS variants and
then with its respective MC calculated radial dose function and anisotropy function. The dose
differences at point P calculated using the BPS formalism and variants are +15:4% and +3:1% for
the source step size of 1 cm and 0.25 cm respectively. This reduction in dose difference is caused
by the increased importance of errors in the anisotropy function with the smaller step size, which
counter the errors in the radial dose function. Using the MC calculated radial dose function and
anisotropy function with the BPS formalism, 1% dose calculation accuracy can be achieved, even
in the near field, with negligible extra demand on computation time.
1. Introduction
There has been a growing interest in recent years in endovascular irradiation to prevent
restenosis caused by intimal hyperplasia in the arteries following angioplasty (Bottcher et al
1994, Liermann et al 1994, Scholpohl et al 1996, Fox 1997). A high dose (typically 12 Gy)
must be delivered to the arterial wall (Waksman 1996). The use of brachytherapy is favourable
to external beams, as such a high dose can be applied to the arterial wall while the dose to the
normal tissue is minimized.
There are advantages and disadvantages in using an HDR stepping source in vascular
brachytherapy as opposed to some beta emitters in the form of liquid, seeds, wires or stents.
However, the use of an HDR stepping source to prevent restenosis has a great potential to
provide quick and easy treatment. Therefore, the accuracy of the dose calculation algorithm
implemented in treatment planning systems to handle near-field dosimetry becomes important
for such an application. Moreover, even for some conventional HDR brachytherapy interstitial
implants, dose points may be placed very close to the catheters or needles (less than 1 cm) due
to the physical configuration of the implants. This requires an algorithm which can calculate
dose accurately in the near field.
There have been several analytical and Monte Carlo dosimetry studies on the
microSelectron HDR brachytherapy stepping source (Podgorsak et al 1995, Williamson and
Li 1995, Dries 1997, Wallace et al 1998a, b, Baltas et al 1998). They have shown that dose
§ Address for correspondence: Radiation Oncology Centre, Austin and Repatriation Medical Centre, Banksia Street,
West Heidelberg, Victoria 3081, Australia. E-mail address: typwong@ozemail.com.au
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calculation algorithms based on a point source approximation would have errors in the near
field (less than 1 cm). These are caused by errors in the radial dose function and the anisotropy
function. Dries (1997) has suggested that the near-field dosimetry accuracy of the Plato
brachytherapy planning system† (BPS) version 13 can be greatly improved by using an HDR
source step size of 0.25 cm instead of 1 cm. He explained that the negative error opposite
the source tips was largely compensated by the positive error opposite the source centre when
the source was moved to the next dwell position at 0:25 cm. However, the sources of these
positive and negative errors were not fully explained. The present study examines the near-
field dosimetry using the Monte Carlo code MCNP (Monte CarloN particle) version 4A. The
Monte Carlo results are used to validate the accuracy of the BPS, and in particular, focus on
the cause of the reduction of dose calculation differences by reducing the source step size
as reported by Dries (1997). A modified algorithm is also proposed to achieve an accuracy
comparable with Monte Carlo results with negligible extra demand on computation time.
2. Materials and methods
The internal construction and dimensions of the Nucletron microSelectron HDR source as
reported by Williamson and Li (1995) were used for the Monte Carlo simulation. The MCNP
4A Monte Carlo code was used to calculate the dose distribution in water about the source.
A minimum of 5 million source photon histories were simulated for a statistical error of
approximately 1% in dose calculation. Dose distribution along the transverse bisector axis
of the source was first calculated. This was then followed by the calculation of angular dose
distribution at radial distances of 0.25 cm, 0.5 cm, 1 cm, 3 cm, 5 cm and 7 cm from the centre of
the source. Each angular dose profile was normalized to unity at the transverse axis. Readers
are referred to Wallace et al (1998 a, b) for details of the Monte Carlo calculations.
The dose calculation formalism used by the Plato brachytherapy planning system version
13.X (Yeung 1996, Plato BPS Training Manual 1994) is that the dose rate
˙D.r; / D Sk

en

tiss
air
1
r2
’.r/F ./ (1)
where Sk is the air kerma source strength (Gy m−2 h−1), .en=/tissair is the ratio of the mean
mass energy absorption coefficient in tissue and air, having a value of 1.11 for the 192Ir source,
’.r/ is the modified Van Kleffens and Star correction for absorption and scattering in water,
F./ is the anisotropy function and 1=r2 is the geometric factor. Note that equation (1) can
easily be modified to the AAPM TG-43 formalism (Nath et al 1995):
˙D.r; / D Sk3 1
r2
g.r/F .r; / (2)
where 3 is the dose-rate constant for the source and surrounding medium (cGy h−1 U−1)
(1 U D 1 cGy cm−2 h−1/ for the microSelectron HDR source, the value of 3 in water is
1:115 cGy h−1 U−1 (Williamson and Li 1995, Wallace et al 1998a), g.r/ is the radial dose
function and F.r; / is the anisotropy factor. In AAPM TG-43, the recommended value for3
in water is 1.12, which is a round-off value of 1.115. Strictly the TG-43 formalism uses a line
source model for the geometric factor, but the point source model (1=r2) is retained here for
ease of comparison.
Figure 1 shows a straight catheter with an active source dwell length of 2 cm. The dose
rate at the point P , ˙DP , at a distance r of 0.25 cm in water on the transverse bisector of the
2 cm active source length catheter was calculated using equation (1), one at a source step size
† Nucletron BV, Waardgelder 1, 3905 TH Veenendaal, The Netherlands.
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Figure 1. A straight catheter with an active source dwell length of 2 cm for (a) 1 cm source step size
and (b) 0.25 cm source step size. Dose point P is located at 0.25 cm in water from the transverse
bisector of the 2 cm active source length catheter.
of 1 cm and the other at 0.25 cm. The source dwell time, t , at each source stepping position
was assumed to be identical. The dose rate ˙DP is
˙DP D
nX
iD1
d.si/ (3)
where d.si/ is the dose rate to the point P from the source at position si , calculated using
equation (1). Note that in the calculation of d.si/ only the BPS (version 13.X) dose calculation
formalism as shown in equation (1) was used, not the BPS itself.
˙DP was first calculated with the BPS variants, namely ’.r/ and F./. Calculations were
then repeated with either the BPS’s F./ or ’.r/ replaced by the respective Monte Carlo (MC)
calculated F.r; / or g.r/. Note that as the geometric factor is accounted for by (1=r2), radial
dose is equal to the medium’s ‘absorption and scattering’ factor since 3 is numerically equal
to the mean mass absorption coefficient in tissue and air. Calculations were again repeated so
that both the MC calculated F.r; / and g.r/were used. The calculated results were compared
with the results obtained by full Monte Carlo calculations.
3. Results
The Monte Carlo calculated transverse radial dose distribution and the angular dose profiles
˙D.r; /= ˙D.r; =2/ are in good agreement with those obtained by Williamson and Li (1995)
and Dries (1997). Figure 2 shows the variation of the radial dose (dose rate times distance2)
with the distance from the source. This is in effect to compare the Monte Carlo calculated
transverse radial dose, g.r/, with ’.r/ used in the BPS, which is modelled by the Van Kleffens
and Star correction. They are in good agreement except in the near field where the distance is
less than 1 cm from the source centre. In such a near field the Van Kleffens and Star correction
overestimates the radial dose. For example, at a distance of 0.25 cm from the source centre,
’.r/ overestimates the dose by 17.7% compared with the Monte Carlo calculated g.r/.
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Figure 2. Dose rate times distance2 (Gy m2 h−1) in a water phantom (80 cm diameter) per unit
air kerma strength (1 U D 1 Gy m2 h−1) versus distance from the source centre. All results are
absolute with no cross normalization.
The source anisotropy in BPS is taken as radially invariant, based on average values
determined from measurements at 3 cm, 5 cm and 7 cm as reported by Baltas et al (1992).
Figure 3 shows that the anisotropy function implemented in BPS is in good agreement with
the Monte Carlo calculated angular dose profiles at distances of 3 cm, 5 cm and 7 cm from
the source centre. Note that the anisotropy function in the BPS is identical to the angular
dose profile as the geometric factor is modelled by 1=r2. Figure 4 shows the angular dose
profiles at distances of 0.25 cm, 0.5 cm and 1 cm from the source centre. The profiles show
significant variation at distances of 0.25 cm and 0.5 cm from the source centre compared with
the BPS’s anisotropy function. For example, at 160 the BPS anisotropy factor is 0.89 while
the Monte Carlo calculated anisotropy factor is 1.57 and 0.97 at distances r of 0.25 cm and
0.5 cm respectively. This indicates that large errors in dose calculation can be introduced in
the near field (less than 1 cm) due to errors in the anisotropy function as well as in the radial
dose function.
Table 1 summarizes the dose rate at P , ˙DP , calculated using the BPS formalism
(equation (1)) and BPS variants (i.e. ’.r/ and F./) or Monte Carlo variants (i.e. g.r/ and
F.r; /), and compared with the full Monte Carlo calculation. For the 2 cm active source length
catheter with a 1 cm source step size, the dose difference at the point P calculated by the BPS
formalism and variants is +15:4% compared with the full Monte Carlo calculation. With the
source step size reduced to 0.25 cm, the dose difference is reduced to +3:1%. However, when
the BPS’s ’.r/ is replaced with the MC calculated g.r/, the dose difference at P increases to
−7:6%. Similarly, a dose difference of +12:6% is found when only the BPS’s F./ is replaced
with MC calculated F.r; /. When both the MC calculated F.r; / and g.r/ are used, the dose
differences at P are reduced to 1% for source step sizes of both 1 cm and 0.25 cm.
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Figure 3. Monte Carlo calculated polar dose profiles in water at the distances of 3, 5 and 7 cm
from the source centre (normalized to 1.0 at 90) versus the polar angle relative to the source’s
cable. The BPS dose profile is in good agreement with the Monte Carlo results.
Figure 4. Monte Carlo calculated polar dose profiles in water at the distances of 0.25, 0.5 and 1.0 cm
from the source centre (normalized to 1.0 at 90) versus the polar angle relative to the source’s
cable. The BPS dose profile shows large errors with the Monte Carlo results at the distances of
0.25 and 0.5 cm from the source centre.
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Table 1. The dose rate at P , ˙DP , calculated with the BPS formalism and BPS variants or Monte
Carlo (MC) variants compared with full Monte Carlo calculations. The values in brackets indicate
the percentage dose difference with respect to the full MC calculation.
˙DP (cGy h−1 U−1) calculated by the BPS formalism with
Step size Monte Carlo calculated BPS ’.r/ and MC g.r/ and MC F.r; / and MC F.r; / and
(cm) ˙DP (cGy h−1 U−1) BPS F./ BPS F./ BPS ’.r/ MC g.r/
1.0 17.18 19.83 17.08 19.81 17.06
(15.4%) (0.6%) (15.3%) (0.7%)
0.25 45.43 46.83 41.98 51.13 45.92
(3.1%) .−7:6%/ (12.6%) (1.1%)
4. Discussion
A minimum of 5 million source photon histories were simulated using the MCNP 4A Monte
Carlo code, which resulted in a statistical error of approximately 1%. The calculated dose
distribution around the microSelectron 192Ir stepping source agrees to within 2% with the
independent Monte Carlo data calculated by Williamson and Li (1995). Moreover, compared
with the anisotropy factors at a radial distance of 5 cm from the source measured by Mishra
et al (1997), our Monte Carlo results agree to within3% over the entire range of polar angles.
These results justify the accuracy of the Monte Carlo dose calculation for the microSelectron
192Ir stepping source.
Compared with the Monte Carlo results, the dose difference at P as calculated by BPS
has reduced from +15:4% to +3:1% when the step size is reduced from 1.0 cm to 0.25 cm.
This result agrees with the finding by Dries (1997). While Dries (1997) did explain that
this reduction of dose difference was caused by the negative error opposite the source tips
compensating the positive error opposite the source centre, he did not explain the sources of
these positive and negative errors in detail.
At a step size of 1.0 cm, the dose difference of +15:4% is mainly due to errors in the
BPS’s ’.r/ in the near field. When a step size is reduced to 0.25 cm, extra errors of the BPS’s
F./ (in addition to ’.r/) in the near field, as shown in figure 4, are introduced at source
positions close to the point P . The reduction of dose difference at P to +3:1% is caused by
the ‘countering effect’ of these two errors. This is evident when the BPS’s ’.r/ is replaced
with the MC calculated g.r/; the dose difference at P increases to −7:6%. Similarly, a dose
difference of +12:6% is found when only the BPS’s F./ is replaced with the MC calculated
F.r; /.
5. Conclusion
Based on the point source approximation, both the radial dose distribution and source
anisotropy currently used in the BPS algorithm (version 13.X) have errors in the near field
where the distance is less than 1 cm from the source centre. At the point P , using the BPS
formalism and variants the dose difference as compared with the Monte Carlo calculation is
reduced from 15.4% to 3.1% simply by changing the source step size from 1 cm to 0.25 cm.
Note that when using the 0.25 cm step size, source anisotropy error will be introduced in
addition to the radial dose error. It is, therefore, important to emphasize that this reduction in
dose difference is due to the ‘countering effect’ of these two errors. It certainly does not imply
that the dose calculation accuracy has been improved by reducing source step size.
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It is straightforward to modify the BPS formalism to the AAPM TG-43 recommended
formalism as shown in equation (2). Note that the AAPM TG-43 recommends using a line
source model for the geometric function of the HDR stepping source. The geometric factor
of 1=r2, currently implemented in BPS, can still be retained provided that the line source
effect is accounted for by the radial dose function, g.r/, and the anisotropy function, F.r; /.
By replacing both the BPS’s ’.r/ and F./ with MC calculated g.r/ and F.r; /, 1% dose
calculation accuracy can be achieved even in the near field.
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Abstract
Clinical dosimetry for high dose rate (HDR) brachytherapy with a single
stepping source generally neglects the transit dose. This study investigates
the effects of the transit dose in the target volume of an HDR brachytherapy
stepping source. A video method was used to analyse the entrance, exit and the
interdwell transit speed of the source for different path lengths and step sizes
ranging from 2.5 mm to 995 mm. The transit speed was found to vary with
the step size and path length. For the travelled distances of 2.5, 5.0, 10.0, 230
and 995 mm, the average transit speeds were 54, 72, 233, 385 and 467 mm s−1
respectively. The results also show that the manufacturer has attempted to
compensate for the effects of interdwell transit dose by reducing the actual
dwell time of the source. A well-type chamber was used to determine the dose
differences between two sets of measurements, one being the stationary dose
only and the other being the sum of stationary and transit doses. Single catheters
of active lengths of 20 and 40 mm, different dwell times of 0.5, 1, 2 and 5 s and
different step sizes of 2.5, 5 and 10 mm were used in the measurements with the
well-type chamber. Most of the measured dose differences between stationary
and stationary plus interdwell source movement were within 2%. The additional
dose due to the source transit can be as high as 24.9% for the case of 0.5 s dwell
time, 10 mm step size and 20 mm active length. The dose difference is mainly
due to the entrance and exit source movement but not the interdwell movement.
1. Introduction
Dosimetry of high dose rate (HDR) brachytherapy with a stepping Ir-192 source has been
reported in many studies (Williamson and Li 1995, Kirov et al 1995, Muller-Runkel and Cho
1994, Podgorsak et al 1995, Nath et al 1995, Russel and Ahnesjo 1996, Mishra et al 1997,
Dries 1997, Baltas et al 1998, Wallace et al 1998, Wong et al 1999). The results of various
studies have indicated that the dose calculation algorithm for HDR brachytherapy using a
stepping source should conform to the AAPM TG43 formalism (Nath et al 1995).
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Clinical treatment planning for a single stepping source HDR brachytherapy unit generally
neglects the transit dose, in line with the AAPM TG-43 formalism which also neglects the transit
dose. This assumes that clinically significant dose delivery only occurs while the source is
stationary and that the dose is proportional to the dwell time of the source at each dwell
position. However, the source moves with a finite speed and does deposit additional dose
within the target volume as well as along the entrance and exit path. The additional dose
comprises the dose associated with the entry, interdwell and exit of the source and is related to
the speed of the source. This additional dose may be significant for a high-activity source and
small dwell times, as the source transit time may become significant. The investigation of the
transit dose requires measurement of the source speed under various conditions. The validity
of the stationary source dosimetric approximation (i.e. ignoring the source transit dose) can
then be evaluated and appropriate corrections implemented if necessary.
There are limited reports in the literature on the measurement of transient dose or transient
speed of HDR brachytherapy stepping sources. Houdek et al (1992) used an oscilloscope to
count the Nucletron microSelectron HDR (Nucletron BV, The Netherlands) stepping motor
pulses as a measure of source speed. Williamson et al (1994) used a large-volume ion chamber
and Sahoo (1998) used a well-type ionization chamber to measure the source speed from
ionization measurements. The results reported by Williamson et al and Sahoo are not in
agreement with each other. For example, while Sahoo found the speed of the source to be in
the range of 50–172 mm s−1 for source step intervals of 5, 50 and 100 mm, Williamson et al
reported the speed to be in the range of 450–570 mm s−1 for source step intervals of 5, 10
and 20 mm. Bastin et al (1993) measured the transit speed of the microSelectron HDR Ir-192
source to be 452 mm s−1 for a pathlength of 995 mm using a videomonitor and stopwatch, but
their method was not reported. They also measured the transit dose using TLD and reported
that the total transit dose delivered to tissue within or outside the prescribed treatment volume
could exceed a few hundred cGy, but is typically under 100 cGy. DeWerd et al (1995) reported
the use of a well-type ionization chamber as a quality assurance tool and for measurement of
the transit time of the microSelectron HDR stepping source. However, the reported transit
time of 0.39± 0.06 s is the end effect time accounting for the transit of the source to the dwell
position only. It is not the transit time for the complete travel of the source. Hence, the result
cannot be used to evaluate the actual transit dose for different step sizes and path lengths of
the source.
There are few reliable results reported in the literature on transit speed and transit dose of
the HDR stepping source. This leads to difficulties in predicting the significance of transit dose
in situations when the source dwell times are short, especially in situations when high source
activity and multiple-channel implant are involved, for example in the treatment of prostate
cancer where 15 to 18 needles are frequently used.
This paper reports the measurement of the transit speed of the Nucletron microSelectron
HDR Classic Ir-192 stepping source using a video method. A new method of measuring the
transit dose using a well-type ionization chamber was developed to determine how well the
transit dose compensation algorithm in the HDR control console corrects for transit dose in
the target volume.
2. Methods and materials
2.1. Stationary and dynamic movement of the HDR afterloader
From the information given by Nucletron, the maximum travel speed of the microSelectron
HDR Ir-192 stepping source is 500 mm s−1. The step size is 0.25 mm for the stepping motor
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for both an in or out drive. Both values correlate to a 500 µs period (2000 Hz) for each pulse.
Along each trajectory the source travels, one-fifteenth of the transit pathlength is used for
acceleration and one-fifteenth is used for deceleration. The acceleration and deceleration is
achieved by increasing or decreasing the pulse frequency of the stepping motor.
During a short trajectory the maximum speed of the source is lowered to avoid overshoot.
For step sizes of 2.5, 5 and 10 mm the frequency of the motor pulses is approximately 1136 Hz,
which results in a speed of 284 mm s−1. So the times taken for moving the distance of 2.5, 5
and 10 mm are 8.8, 17.6 and 35.2 ms respectively. The dwell time at each dwell position is
modified by the HDR control console algorithm to compensate for transit dose. We describe
this time difference to be the transit dose compensation time. Therefore, the actual dwell
time will be the planned dwell time minus the transit dose compensation time. The maximum
transit dose compensation time is 100 ms, because for interdwell times greater than 100 ms,
the internal clock drive is reset. Therefore, for n dwell positions with a programmed dwell
time of Ti and transit speed of vi in between the dwell positions, the actual dwell times, in
seconds, are (Williamson et al 1994)
T1 −min
(
0.1,
δx1
v1
)
, . . . Tn−1 −min
(
0.1,
δxn−1
vn−1
)
, Tn. (1)
2.2. Video method
A video camera (JVC Videomovie GR-S707) was used to capture the source movement in a
6 French flexible and transparent endobronchial catheter (Lumencath, Nucletron) along with
a digital stopwatch of 0.01 s resolution placed next to the catheter. The shutter speed of the
camera was set at 1 ms. The catheter was connected to the HDR afterloader with an indexer
length of 995 mm. The speed of the source was measured while it travelled through distances
of 995, 230, 10, 5 and 2.5 mm. A video player (JVC HR-55520 AM) was used to replay the
captured source movement in a frame-by-frame motion.
To measure the source speed while it travelled a path length of 995 mm, the source was sent
to the most distal dwell position, which is at 995 mm from the indexer of the HDR afterloader,
for a dwell time of 1 s. The catheter was kept straight to minimize any drag effects. To achieve
the best resolution of the source movement and display of the stopwatch, the maximum length
of the catheter that the camera could capture was approximately 300 mm. The video camera,
therefore, was positioned to capture the movement of the source at the middle portion of the
catheter over a length of 230 mm. Therefore, the recorded speed was the maximum speed that
excluded the acceleration and deceleration of the source. Six measurements were taken—three
for entry and three for exit source movement.
To measure the source speed for travelling a distance of 230 mm, the source was sent to
995 mm and 765 mm positions, with a dwell time of 1 s at each position. The captured image
of the source movement in this case would include acceleration and deceleration of the source.
Six measurements were taken—three for entry and three for exit source movement.
To measure the source speed while it travelled distances of 10, 5 and 2.5 mm the source
was sent to an initial dwell position of 915 mm and then stepped to 995 mm in the required
steps. The dwell time at each dwell position was set to be 2 s and the measurement was
repeated with dwell times of 5 and 10 s.
2.3. Well-type chamber method
A well-type ionization chamber (PTW type no 077.091) (dimensions: height 150 mm, diameter
93 mm, insert height 160 mm, insert diameter 32 mm) was used to measure the total charge
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due to the stationary dose alone and the total charge due to the stationary and transit doses
for a particular active length, step size and dwell time of the stepping source. The ionization
chamber was calibrated to measure air kerma strength and from which dose could be calculated.
However, in the present work only the proportionality of charge and dose is required.
The standard Perspex insert, which was supplied with the well-type ionization chamber,
was used in the measurement to provide reproducible and stable measurement geometry. The
ionization chamber was connected to an electrometer (NE Doseleader) with a polarizing voltage
of 300 V. The Perspex insert and its connecting catheter, which in turn was connected to the
indexer of the HDR afterloader, was used in the measurements. When the source was sent to
the 830 mm position, which was the position of maximum response in the well-type chamber,
the source was at a distance of 61 mm from the bottom of the well.
For the measurement of the total charge contributed by the stationary dose alone, the source
was sent to the dwell positions from the indexer length of 810 mm to 850 mm. At each dwell
position, the dwell time was programmed to be at least 100 s so that at least two measurements
were taken with the source stationary at the dwell position. The measured charge at each dwell
position did not contain any transit dose component. This was because measurement of the
charge collected by the well-type chamber was only started when the source was stationary in
the dwell position. The built-in timer of the electrometer, which had been validated with a stop-
watch, was used in these measurements. The stop time of the electrometer was set to be 20 s for
each measurement to obtain the charge per second at each stationary dwell position. The mea-
surements were repeated at the next dwell position, which was 2.5 mm from the previous one.
The same set-up for the stationary dose measurement was used for the measurement of
the entry and exit components of the transit dose, except that the electrometer was started for
charge measurement as soon as the source was about to leave the HDR afterloader. For the
measurement of entry and exit charges at 850 mm and 810 mm, the source was sent to the two
dwell positions, marked as position A and B respectively as shown in figure 1. The source was
first programmed to dwell at B for T1 = 5 s and the charge was measured, QT 1(B). Three
measurements were taken and the average reading was noted. Measurements were repeated
for a dwell time of T2 = 10 s at B, QT 2(B). For the source position A, the same measurements
as for B were taken for dwell times of 5 and 10 s at A. Assume Qx and Qy are the transit
charge from the safe of the HDR afterloader to B and A respectively and Qa(t), Qa(2t), Qb(t)
and Qb(2t) are the stationary charge at A and B for time t and 2t . At position B:
2Qx + Qb(t) = QT 1(B) (2)
2Qx + Qb(2t) = QT 2(B). (3)
Using the above equations and assuming 2Qb(t) = Qb(2t), the entry and exit charges at 810
and 850 mm can be found. The same method was used for measurement of the entry and exit
charges at 820 and 840 mm. In these measurements A would be 840 mm and B would be
820 mm.
Using the same set-up as the above, the total charge contributed by the stationary and transit
doses (i.e. stationary, entry, interdwell and exit) was measured. Again, the electrometer was
started for charge measurement as soon as the source was about to leave the HDR afterloader.
Therefore, the integral charge measured by the electrometer was the total charge from the
dwell positions as well as during source transit. The active lengths used in the measurement
were either 40 mm (850–810 mm) or 20 mm (840–820 mm), with different source step sizes
ranging from 2.5 mm to 10 mm and a dwell time of 5 s at each dwell position. Measurements
were repeated with shorter dwell times of 2, 1 and 0.5 s. The results were used to compare the
measured total charge given from the stationary dwell positions only, with an identical active
length, step size and dwell time.
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Figure 1. A sketch of the measurement of entry and exit charges at two dwell positions, A and B.
The distances x and y are the indexer length at position B and A respectively.
3. Results
3.1. Video method
Using the video method the average transit speeds were 54 ± 23 mm s−1, 72 ± 16 mm s−1
and 233 ± 73 mm s−1 for step sizes of 2.5, 5.0 and 10 mm respectively. The average transit
speeds for the source to travel the distances of 230 mm and 995 mm were 385± 7 mm s−1 and
529± 15 mm s−1 respectively. The uncertainties in the measurements of the transit speeds are
in the measurement of the source position and the reading of the time display of the stopwatch.
The measured 529 mm s−1 for the travelled distance of 995 mm was the maximum speed,
and it did not include the acceleration and deceleration of the source as the video camera
only captured the source movement at the middle portion of the catheter. Assuming constant
acceleration, one-fifteenth of the distance for acceleration and one-fifteenth for deceleration,
the actual average source speed to travel the distance of 995 mm is computed to be 467 mm s−1.
The results also showed that the dwell time of the source at each dwell position was reduced
by the time taken for the source during transit to compensate for the transit dose. For example,
for a source step size of 5.0 mm and a planned source dwell time of 2 s, the measured average
dwell time was 1.93± 0.01 s with an average transit dose compensation time of 0.07± 0.01 s.
3.2. Well-type chamber method
The response of the well-type chamber over the dwell positions from 810 mm to 850 mm, which
is expressed in the unit ofµC s−1 per air kerma strength (cGy m2 h−1), is shown in figure 2. The
measured charge at each dwell position does not contain any transit dose component and the
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Figure 2. Response of the well chamber, which is the ratio of the measured stationary charge per
second to the source air kerma source, over the dwell positions (indexer lengths) from 810 mm to
850 mm.
Table 1. Well chamber measured stationary charges for the two active lengths of 40 mm
(810–850 mm) and 20 mm (820–840 mm), with different step sizes ranging from 2.5–10 mm
and different source dwell times of 5, 2, 1 and 0.5 s.
Active length (mm) Step size (mm) Dwell time (s) Measured charges (µC)
40 10 5.0 0.9330
2.0 0.3732
1.0 0.1866
0.5 0.0933
20 10 5.0 0.5662
2.0 0.2265
1.0 0.1132
0.5 0.0566
5 5.0 0.9450
2.0 0.3780
1.0 0.1890
0.5 0.0945
2.5 2.0 0.6809
1.0 0.3404
0.5 0.1702
measured charge is proportional to the dose. From figure 2 the stationary charge component
at each dwell position for any dwell time and active length can be calculated.
Table 1 summarizes the stationary charge obtained from figure 2 for the two active lengths
of 40 mm (810–850 mm) and 20 mm (820–840 mm), with a different step size ranging from
2.5–10 mm and different source dwell times of 5, 2, 1 and 0.5 s.
The combination of the entry and exit components of the transit charge measured by the
well-type chamber for the active lengths of 40 mm (810–850 mm) and 20 mm (820–840 mm)
were 0.0134 and 0.0157 µC respectively for a source air kerma strength of 3.4902 cGy m2 h−1.
The stationary and interdwell charge components can be calculated by deducting the entry and
exit components of the transit charge from the measured total stationary plus transit charge
for these two active lengths. Table 2 compares the percentage differences between the charge
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Table 2. Percentage differences between the stationary charge (stat) alone to the charge of
(stat + total transit) and to the charge of (stat + interdwell) for the two active lengths of 40 mm
(810–850 mm) and 20 mm (820–840 mm), with different step sizes ranging from 2.5–10 mm and
different source dwell times of 5, 2, 1 and 0.5 s. Percentage difference is defined as [stat−(stat+total
transit)]/stat or [stat−(stat + interdwell)]/stat. The total transit charge comprises entry, interdwell
and exit charges.
% Difference % Difference
Active length Step size Dwell time stat versus (stat+ stat versus (stat+
(mm) (mm) (s) total transit) interdwell)
40 10 5.0 −1.2 0.2
2.0 −3.3 0.3
1.0 −7.1 0.1
0.5 −14.0 0.3
20 10 5.0 −1.9 0.9
2.0 −5.4 1.5
1.0 −11.6 2.2
0.5 −24.9 2.8
5 5.0 −1.1 0.6
2.0 −3.0 1.2
1.0 −6.6 1.7
0.5 −12.7 3.9
2.5 2.0 −1.9 0.6
1.0 −3.4 1.2
0.5 −7.5 1.8
for the stationary component alone with the charge for (stationary + entry + interdwell + exit),
and to the charge for (stationary + interdwell). The former can be regarded as a comparison
between the dose calculated by most algorithms, where only the doses from stationary dwell
positions are calculated, and the dose actually delivered to patients.
For the percentage difference between the charge for stationary component alone and
the charge for (stationary + entry + interdwell + exit), the differences are negligible when the
dwell times are more than 2 s. The difference increases with a decrease in dwell time. This is
because the stationary dose is related to the dwell time. With a decrease in dwell time for a fixed
active length and step size, the stationary dose component will be reduced compared with the
transit dose component. Therefore, the transit dose component is becoming more significant,
resulting in an increase in charge difference. In an extreme case where the active length is
20 mm, 10 mm step size and 0.5 s dwell time, the dose based on the stationary component
alone underestimates the dose due to stationary and total transit components by 24.9%.
For the percentage difference between the charge for the stationary component alone and
to the charge for (stationary + interdwell), the differences are negligible and are mostly within
2%, with the highest being 3.9%. This is because the dwell time at each dwell position has
been reduced to absorb the transit time of the source; that is, the actual dwell time is the planned
dwell time minus the transit dose compensation time.
4. Discussion
The source speed is approximately proportional to the distance travelled by the source. The
measured maximum speed of the source of 529 mm s−1 matches well with the maximum
speed of 500 mm s−1 claimed by Nucletron. Nucletron also claims that for a shorter distance
the speed will be reduced to 284 mm s−1 to avoid overshoot of the source, but they have not
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specified the actual distance this speed refers to. The results obtained for the smaller step sizes
indicate that the speed is much slower when the step size is reduced to 2.5 mm. The Nucletron
quoted speeds are based on the pulsing of the stepping motor by which the source cable is
driven. The slower speeds obtained from video measurements may be due to mechanical
resistance in the whole driving mechanism of the source cable, and as such they represent
the true speed of the source in travel. The slower speed at small step sizes may contribute a
relatively large transit dose and may cause dose errors if the transit dose is not accounted for.
However, it has been shown that the Nucletron HDR afterloader does attempt to compensate
for the transit dose. This is achieved by reducing the actual dwell time at each dwell position
to absorb the transit time of the source. The maximum transit dose compensation time is
100 ms. The commonly used step sizes for treatment are 2.5, 5 and 10 mm. The average
transit speeds that we measured using the video method for step sizes of 2.5, 5 and 10 mm are
54, 72 and 233 mm s−1 respectively. Therefore, the interdwell transit times for step sizes of
2.5, 5 and 10 mm are 46, 69 and 43 ms respectively. These transit times are well within the
maximum transit dose compensation time of 100 ms. The results in table 2 also show that the
dose differences between the stationary and (stationary + transit) doses are due to the entry and
exit components of the transit dose, but not the interdwell transit.
For the entry and exit components of the transit dose, the average transit speed of the
source is found to be 467 mm s−1. At this high speed, the effect of transit dose can be regarded
as negligible in the planning target volume (PTV) for most clinical cases. For example,
considering an active length catheter of 20 mm, 10 mm step size and dwell time of 5 and 0.5 s,
the doses at 10 mm on the transverse bisector of the 20 mm active length catheter would be
111 cGy and 11.1 cGy respectively, for a source air kerma strength of 3.5898 cGy m2 h−1.
While the dose difference between the stationary dose alone and the stationary plus transit
doses is 24.9% for a dwell time of 0.5 s, the difference for a dwell time of 5 s is 1.9%. For most
endobronchial treatments with HDR brachytherapy, the prescribed dose at 10 mm is much
higher than 111 cGy per fraction. For most brachytherapy implants the dose at the prescribed
points would be typically a few Gy per fraction.
While the effect of entry and exit components of the transit dose may not be clinically
significant for the PTV, they may be significant for tissue residing along the source path
outside the PTV. This would be the case if the HDR treatment involves many fractions or many
applicators in which a large number of source movements to and from the HDR afterloader
are involved. For those cases, the transit dose can be calculated as the transit speed is known.
5. Conclusion
There have been many improvements in the accuracy of dose calculation for HDR
brachytherapy using a stepping source. However, the current HDR brachytherapy treatment
planning systems still only calculate the dose from the stationary dwell positions. The transit
dose from the movement of the source is assumed to be negligible and is ignored. The transit
dose is inversely proportional to the transit speed. It has been found that the transit speed of the
stepping source in the Nucletron microSelectron HDR afterloader increases with the increase
in its distance travelled. If the afterloader does not compensate the interdwell transit dose by
reducing the actual dwell time at each dwell position, the slower speed of the source for step
sizes smaller than 10 mm may create noticeable dose errors in the PTV.
It is found that the transit dose for the microSelectron HDR afterloader is mainly made
up of the entry and exit components, as the interdwell transit dose has been mostly accounted
for by the afterloader itself. The transit speed for the entry and exit movement of the source is
467 mm s−1. With this high transit speed, the transit dose to the PTV is negligible. However,
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the transit dose may be significant for tissue residing along the source path outside the PTV.
Knowing the transit speed of 467 mm s−1 for the source entry and exit movement, the transit
dose to the organs at risk can be calculated if necessary.
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The volume effect of detectors in the dosimetry of small fields
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In this study we investigate the effect of detector size in the dosimetry of small fields and steep dose
gradients with a particular emphasis on IMRT measurements. Comparisons of calculated and mea-
sured cross-profiles and absolute dose values of IMRT treatment plans are presented. As a conse-
quence of the finite size of the detector that was used for the commissioning of the IMRT tool, local
discrepancies of more than 10% are found between calculated cross-profiles of intensity modulated
beams and intensity modulated profiles measured with film. Absolute dose measurements of inten-
sity modulated fields with a 0.6 cm3 Farmer chamber show significant differences of more than 6%
between calculated and measured dose values at the isocenter of an IMRT treatment plan. Differ-
ences of not more than 2% are found in the same experiment for dose values measured with a 0.015
cm3 pinpoint ion chamber. A method to correct for the spatial response of finite-sized detectors and
to obtain the ‘‘real’’ penumbra width of cross-profiles from measurements is introduced. Output
factor measurements are performed with different detectors and are presented as a function of
detector size for a 131 cm2 field. Because of its high spatial resolution and water equivalence, a
diamond detector is found to be suitable as an alternative to other detectors used for small field
dosimetry as there are photographic and photochromic film, TLDs, or water-equivalent scintillation
detectors. © 2003 American Association of Physicists in Medicine. @DOI: 10.1118/1.1544678#
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The concept of intensity modulated radiation therapy ~IMRT!
succeeds in limiting damage to normal tissue, while high
doses can be delivered to target volumes.1,2 This has the
potential to improve local control and tolerance of radiation
therapy. To be able to deliver the planned dose distributions,
intensity profiles are most commonly translated into various
multileaf collimated ~MLC! segments. The delivery of small
segments with at least one dimension smaller than 2 cm is
often required as a result. To be able to calculate dose distri-
butions and monitor units ~MUs! for such small segments
accurately, high-resolution absolute and relative dosimetry is
of great importance. Another problem that occurs as a con-
sequence of the step and shoot technique is that the exact
position of multileaf collimators ~MLCs! depends on the
penumbra calculated in the IMRT planning engine for seg-
ments. An inaccurate calculation of the penumbra can result
in cold or hot spots between two adjacent segments. This is
another reason why it is important to provide IMRT planning
engines with accurate dosimetric data.
In this study we investigate the effect of detector size
~volume effect! in the dosimetry of small fields and of steep
dose gradient regions that are frequently encountered in
IMRT. Calculated and measured absolute dose values and
cross-profiles of IMRT treatment plans are compared. Pre-
sented is the penumbra width of cross-profiles plotted versus
detector size of various different detectors. In order to obtain
the ‘‘real’’ penumbra width of cross-profiles from measure-341 Med. Phys. 30 3, March 2003 0094-2405Õ2003Õ30ments, an established method to correct for the spatial re-
sponse of finite-sized detectors is modified and applied. Out-
put factor measurements are performed with different
detectors and are presented as a function of detector size for
a 131 cm2 field.
II. METHODS
A. Detectors
The dosimetry diode type 60008 ~PTW—Freiburg! is a
p-type Si diode. Because of the high signal-to-noise ratio of
the diode, the effective measuring volume of the detector can
be made small and allows data acquisition with a very good
spatial resolution. The detector features a small sensitive vol-
ume shaped as a disk with an area of 1 mm2 and a thickness
of only 2.5 mm. The relatively high atomic number of silicon
leads to a higher sensitivity to low-energy photons as com-
pared with water. As a consequence, an over-response is ex-
pected for broad beams, where scattered photons contribute a
larger portion of dose. This is, however, not a big problem,
as the detector is designed for narrow photon beams where
the effect is not critical.3 Another disadvantage of single di-
ode detectors is the relatively large directional dependence of
the detector response,3 which is due to the asymmetry inher-
ent in the silicon chip and has a magnitude of about 3%.
Therefore, over-response can be noticed in the low dose re-
gion of profiles measured with a diode for positive lateral
distances to the central axis. The resulting profiles are3413Õ341Õ7Õ$20.00 © 2003 Am. Assoc. Phys. Med.
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difficult to correct for the directional dependence of the di-
ode response, but the effect is minor and can be tolerated.
The advantage of a high spatial resolution is of more rel-
evance.
The radiation-sensitive region of the diamond detector
type 60003 ~PTW—Freiburg! is a low-impurity natural dia-
mond disk of thickness 0.32 mm and volume 3 mm3. This
diamond plate is fixed in a polystyrene housing of diameter
7.3 mm, the surface of the crystal lies 1.0 mm below the top
of the housing. The diamond detector was connected to a
Unidos Universal Dosimeter ~PTW—Freiburg! with an ap-
plied detector bias of 1100 V. After the high voltage was
switched on, a preirradiation of the detector with a dose of
about 5 Gy was performed to settle the response of the dia-
mond at a stable level. Diamond detectors are known to
show a slight sublinearity of the current and dose rate.4,5
Detector current and dose rate are related by the expression
i}D˙ D, where i is the detector current, D˙ is the dose rate, and
D is a correction factor. A correction factor of approximately
0.963 was found for the used diamond detector and applied
to all measured data with the diamond detector similar to
data presented in various studies.4,5
Another detector that is specifically designed for small
field dosimetry is the pinpoint ionization chamber type
31006 ~PTW—Freiburg!. The measuring volume of this ion-
ization chamber is 0.015 cm3. As reported, the chamber over-
responds to low-energy Compton scatter due to its aluminum
electrode. Therefore, the pinpoint chamber is primarily suit-
able for relative dose measurements in small field
dosimetry.6
Other detectors used in this study are the 0.125 cm3 semi-
flex tube type 31002, with a uniform spatial resolution dur-
ing phantom measurements along all three axes and designed
for relative dose measurements, the 0.3 cm3 type 233641 and
0.125 cm3 type 233642 rigid stem chambers, both designed
as reference chambers for absolute dosimetry, the linear ar-
ray LA 48, designed for relative dosimetry, the 0.6 cm3
Farmer-chamber type 30001, designed for absolute dosime-
try, and the Markus chamber type 23343, designed mainly
for electron absolute dosimetry ~all PTW—Freiburg!.
Film measurements were performed in RW-3 solid-water
phantom. Kodak EDR2 films were irradiated with doses of
approximately 180 cGy and scanned with a VXR-12 scanner
~Vidar Systems Corp.!. Calibration data were measured for
each film batch separately and for doses higher than 25 cGy
in 25 cGy increments.
B. Measurements
Two linear accelerators were deployed: an Elekta Sli plus
linear accelerator with 6 and 15 MV x rays and an Elekta Sli
plus linear accelerator with 6 and 18 MV x rays. All detector
measurements were carried out in an MP3-water tank
~PTW—Freiburg! or in a 30330323 cm3 solid-water phan-
tom. Absolute dose measurements were performed with a
Unidos Universal Dosimeter with an applied detector bias of
300 V. Ionization chambers were calibrated at room tempera-Medical Physics, Vol. 30, No. 3, March 2003ture, using a reference system with a radioactive emitter for
measuring pressure and temperature. Therefore a tempera-
ture correction factor, allowing for the difference between
water and room temperature, was required. Unless stated oth-
erwise, detectors were always positioned at the central beam
axis of a photon beam with gantry angle zero degree normal
to the surface of the water phantom.
1. Profile and dose measurements for IMRT beams
To emphasize the importance of high-resolution dosime-
try in IMRT, prostate treatment plans with five equally
spaced 18 MV photon beams were generated in the treatment
planning system Pinnacle ~ADAC, Milpitas! with the IMRT
tool Orbit ~RaySearch Laboratories, Sweden!. Each beam
had a field size of about 12312 cm2 and between three and
seven step and shoot segments. For the commissioning of
Pinnacle, the required water phantom measurements across
the beam profiles at different depths were carried out with a
standard 0.125 cm3 ionization chamber type 31002. Because
of the volume effect of this ion chamber, the penumbra of
measured profiles is broadened compared to the ‘‘real’’ pen-
umbra of the beams. As a result, the penumbra of profiles
calculated in Pinnacle is also expected to be broadened, since
the measured data are used for beam modeling in Pinnacle.
After the IMRT planning process on the CT dataset of a
patient, the prostate treatment plans were mapped to the CT
dataset of a 30330323 cm3 solid-water phantom. In the
phantom the dose distribution was recalculated for each im-
ported intensity modulated beam separately, with the gantry
angle of all beams set to zero degrees. For comparison with
the dose calculations in Pinnacle, Kodak EDR2 film mea-
surements were performed at a depth of 5 cm in the solid-
water phantom. The MLC positions were validated before
film measurements. The phantom was positioned with its
geometrical center at the isocenter position and irradiated
with the step and shoot segments of the intensity modulated
photon beams. To minimize artefacts caused by inaccuracies
in the reproducibility of the MLC positioning, each film was
irradiated with the same intensity modulated beam twice. All
data from the film measurements were imported into the RIT
113 software tool ~Radiological Image Technology, Inc.!.
The dose cube calculated with a 2 mm grid size in Pinnacle
was also imported into RIT and compared to the measured
film data. In addition, absolute dose measurements were car-
ried out at the center of the solid water phantom with a
Farmer chamber and with a pinpoint chamber.
2. Penumbra measurements
The volume effect of detectors was investigated by the
determination of the penumbra width with different detec-
tors. The size of a detector was defined as the geometrical
dimension of the measuring volume in the scan direction.
Measured profiles were normalized to a relative dose value
of 50% at the point of inflection in the penumbra region. To
produce a sharp penumbra, a rectangular 153837 cm3 cer-
robend block was aligned in the transverse ~A–B! direction
and attached to a block tray with one edge at the center of a
343 W. U. Laub and T. Wong: The volume effect of detectors 34315 MV photon beam. A SSD of 110 cm was set and mea-
surements were performed at the depth of maximum dose
dmax of 27 mm. To achieve the best possible spatial resolu-
tion, the diamond detector was oriented with its axis in the
scan direction. The diamond detector was also used with its
axis perpendicular to the water surface. The 0.125 and 0.3
cm3 rigid stem chambers type 233641 and 233642 were both
used with their detector axis in the scan direction and per-
pendicular to the scan direction. The linear array LA 48 and
the Markus chamber type 23343 were used with their flat
surface parallel to the water surface.
Inaccuracies in the determination of the ‘‘real’’ penumbra
width of profiles as a result of the finite-sized measuring
volume of detectors have been reported earlier.7,8 Garcia-
Vicente et al.8 have presented an experimental method for
the determination of the spatial convolution kernel of detec-
tors. They mathematically describe the effect of the finite
size of any detector as the convolution of a kernel K(x)
representative of a measuring system with the real profile:
Dm~x !5E
2‘
1‘
D~u !K~u2x !du ,
where D(u) represents the real profile of a beam and Dm(x)
is the measured profile. The authors use the scanned profile
of a step function to determine the kernel of the densitometer
system. Next, film is exposed with an x-ray beam from a
linear accelerator and scanned. By deconvolution of the mea-
sured profiles with the known kernel of the densitometer
system, the real profiles are derived. Once the real profiles
are known, they can be used to determine the kernels of other
measuring devices. The major disadvantage of this method is
that it makes film measurements necessary to correct ioniza-
tion chamber measurements. Photographic films have a high
spatial resolution, but the calibration curve can be slightly
different for each film and an over-response of low dose
values in the penumbra region can occur as a result of an
energy dependence of the used film.9,10 Hence, a detailed
study of the properties of the film material and of the used
film scanner is necessary to achieve accurate dosimetric re-
sults with photographic films. We therefore modified the
method of Garcia-Vicente et al. and present a method to cor-
rect for the spatial response of finite-sized detectors and to
obtain the ‘‘real’’ penumbra width of cross-profiles from
measurements with ionization chambers and without film
measurements.
3. Output factor measurements
Output factors for fields with sizes between 131 and
15315 cm2 were measured with the dosimetry diode and the
diamond detector, as well as with the pinpoint chamber, the
0.125 cm3 semiflex tube and the Farmer chamber. The size of
a detector was defined as the maximum of the geometrical
dimension of the measuring volume in the gantry–couch
~G–T! and transverse ~A–B! direction. Output factors were
defined as the ratio of the dose at a reference depth for a
given field to the dose at the same depth for a 10310 cm2
field. To avoid dose from electron contamination of the pho-Medical Physics, Vol. 30, No. 3, March 2003ton beam at the measuring depth, a measuring depth of 10
cm was chosen as the reference depth with a SSD of 100 cm.
Output factor measurements were performed with 6 and 15
MV photon beams. The Monte Carlo system EGS4/BEAM was
used to model the 6 MV photon beam of the Sli accelerator.
Individual component modules that are available with the
code and data provided by the manufacturer were used to
model the beam.11,12 Output factors were obtained from
Monte Carlo simulations for field sizes between 131 and
10310 cm2 and for different voxel sizes of 1 and 5 mm, as
defined in the irradiated water phantom used in the simula-
tions. More details about the output factor measurements and
Monte Carlo simulations in this study are given in Haryanto
et al.13
To investigate the volume effect for output factor mea-
surements in small fields, which leads to an averaging of the
dose across the detectors volume, profiles of a 131 cm2 field
were measured at 15 mm dmax with a dosimetry diode. A
good fit for the measured profiles in G–T and in A–B direc-
tion was found with a Gaussian curve. In general, average
values of a three-dimensional Gaussian function f (x ,y) can
be calculated using the equation
f ~x ,y !5 ** f ~x ,y !dx dy
**dx dy .
If g(x) is the best Gaussian fit function for the profiles mea-
sured in the G–T direction and h(y) the best Gaussian fit
function for the profiles measured in the A–B direction, we
can write
f ~x ,y !5 12ps1s2 e
~21/2!~x2/s121y2/s22!
5
1
A2ps1
e ~21/2!~x2/s12! 1
A2ps2
e ~21/2!~y2/s22!5g~x !h~y !.
If we assume that our detectors have a measuring volume
with a dimension of 2a in the G–T direction and 2b in the
A–B direction, it follows that
f ~x ,y !5 *g~x !dx
*dx 
*h~y !dy
*dy
5g~x !h~y !
’
(2a
a g~x !Dx
2a 
(2b
b h~y !Dy
2b .
Dividing 2a into n intervals and 2b into m intervals leads to
2a5nDx and 2b5mDy . As a result, we can form the
equation
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(2a
a g~x !Dx
nDx 
(2b
b h~y !Dy
mDy
5
(2a
a g~x !
n
 (2b
b h~y !
m
54 (0
ag~x !
n
 (0
bh~y !
m
.
Mean values inside an area of the three-dimensional Gauss-
ian function that fit the measured cross-profiles of the 131
cm2 field were calculated with this expression for the geom-
etry of a dosimetry diode, a diamond detector, a pinpoint
chamber, and a 0.125 cm3 ionization chamber.
III. RESULTS AND DISCUSSION
A. Profile and dose measurements for IMRT beams
Figures 1 and 2 show a comparison of cross-profiles cal-
culated in Pinnacle and measured with film for two different
beams of a prostate IMRT treatment plan. The profiles rep-
resent scans in the A–B direction and have different off-axis
distances to the central beam axis. As expected, the penum-
bra of the calculated profiles is broader than the penumbra
measured with film ~Fig. 1!.
Because of the high spatial resolution of film and of the
VXR-12 scanner ~0.2 mm!, the penumbra measured with
film is close to the ‘‘real’’ penumbra of the beam. As men-
tioned before, water phantom measurements were carried out
with a standard 0.125 cm3 ionization chamber for the com-
missioning of Pinnacle, which leads to penumbra broadening
due to the volume effect at regions with high dose gradients.
For conventional treatment planning, this volume effect is of
little importance. The planning target volume ~PTV! gener-
ally has to be encompassed by the 95% isodose line and field
edges must therefore have a margin to the PTV of at least the
penumbra widths. Consequently, the penumbra region is situ-
ated outside the PTV and penumbra broadening will only
FIG. 1. Cross-profiles as calculated in Pinnacle and measured with film for
one beam of an IMRT treatment plan. The profiles represent scans in the
A–B direction and have an off-axis distance to the central beam axis of
0.5 cm.Medical Physics, Vol. 30, No. 3, March 2003lead to an overestimation of dose values in a small volume of
surrounding tissue. However, for IMRT with step and shoot
delivery, the situation is different. Intensity modulated beams
are composed of a number of step and shoot segments. Seg-
ments can have a small field size and their field edges are
often situated inside the PTV. As shown in Fig. 2, this can
lead to local differences between calculated and measured
dose values of more than 10%. Although no further investi-
gations have been made in the study to determine the clinical
effect of inaccurate dose calculations in the penumbra region
of beam segments, it is reasonable to suggest that such dif-
ferences may be of clinical significance.
In Fig. 3, the deviation between absolute point dose val-
ues calculated in Pinnacle and dose values measured with a
Farmer chamber and a pinpoint chamber are plotted for all
five beams of a prostate IMRT treatment plan. Deviations of
measurements using the pinpoint chamber are much smaller
than deviations of measurements using the Farmer chamber.
FIG. 2. Cross-profiles as calculated in Pinnacle and measured with film for
one beam of an IMRT treatment plan. The profiles represent scans in the
A–B direction and have an off-axis distance to the central beam axis of
2.5 cm.
FIG. 3. The deviation between absolute dose values calculated in Pinnacle
and measured with a Farmer chamber and a pinpoint chamber for all five
beams of a prostate IMRT treatment plan.
345 W. U. Laub and T. Wong: The volume effect of detectors 345Maximum differences of less than 2% are found for the pin-
point chamber, while differences of more than 6% can be
found for the Farmer-chamber measurements. The larger
measuring volume of the Farmer chamber in comparison to
the small measuring volume of the pinpoint chamber ex-
plains why high dose gradients in the proximity of the effec-
tive measuring point can lead to an over- or underestimation
of dose values. This volume effect of the Farmer chamber
could lead to inaccurate conclusions upon clinical verifica-
tion of IMRT plans. The possibility of calculating a volume
dose value in Pinnacle instead of a point dose to account for
the volume effect of the Farmer chamber was not investi-
gated.
B. Penumbra measurements
Figure 4 shows the lateral distance between the 50% dose
value and various other dose values ~ranging from 10% to
90%! in the penumbra region of a beam profile. These mea-
surements were made using several different detectors. The x
axis reflects both detector size and orientation: ~a! the dia-
mond with its axis in the scan direction, ~b! the diamond
with its axis perpendicular to the water surface, ~c! the linear
array LA 48, the 0.125 cm3 rigid stem chamber with its de-
tector axis ~d! in the scan direction, and ~e! perpendicular to
the scan direction, the 0.3 cm3 rigid stem chamber with its
detector axis ~f! in the scan direction, and ~g! perpendicular
to the scan direction, and ~h! the Markus chamber. With de-
creasing detector size, the measured penumbra width and
therefore the distance to the point of inflection decreases.
Linear fit curves are plotted for each relative dose value. No
data obtained from detectors with a detector size of 3 mm or
FIG. 4. The lateral distance between the 50% dose value and various other
dose values ~ranging from 10% to 90%! detector size. The x axis reflects
both detector size and orientation: ~a! the diamond with its axis in the scan
direction, ~b! the diamond with its axis perpendicular to the water surface,
~c! the linear array LA 48, the 0.125 cm3 rigid stem chamber with its detec-
tor axis ~d! in the scan direction and ~e! perpendicular to the scan direction,
the 0.3 cm3 rigid stem chamber with its detector axis ~f! in the scan direction
and ~g! perpendicular to the scan direction, and ~h! the Markus chamber. For
each relative dose value, linear fits are plotted.Medical Physics, Vol. 30, No. 3, March 2003better were used to find the best linear fit curve. Neverthe-
less, confidence values of 0.99 and higher are found for the
fit curves and indicate that the linear dependency between
the distance to the point of inflection and the size of the
detector is very strong. Discrepancies between the linear fit
curves and the measured distances can only be noticed for
the 10% and 20% dose values measured with the diamond
detector positioned with its axis in the scan direction, and for
the 10%, 90% dose values measured with the diamond de-
tector positioned with its axis perpendicularly to the water
surface. Dose gradients are lower in the high- and low-dose
regions of the penumbra and as a result small differences in
the measured dose can lead to relatively large differences in
the distance to the point of inflection. Hence, the reconstruc-
tion of the ‘‘real’’ penumbra of profiles is possible by a linear
extrapolation of the data of penumbra measurements with
detectors that do not have a high spatial resolution and are
not primarily designed for relative dose measurements.
A good agreement between the reconstructed penumbra
region and the penumbra region measured with the diamond
detector is found in Fig. 5 as a consequence, if the diamond
detector is oriented with its axis in the scan direction to
achieve the best possible spatial resolution. In agreement to
the results in Fig. 4, differences can only be noticed for dose
values in the shallow part of the penumbra region. Results of
measurements performed with the diamond detector, oriented
with its axis perpendicular to the water surface, and with a
0.3 cm3 ionization chamber, oriented with its axis in the scan
direction, are also plotted in Fig. 5. Large discrepancies can
be noticed between the measurements and the reconstructed
penumbra region, which emphasizes the importance of a
high spatial resolution in regions with high dose gradients.
Our results show that a reconstruction of the real penum-
bra width of beams is possible with a linear extrapolation, if
measurements are performed with different detectors or de-
tector orientations. Once the real penumbra is known, the
kernel K(x) representative of a measuring system can be
FIG. 5. Reconstructed penumbra region of a half-blocked 15 MV photon
beam, corrected for the volume effect of finite-sized detectors. The penum-
bra region is also plotted as measured with ~a! the diamond detector with its
axis in the scan direction, ~b! the diamond detector with its axis perpendicu-
lar to the water surface, and ~c! the 0.3 cm3 rigid stem ionization chamber
with its detector axis in the scan direction.
346 W. U. Laub and T. Wong: The volume effect of detectors 346derived for all used detectors and measured profiles can be
corrected, as described by Garcia-Vicente et al.8 However, in
contrast to Garcia-Vicente et al., no film measurements are
required with the modified method for the determination of
the spatial convolution kernel of detectors. This can be an
advantage, since determining the real penumbra width of
beams from film measurements can be problematic if the
used film has an over-response to low-energy photons. Ac-
curate film dosimetry is also very time consuming.
C. Output factor measurements
Another important aspect of small field dosimetry is the
measurement of output factors. For field sizes larger than
10310 cm2, the pinpoint chamber overestimates output fac-
tors due to its over-response to low-energy Compton
scatter.12 For field sizes smaller than 333 cm2, significant
differences of measured output factors can be found among
different detectors.13 If measured with a diode detector,
which is non-water-equivalent, the increase of the impor-
tance of secondary electrons in small fields leads to an over-
estimation of output factors. If measured with ionization
chambers, the reason for an underestimation of output factors
is the increase of lateral electron disequilibrium with an in-
crease of the detectors measuring volume. Another reason for
differences is the volume effect of detectors. In this section
we investigate the importance of the volume effect in the
measurement of output factors of small fields for different
detectors.
Figure 6 shows output factors of a 6 and 15 MV photon
beam versus detector size for a 131 cm2 field. A quadratic
function was used to fit the output factors measured with a
dosimetry diode, a diamond detector, a pinpoint chamber and
a 0.125 cm3 ionization chamber. The detector size of the
Farmer chamber that was used is 26 mm. Output factors
FIG. 6. Output factors of a 6 and 15 MV photon beam versus detector size
for a 131 cm2 field. With increasing detector size, a dosimetry diode, a
diamond detector, a pinpoint chamber, a 0.125 cm3 ionization chamber, and
a Farmer chamber. Mean values from inside an area of the three-
dimensional Gaussian function that fits the measured cross-profiles of the
131 cm2 field were calculated for the geometry of the different detectors.
Quadratic fit curves are plotted for the measured output factors and for the
resulting mean values.Medical Physics, Vol. 30, No. 3, March 2003determined with the Farmer chamber for both photon ener-
gies are plotted on the quadratic fit curves, at 12 mm for 6
MV and 11.4 mm for 15 MV ~Fig. 6!. The 131 cm2 field
blocks a large part of the measuring volume, but, obviously,
a slightly larger part of the measuring volume contributes to
the measured dose value if the detector is irradiated with the
6 MV photon beam due to lateral scatter.
The cross-profiles of a 131 cm2 field were measured at
dose maximum with a dosimetry diode ~Fig. 7!. Mean values
inside an area of the three-dimensional Gaussian function
that fits the measured cross-profiles of the 131 cm2 field
were calculated for the geometry of a dosimetry diode, a
diamond detector, a pinpoint chamber, and a 0.125 cm3 ion-
ization chamber. The determined mean values and a qua-
dratic function that fits these values are added to Fig. 6. The
Gaussian function was normalized to a maximum value of
0.68, in agreement to the output factor determined with
Monte Carlo simulations for the 6 MV photon beam.13
The quadratic fit curves of the measurements and of the
mean values are different. This is expected, since the deter-
mined mean values simply reflect the volume effect, while
the detector measurements also reflect other influences. The
small differences between the correct output factor and the
output factor that was measured with the diamond detector,
which is water equivalent and has a very high spatial reso-
lution, can be explained with the volume effect. The overes-
timation of the output factor, as measured with the diode
detector, is a result of the non-water-equivalent material sur-
rounding diode detectors, and was investigated in detail by
Haryanto et al.13 As a consequence, the extrapolation of the
quadratic fit curves for a detector size of 0 mm that result
from measurements leads to an overestimation of the correct
output factor.
For ionization chambers the importance of the volume
effect is relatively small ~Fig. 6!. With increasing measuring
volume, the volume effect increases, but its importance rela-
tive to the total underestimation of the output factor de-
creases. The main reason for an underestimation of the cor-
FIG. 7. Cross-profile of a 6 MV photon beam with a field size of 131 cm2
as measured at the 15 mm dose maximum and in the A–B direction with a
dosimetry diode. The best Gaussian fit curve is plotted.
347 W. U. Laub and T. Wong: The volume effect of detectors 347rect output factor is the increase of lateral electron
disequilibrium with an increase of the detectors measuring
volume. Consequently, if corrections are applied, they prima-
rily need to correct for lateral electron disequilibrium, not so
much for the averaging of the dose across the detector vol-
ume. In general, it can be concluded that both spatial reso-
lution and water equivalence of the detector are important for
output factor measurements in small fields.
IV. SUMMARY AND CONCLUSION
In this study we deal with the importance of accurate
absolute and relative dose measurements, with particular em-
phasis on quality assurance measurements in IMRT. Mea-
surements at the isocenter of an IMRT treatment plan were
performed in a phantom with a 0.6 cm3 Farmer chamber.
Significant differences of more than 6% were found between
calculated and measured absolute dose values. In contrast,
differences of less than 2% were found in the same experi-
ment for dose values measured with a 0.015 cm3 pinpoint ion
chamber. This volume effect of the Farmer chamber could
lead to inaccurate conclusions upon clinical verification of
IMRT plans. Because of the insufficient spatial resolution of
the detector that was used to collect beam data for the com-
missioning of the IMRT planning tool, local relative discrep-
ancies of more than 10% were found between calculated
cross-profiles and profiles measured with film. The results
demonstrate that the commissioning of IMRT treatment plan-
ning tools with detectors that have a limited spatial resolu-
tion can lead to the introduction of systematic errors. Re-
quirements for both the commissioning of clinical IMRT
planning tools and the quality assurance procedures in IMRT
should therefore be similar to the requirements for stereotac-
tic treatment planning and delivery. The MLC positioning
and reproducibility of the MLC positioning is equally impor-
tant and requires appropriate quality assurance tests as well.
However, a discussion about MLC quality assurance tests is
beyond the scope of this paper. Further studies are warranted
to investigate the clinical significance of the found discrep-
ancies between IMRT film and treatment plan comparisons.
An established method to correct for the volume effect of
finite-sized detectors in the penumbra region of profiles was
modified so that film measurements are no longer required to
determine the convolution kernel that describes the effect of
the finite size of a detector. As demonstrated in Fig. 4, the
modified method can be applied by extrapolating penumbra
widths measured with detectors with different spatial resolu-
tions.
Output factor measurements with different detectors dem-
onstrate that both spatial resolution and water-equivalence ofMedical Physics, Vol. 30, No. 3, March 2003the used detector are important for output factor measure-
ments in small fields. For ionization chambers, the impor-
tance of the volume effect is small compared to the underes-
timation of the correct output factor that results from lateral
electron disequilibrium. A diamond detector was found to be
suitable for output factor measurements of small fields be-
cause of its water equivalence and high spatial resolution.
Therefore, the diamond detector is a good alternative to other
detectors used for small field dosimetry as there are photo-
graphic and photochromic film, TLDs, or water-equivalent
scintillation detectors.
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